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Abstract 
Post-transcriptional gene regulation (PTGR) processes play a major role in eukaryotic and 
prokaryotic gene expression and mainly act on the mRNA level. Therefore, among other cellular 
processes, PTGR allows cells to react on constantly changing environmental influences, by the 
ability to rapidly adjust internal protein levels. As key players in such regulatory processes, RNA-
binding proteins (RBPs) interact with mRNAs to regulate their maturation, localization, 
translation and decay. Thereby RBPs can directly recognize their RNA target sequences via 
specific contacts with the RNA bases, for example. In other cases, the RBP binds to a short 
fragment of nucleic acids, which guides the RBP-RNA complex to a complementary target 
sequence via Watson-Crick base pairing with the target RNA. Examples for such RNA guides are 
microRNAs (miRNAs), short-interfering RNAs (siRNAs) and P-element-induced wimpy testis 
(Piwi)-interacting RNAs (piRNAs). 
MiRNAs represent a class of small non-coding RNAs (ncRNAs), which are highly conserved in 
biogenesis and function among eukaryotes. After processing of the miRNA from double stranded 
precursors, by a variety of different proteins, including the RNase III enzyme Dicer and its 
double-stranded RNA binding protein (dsRBP) partners, mature miRNAs assemble with 
Argonaute (Ago) proteins into so called miRNA-induced silencing complexes (miRISCs). In this 
study, the processing of the Drosophila melanogaster (Drosophila) Dicer-1 (dmDcr-1) in 
complex with its dsRBP partner Loquacious (Loqs) has been structurally and functionally 
investigated. Loqs contains three different dsRBDs and the crystal structure of the third dsRNA 
binding domain (dsRBD) reveals specific structural elements that are responsible for the 
interaction with dmDcr-1 and a linker preceding the dsRBD3 strongly enhances the affinity of the 
binding. Furthermore, the Loqs-dmDcr-1 complex revealed a 1 to 1 stoichiometry identified by 
single molecule spectroscopy but formed dimers in the absence of dmDcr-1. In consideration of 
the conservation of critical sequence elements, it is likely that dimerization might comprise a 
general feature of dsRBPs in gene silencing. 
Ago proteins, as protein-binding partners of miRNAs, are key players in miRNA-mediated gene-
silencing processes. For their correct function, they require a strict regulation that is supposed to 
be mainly achieved by phosphorylation of specific residues within the sequence of Ago proteins. 
In mass spectrometry (MS) screens, several potential regulatory sites have been reported in 
literature, for example Y593 and S798 within the sequence of Ago2. To be able to investigate the 
kinetical details behind Ago-loading processes of wildtype (wt) and mutant Ago proteins, a 
confocal fluorescence cross-correlation spectroscopy (FCCS) assay was established. Thereby, the 
binding of a fluorescently labeled siRNA duplex to GFP-tagged Ago1-4 and respective mutants 
was investigated. Furthermore kinetic data from different mutations of the potential post-
translational regulatory phospho-sites was measured, providing information on the binding of a 
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siRNA 5’ end within the 5’ binding pocket. Furthermore, the established FCCS assay provides a 
valuable tool for the future analysis of any mutation within the sequence of an Ago protein and its 
influence on Ago-loading processes. 
In the second part of this thesis, the Drosophila RBP brain tumor (Brat), which belongs to the 
conserved NHL-domain containing tripartite motif (TRIM) protein family, has been structurally 
characterized. Brat is responsible for the differentiation of neuronal stem cells by repressing the 
expression of self-renewal factors. Thereby, Brat directly contacts a specific target sequence motif 
on mRNAs, coding for self-renewal factors and is supposed to function as a translational 
repressor. The molecular details for the interaction of Brat with its RNA targets, however, were 
unknown. Therefore, the crystal structure of the Brat NHL-domain in complex with its consensus 
target sequence has been solved at 2.3 Å resolution. The high resolution protein-RNA structure 
reveals several features of sequence-specific substrate contacts of the Brat-NHL domain to its 
consensus RNA motif, adding the β-propeller fold as a novel member to the growing family of 
RBDs. 
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I. Introduction 
For any living cell from all three kingdoms of life, the genetic code is stored within the sequence 
of its own deoxyribonucleic acid (DNA). Since the sequencing of the human genome (Lander et 
al., 2001) it is known that sequences for protein-coding genes make up only 25 % (Introns and 
Exons) of the total DNA. The proportion of Exons, which actually encode for polypeptides, is 
even less with only ~1 % (Figure 1.1 A). The remaining part belongs to other intergenic (22 %) or 
repetitive DNA (53 %). 
To make the information accessible for the cell, it has to be transcribed into a ribonucleic acid 
(RNA) macromolecule by a DNA-dependent RNA polymerase. In eukaryotes, three different 
polymerases have been identified (Roeder and Rutter, 1969) and (Roeder and Rutter, 1970), 
which are distributed to different loci within the nucleus and are responsible for the synthesis of 
diverse RNA species. RNA polymerase I (PolI) is located in the nucleolus where its main function 
is to transcribe the 28S, 18S and 5.8S precursor ribosomal RNAs (pre-rRNAs), which are then 
further processed to mature rRNAs. Although only 6 species exist among that class of RNA, 
rRNAs represent the highest abundance referred to the total RNA mass in the cell (Figure 1.1 B). 
RNA polymerase III (PolIII) is mainly required for the synthesis of transfer RNAs (tRNAs), 
which represent the second most abundant class of RNAs (Figure 1.1, B), the 5S rRNA and 
several other shorter RNA species (e.g U6-, RNaseP- and MRP-, 7SL-, 7SK-, Vault- Y-RNAs, 
reviewed in Dieci et al. (2007)). The main function for RNA polymerase II (PolII) is the 
transcription of protein-coding genes into a precursor messenger RNA (pre-mRNA) transcript. 
Additionally, PolII is required for the transcription of noncoding RNAs, such as small nuclear 
RNAs (snRNAs), miRNAs and piRNAs. 
 
 
Figure 1.1: Schematic overview of the genomic DNA and RNA classes in humans. (A) Genes consisting 
of Introns (24 %) and Exons (1 %) only constitute a small fraction of the human genome. The main part of 
genomic DNA consists of repetitive (53%) and other intergenic DNA (22%). (B) Overview of different 
classes of the RNA transcriptome. Adapted from Krebs et al., (2014) and Jankowsky and Harris, (2015). 
4 
 
Soon after synthesis, the pre-mRNAs are further processed by a specific splicing machinery, 
which removes intron sequences and retains exon sequences containing the genetic information. 
This process is not linear, resulting in only one particular splice isoform of a protein, but can 
exhibit a variety of different isoforms by alternative splicing pathways. The protein coding 
regions located on the mRNA are flanked by two untranslated regions (UTR). The 5’ UTR ranges 
from the start point of transcription to the start codon of translation and harbors the ribosomal 
binding site. Additionally, 5’ UTRs are binding platforms for various regulatory proteins, which 
can influence the stability of the mRNA or regulate translational activity. The 5’ end is capped 
with 7-methylguanosine (m
7
G), which protects the mRNA from 5’->3’ exonucleolytic 
degradation. The 3’ UTR starts directly after the stop codon and harbors a polyadenylation signal, 
which then leads to polyadenylation of the 3’ end of the mRNA. The poly(A) tail is bound by the 
poly(A) binding protein (PABP) that protects the end from degradation and has various additional 
regulatory functions. Compared to the 5’ UTR, the 3’ UTR is more frequently bound by a 
multitude of regulatory proteins which either bind directly or indirectly to that region. As protein 
synthesis is one of the most important biochemical processes this step needs to be strictly 
regulated to provide the possibility to react on various environmental influences. 
 
1. PTGR mediated by RBPs 
PTGR can occur on many RNA transcripts in living organisms. Therefore, cells are provided with 
an extensive repertoire of specific RBPs, which are indispensable for the biogenesis, stability, 
function, transport and cellular localization of functional RNA precursors. In prokaryotes, where 
transcription is directly coupled to translation, the amount of RBPs is rather limited. In 
eukaryotes, however, transcription and translation are spatially separated (nucleus and cytoplasm), 
which creates an additional layer of gene regulation. Hence, the number of RBPs increases 
strongly with the complexity of the organism, which might derive from an evolution of highly 
specific processes to fine-tune gene expression (Anantharaman et al., 2002). A census of human 
RBPs ends up with 1542 different proteins that interact with all known classes of RNAs 
(Gerstberger et al., 2014). PTGR is not restricted to mRNA-associated processes in general, but 
can also be found in processes acting on non-coding RNAs (ncRNAs). In the Online Mendelian 
Inheritance in Man (OMIM) database, which contains information on human genes and genetic 
disorders, there are ~150 annotated RBPs linked to human diseases, where only one third is 
associated with mRNA binding, whereas two third of RBPs act on ncRNAs (Gerstberger et al., 
2014; Hamosh et al., 2005). 
Gene expression of protein coding genes involves transcription, translation and turnover of 
mRNAs and proteins. The expression of a certain mRNA correlates largely with the abundance of 
the encoded protein. However, there is a strong deviation between half-lives of mRNAs and 
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proteins (Schwanhäusser et al., 2011). This emphasizes the meaning of RBP-mediated post-
transcriptional mechanisms that are required for the regulation of mRNAs. Although many RBPs 
have been identified, only a limited number of RNA binding domains have been structurally 
characterized and little is known how binding selectivity and specificity are accomplished. 
Although RNA molecules are single stranded, they are able to form intra- and intermolecular 
double stranded structures by specific base pairing. For PTGR these structures need to be 
recognized by RBPs, which therefore comprise a repertoire of several different RBDs, to 
specifically identify their target sequences on RNAs. The most prominent representatives for 
either single stranded (ss) or double stranded (ds) RNA recognition will be introduced within the 
following paragraphs. 
 
1.1 RBP-RNA interactions 
RBPs are highly specialized proteins for the recognition of certain features from their target RNA 
macromolecules. The driving forces behind this interaction can be as diverse as electrostatic 
interactions of positively charged protein side chains with the negative phosphate backbone of the 
RNA, stacking interactions of aromatic side chains with the aromatic purine or pyrimidine bases 
and specific hydrogen bonds of donor and acceptor groups between the protein and the RNA. 
 
1.1.1 Electrostatic interactions 
Electrostatic interactions play an important role for the interaction between RBPs and their target 
RNAs. Nucleic acids are highly negatively charged molecules, which can be coordinated by 
positively charged protein-surfaces. Salt bridges between two contrary charged molecules 
strongly contribute to the binding affinity and are present in almost every RBP to tightly anchor 
its respective RNA substrate. In some cases, the arrangement of positively charged amino acids 
allows the RBP to recognize characteristic shapes of tertiary RNA structures (Oberstrass et al., 
2006; Stefl et al., 2005). The contribution of electrostatic interactions for sequence-specific 
recognition of RNA molecules, however, is rather limited, as the distribution of charges from 
ssRNA is made up from its sugar-phosphate backbone and therefore independent from its 
nucleotide sequence. Therefore, electrostatic interactions represent the major part of protein-RNA 
contacts in proteins, which function sequence independently. Some examples are RNA 
polymerases (Westover et al., 2004), the DEAD-box protein Vasa (Sengoku et al., 2006) or 
certain viral nucleoproteins (Albertini et al., 2006). 
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1.1.2 π stacking interactions 
Another possibility for the interaction of RBPs with ssRNA is by quadrupole interactions of two 
delocalized electron systems with the positively charged carbon backbone, a so called π-π 
interaction. Thereby aromatic side chains of phenylalanine, tyrosine, tryptophan and histidine in 
RBDs of different RBPs are able to form π-stacking interactions with bases of nucleic acids in an 
parallel orientation with an average distance of ~3.3 Å in between the planes   poner and  ob a, 
2003). For aromatic heterocycles it has been shown that purines are better stacking partners then 
pyrimidines and that stacking of aromatic systems is also strongly influenced on the substitution 
of the aromatic system (Sigrid D. Auweter et al., 2006; Cozzi and Siegel, 1995). Statistical 
comparisons of protein-RNA complexes, however, indicate that stacking interactions are more or 
less equally distributed among all four bases and are mediated most often by phenylalanines on 
the protein side (Allers and Shamoo, 2001). This indicates that aromatic π-stacking interactions 
alone rather contribute to the binding affinity then to sequence-specificity. Single point-mutations 
from aromatic amino acids, which are involved in π-stacking interactions, can influence the 
binding affinities by the magnitude of ~0.2-3x10
3
 (Sigrid D Auweter et al., 2006; Deardorff and 
Sachs, 1997; LeCuyer et al., 1996). 
Another way for the coordination of aromatic heterocycles of the nucleobases, which is similar to 
π-stacking interactions, is the formation of cation-π interactions that are mediated by arginine 
(Arg) residues. Thereby, the planar, positively charged guanidinium group of Arg interacts with 
the aromatic system of RNA bases with the preferential order of U,A,C > G, which allows a 
binding in a more sequence specific manner (Allers and Shamoo, 2001; Gallivan and Dougherty, 
1999; Hudson et al., 2004). 
 
1.1.3 Hydrogen bonds 
Hydrogen bonds play the most important part in specific RNA-sequence recognition of RBPs. In 
a hydrogen bond, two electronegative atoms share a common proton, which is provided by a 
donor group and transferred to an acceptor group with a free electron pair that is capable of 
accommodating a proton. From the protein part, the side chains of tryptophan (Trp), lysine (Lys) 
and arginine (Arg) act as hydrogen-donors, whereas the side chains of aspartate (Asp), and 
glutamate (Glu) as hydrogen-acceptors and side chains of tyrosine (Tyr), serine (Ser), cysteine 
(Cys) threonine (Thr), asparagine (Asn), glutamine (Gln) and histidine (His) can act as both, 
hydrogen-donors and -acceptors. Additionally to side chains, the main chain of proteins can also 
contribute to the formation of hydrogen bonds with nucleotides by its peptide bond, consisting of 
a hydrogen-donor (N-H) and -acceptor group (C=O). The composition of hydrogen-donor and 
acceptor groups varies within different positions of the bases and thus allows a specific interaction 
with the protein backbone by a respective network of hydrogen bonds. The contribution of each 
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single hydrogen bond to the specificity is rather weak. However, taken all hydrogen-bonds 
together gives a substantial proportion to binding affinity between different RNA sequences and a 
protein and thus constitutes its sequence specificity (Sigrid D. Auweter et al., 2006). Different 
factors can influence the strength of a hydrogen bond. Hydrogen bonds, which are embedded in 
an hydrophobic surrounding, are reinforced compared to those which are located in more 
accessible parts of the protein (Deechongkit et al., 2004). Additionally, the exact relative 
geometrical orientation of the hydrogen donor in relation to the acceptor has a strong impact on 
the binding energy of a single hydrogen bond (Chen et al., 2004). 
 
1.2 Some examples for ssRBDs 
RBPs are commonly classified according to their content of RBDs, which are responsible for their 
binding preferences to a target RNA. RBDs are highly conserved across bacteria, archaea and 
eukaryotes (Gerstberger et al., 2014). From the total number of known RBDs, most members are 
associated in mRNPs, which reflects the rapid expansion of mRNA-related processes in the 
evolution of higher eukaryotes, like alternative splicing and polyadenylation (reviewed in: Chen 
and Manley, 2009; Keren et al., 2010). 
The most abundant and best characterized RBD is the RNA-recognition motif (RRM) (Figure 1.2 
A). It is composed of 80-90 amino acids, which form a four-stranded anti-parallel β-sheet flanked 
by two α-helices, resulting in a βαββαβ topology (Oubridge et al., 1994). RNA contacts are 
mediated at the two central strands of the β-sheet by two conserved sequence stretches, namely 
RNP1 with the sequence consensus K/R-G-F/Y-G/A-F/Y-V/I/L-X-F/Y and RNP2 with the 
sequence consensus V/I/L-F/Y-V/I/L-X-N/L. Thereby RRMs contact the phosphodiester 
backbone of RNAs by salt bridges with the conserved Arg or Lys residue and form specific 
interactions with the aromatic amino acids by stacking interactions. The total number of 
nucleotides which were bound by a single RRM ranges from a minimum of two in the cases of 
e.g. CBP20 (Calero et al., 2002; Mazza et al., 2002) to a maximum of eight for U2B0 (Price et al., 
1998). Others than the name might let expect, RRMs do not only interact with RNAs, but can also 
mediate protein-protein contacts, depending on the positions of the α-helices within the topology 
(Crichlow et al., 2008; Tripsianes et al., 2014). 
A second domain, which is found regularly in RBPs, is the K-homology (KH) domain. This 
unique RNA binding fold was first described in the heterogeneous nuclear ribonucleoprotein 
(hnRNP) K and found to be conserved among eukaryotes, eubacteria and archaea (Siomi et al., 
1993). The domain consists of around 70 aas with a functionally important signature sequence of 
(I/L/V)IGXXGXX(I/L/V) close to the center of the domain and is found to bind both RNA and 
DNA target sequences (Braddock et al., 2002; Lewis et al., 2000). The KH domains consist of 
alternating α-helices and β-strands and according to their topology can be assigned to two 
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subfamilies. Type I (Figure 1.2 B) has a βααββα topology and type II (Figure 1.2 C) a αββααβ 
topology (Grishin, 2001). 
Zinc finger proteins (Figure 1.2 D), which are also strongly involved in the interaction with DNA, 
are found to interact with both, ss- and dsRNA as well. The classification of zinc fingers is 
accomplished according to the coordination of a zinc ion by Cys and His residues within the RBD 
(CCCH, CCHC and CCHH). 
The Piwi-Ago-Zwille (PAZ) and Piwi domains (Figure 1.2 E and F) are two kind of RBDs, which 
are generally found in the miRNA biogenesis pathway and are able to specifically recognize their 
substrates in a rather sequence independent manner. The PAZ domain consists of 110 amino acids 
and contains a β-barrel that is structurally similar to the oligonucleotide/oligosaccharide binding 
(OB) domain, where the nucleic acid binding site is located in a hydrophobic cleft between the β-
barrel and a conserved module comprising strands β3, β4 and helix α3 (Lingel et al., 2003; Schirle 
and MacRae, 2012). In the RNase III-type enzyme Dicer, the PAZ domain is responsible for 
substrate recognition and positioning of the RNA prior to cleavage (Macrae et al., 2010). In 
Argonaute (Ago) proteins the PAZ domain anchors the 3’ end of the miRNA. The Piwi domain of 
Ago-proteins has an RNase H fold and binds the miRNA at the 5’end in concert with the middle 
domain (MID) domain. Furthermore it harbors the catalytic DEDH motive, which is required for 
RNase activity (Meister et al., 2004; Nakanishi et al., 2012; Song et al., 2004; Yang and Steitz, 
1995). 
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Figure 1.2: Overview of different single stranded RBDs in complex with RNA. (A) The tandem RRMs 
of Sex-lethal (PDB-ID: 1B7F). (B) Type I KH domain of Nova (PDB-ID: 1EC6) and (C) Type II KH 
domain of NusA (PDB-ID: 2ATW). (D) Two zinc fingers of TIS11d (PDB-ID: 1RGO). (E) The Ago2 PAZ 
and (F) Piwi domains (PDB-ID: 4W5N). For all single pictures, proteins are shown as grey ribbons, 
ssRNAs as cyan sticks and zinc ions as orange spheres. 
 
1.3 The dsRBD fold 
The dsRBD fold is present in many eukaryotic, prokaryotic and even viral RBPs. RBPs function 
in many biological processes, where recognition of dsRNA is required. In the following, some 
examples will be introduced, which make up only a marginal proportion of dsRBDs that were 
described in literature up to date. The Drosophila protein Staufen 1 (STAU1), for example, 
associates with three double-stranded stem-loop structures within the 3’ UTR of bicoid mRNA 
and mediates the transport of the mRNA to the anterior pole of a freshly laid egg (Ferrandon et 
al., 1997, 1994). In humans, a complex of STAU1 and the long non-coding RNA (lncRNA) 
TINCR is required for somatic tissue differentiation (Kretz et al., 2013). Many family members of 
the adenosine deaminase acting on RNA (ADAR) enzymes comprise at least one dsRBD, which 
are followed by a deaminase domain. ADAR is able to specifically recognize and regulate dsRNA 
substrates, which are commonly found in 3’ and 5’ UTRs, intronic retrotransposons like Alu and 
long interspersed elements (LINEs) and also within miRNA precursors (pre-miRNA), by an A to 
I editing (Nishikura, 2006). DsRBDs play another important role in the processing of pre-
miRNAs by Dicer and its partner proteins in a heterodimeric complex. In Drosophila, dmDcr-1 
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contains one dsRBD and its protein partner Loqs three dsRBDs (Bernstein et al., 2001; 
Förstemann et al., 2005). 
The dsRBD fold was first identified in STAU1 from Drosophila and rbpa from X. laevis, where, 
on the basis of binding studies and computational analysis, a consensus sequence of 65-68 aas 
could be identified (St Johnston et al., 1992). Structural analysis of E. coli RNase III dsRBD and 
STAU1 dsRBD3 revealed a conserved fold (See Figure 1.3 A) containing α-helices and β-sheets 
with a αβββα topology (See Figure 1.3 B) (Bycroft et al., 1995; Kharrat et al., 1995). The N- and 
C-terminal α-helices  α1 and α2) stack against a core element consisting of three anti-parallel β-
sheets  β1, β2, β3) through mainly hydrophobic interactions. Thereby, aliphatic side-chains are 
mainly found in the helices α1 and α2 and aromatic residues in the sheets β1 and β2 to 
complement the hydrophobic core. Structural data from complexes of dsRNA and dsRBPs 
indicate that the binding interface is distributed to three conserved regions from the dsRBD (Ryter 
and Schultz, 1998; Yang et al., 2010). Region 1 which is located in helix α1 consists mainly of a 
conserved glutamate. Region 2 is located in a loop region  L2) between β1 and β2 and contains a 
GPxH consensus motif that is required to anchor the dsRNA to the protein. Region 3 is located at 
the beginning of helix α2 and contains highly conserved positively charged residues forming the 
KKxAK consensus motif (Masliah et al., 2013). All three regions act simultaneously to 
specifically recognize an A-form dsRNA helix. E8 from Region 1 (Positions of the amino acids 
within the dsRBD were numbered according to the sequence alignment from Figure 1.3 A) 
thereby interacts with the minor grove of the dsRNA (See Figure 1.3 C). Region 3, with lysines 
K55, K56 and K58 from the KKxAK motif, specifically interacts with the major groove of the 
dsRNA and H31 from the GPxH motif of region 2 anchors the protein to the dsRNA by 
interacting with the succeeding minor groove. 
Mutations in this regions strongly impact the affinity of the dsRBD to dsRNA and a triple mutant, 
where H31, K55 and K58 are mutated to Ala, even completely abolishes the affinity to a dsRNA 
substrate (Yamashita et al., 2011). 
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Figure 1.3: Characteristics of the dsRBD fold. (A) Sequence alignment of several dsRBDs from 
Drosophila melanogaster (Dm), Homo sapiens (Hs), Xenopus leavis (Xl), Saccharomyces cerevisiae (Sc), 
Arabidopsis thaliana (At), Escherichia coli (Ec) and Aquifex aeolicus (Aa). The names and positions of the 
dsRBDs and the accession code in the UniProt database (http://www.uniprot.org) are listed in front of the 
sequence. Important conserved residues for the folding and RNA binding are highlighted in grey, important 
residues from the RNA binding consensus motives in green. Adapted from Masliah et al., (2013). (B) 
Schematic overview of the dsRBD fold. Three antiparallel β-sheets (β1-3) are flanked by two helices (α1 
and 2) and connected by four loops (L1-4). (C) Structure of the second dsRBD from TRBP in complex with 
dsRNA (PDB-ID: 3ADL). Important residues for the interaction are highlighted in green as in (A). 
 
The dsRBD2 of X. laevis rbpa (Ryter and Schultz, 1998) constitutes the archetype of a canonical 
dsRBD with a sequence consensus of >40% from an alignment of several different dsRBDs 
(Masliah et al., 2013). However there also exist some dsRBDs which differ from the canonical 
sequence but still are able to bind dsRNA. The most variable part for a dsRBD is located within 
the N-terminus. The dsRBDs from S. cerevisiae RNase III, mammalian ADAR2 and Drosophila 
ADAR, for example, have shorter α1 helices, which has no detectable functional impact on the 
dsRBD function (Leulliot et al., 2004; Stefl et al., 2006). In case of S. cerevisiae RNase III, 
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however, there exists an additional helix α3, succeeding α2, which has been shown to have an 
impact on the stability of the domain and play an additional role in dsRNA binding. A second 
region of variability is the loop L2 between β1 and β2. In the Arabidopsis methyltransferase HUA 
ENHANCER 1 (HEN1) there are two dsRBDs with long insertions in L2. Crystallographic 
studies show, that this loop in the dsRBD1 binds to dsRNA and additionally provides protein-
protein contacts with the methyltransferase domain, highlighting a bifunctional feature of the L2 
insertion for both dsRNA binding and protein-protein interaction (Huang et al., 2009). 
Interestingly several dsRBDs exist, which exhibit the classical dsRBD folding but instead of 
binding to dsRNA they are exclusively responsible for protein-protein interactions. Such an 
example can be found in the dsRBD3 of human Dicer interacting proteins TRBP and PACT, 
where the interface of the Dicer-TRBP complex has recently been solved by X-ray 
crystallography (Wilson et al., 2015). In the mammalian STAU1, which contains five dsRBDs, 
the dsRBD5 lacks residues and features required to bind duplex RNA. Together with a so called 
Staufen-swapping motif, STAU1 is able to form homodimers, which are functionally required for 
STAU1-mediated mRNA decay (Gleghorn et al., 2013). 
Compared to the plethora of canonical dsRBD-structures, only little structural information of 
protein-protein interacting dsRBDs is available. Additional structural information of protein-
interacting dsRBDs is required to elaborate the understanding of how dsRBPs are able to 
associate and collaborate with their binding-partners. 
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2. Small ncRNA mediated gene silencing 
The discovery of the lin-4 gene locus in Caenorhabditis elegans (C. elegans) that does not encode 
for protein but express small RNA transcripts, which have a negative regulatory effect on 
translation of the lin-14 mRNA (Lee et al., 1993; Wightman et al., 1993), gave the headstone for 
the discovery of RNA interference (RNAi) by Fire et al. (1998). Although the effect of RNAi was 
already shown earlier in plants (Napoli et al., 1990), the finding that small ncRNA-mediated gene 
regulation is not only restricted to nematodes and plants but conserved among species attracted 
the interest of many researchers in this field and was finally honored with the Nobel Prize in 
2006. 
 
2.1 Classes of small ncRNAs 
The development of deep sequencing methods identified a large number of small ncRNAs with 
different regulatory mechanisms. According to their structure, biogenesis and related function 
these small ncRNAs can be divided into three different groups, the miRNAs, the siRNAs and the 
piRNAs. 
 
2.1.1 MiRNAs 
MiRNAs are approximately 20-25 nts in length and are the predominant class of small RNAs in 
most somatic tissues. miRNA genes belong to one group of the most abundant gene families and 
are distributed among species and are even found in some viruses (Griffiths-Jones et al., 2008). In 
their canonical biogenesis pathway, miRNAs are derived from PolII transcribed primary miRNAs 
(pri-miRNA). However, there also exist miRNAs, which do not originate from canonical 
processing and where the mechanisms are not yet understood in detail. These miRNAs are 
generated from specialized introns (miRtrons), tRNAs, snoRNAs and capped transcripts (See 
Introduction Chapter 2.2 for detailed description of the miRNA biogenesis pathway). 
When a mature miRNA is bound to one of its effector proteins from the Ago family, it functions 
as the so called miRNA-induced silencing complex (RISC), which is able to regulate fundamental 
biological processes like development, diﬀ erentiation, apoptosis and proliferation. Therefore one 
strand of the miRNA duplex guides the RISC by Watson-Crick paring with its 5’ nts 2-8, the so 
called “seed sequence” (Lewis et al., 2003), to a complementary region on the target mRNA 
leading to translational repression, destabilization and degradation of the respective target mRNA. 
Under consideration of all predicted miRNA binding sites that are conserved among species, at 
least 60 % of all protein-coding genes contain a potential binding site and adding also non-
conserved sites it is likely that almost every protein-coding gene is under control of certain 
miRNAs (Friedman et al., 2009). Due to the relevance of the miRNA pathway, the biogenesis and 
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function of miRNAs is strictly regulated and dysfunction in regulation is often associated with 
various human diseases including cancer (Mavrakis et al., 2010) and neurodevelopmental 
disorders (Im and Kenny, 2012). The involvement of miRNAs as cellular key regulators offers the 
potential for the development of miRNA based therapeutics (Kota et al., 2009; Lanford et al., 
2010; Melo et al., 2011), which underlines the importance for the examination of the molecular 
processes of miRNA biogenesis and regulation in every detail. 
 
2.1.2 PiRNAs 
PiRNAs are ~24-32 nucleotides in length and are specifically expressed in the germline. In 
complex with a member of the Piwi clade of Ago proteins, piRNAs are important for 
gametogenesis (Cox et al., 2000; Deng and Lin, 2002; Szakmary et al., 2005) and for silencing of 
mobile genetic elements such as transposons (Vagin et al., 2006) in many different species such 
as diverse as mammals, flies and fishes. The generation of piRNAs, however, differs strongly 
from other small RNA biogenesis pathways and is still not fully understood. Primary piRNAs 
(pri-piRNAs) are expressed as single strands and derive from sense and anti-sense transcription 
from discrete genomic loci (Brennecke et al., 2007), termed piRNA clusters, which do not 
function as a substrate for Drosha and/or Dicer (Das et al., 2008; Houwing et al., 2007; Vagin et 
al., 2006). In Drosophila, the generation of piRNAs requires two nucleases. First pri-piRNAs are 
processed by a protein called Zucchini (Pane et al., 2007), which like its mouse homologue PLD6 
(Ipsaro et al., 2012) belongs to a member of the phospholipase-D family of phosphodiesterases. 
This family includes both, phospholipases and nucleases (Haase et al., 2010) and is supposed to 
be responsible for the generation of the 5’ end from pri-piRNAs. After the 3’ end of the pri-
piRNA is trimmed to the right length (Kawaoka et al., 2011), the piRNA methyltransferase Pimet 
(Hen1) is required for 2′-O-methylation and final maturation of pri-piRNAs (Saito et al., 2007), 
which are further transferred to a Piwi protein. Then an amplification cycle takes place, the so 
called “ping-pong cycle”. In the ping-pong cycle, mature sense pri-piRNAs guide Piwi proteins to 
complementary sequences on antisense transcripts from the respective piRNA cluster. As Piwi 
proteins possess a slicer activity, they are able to cleave the target antisense transcript from the 
cluster and generate a new 5′ end. This 5′ end is then bound again by another Piwi protein and the 
3′ end is trimmed again to the length of a mature piRNA. This piRNA can now target again sense 
transcripts, transcribed from the piRNA cluster, leading to an enrichment efficient piRNAs 
against transposons. In Drosophila, the two Piwi proteins, which are responsible for secondary 
piRNA production, are called Aubergine and Ago3. 
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2.1.3 SiRNAs 
SiRNAs comprise an average length of ~21 nucleotides. Similar to piRNAs, they exhibit a full 
complementarity to their target RNA, which leads to an endonucleolytic cleavage when 
incorporated into a slicer active Ago protein. Endogenous siRNA-production has been described 
first in C. elegans where primary siRNAs, which are derived from Dicer nuclease-mediated 
cleavage of the original long dsRNA trigger, and secondary siRNAs, which are additional small 
RNAs whose synthesis requires an RNA-directed RNA polymerase (RdRP), are generated. The 
generation of secondary siRNAs requires a specialized mechanism, which is fundamentally 
different from other conserved small RNA pathways (Pak and Fire, 2007; Yigit et al., 2006). 
In Drosophila, there exists a small RNA pathway where Dicer 2 and its cofactors R2D2 and a 
specific splice isoform of Loqs (Loqs-PD) are involved in the generation of certain siRNAs from 
exo- or endogenous long dsRNA precursors (Hartig et al., 2009; Liu et al., 2003). Because of the 
relevance for this thesis, the mechanisms behind biogenesis from small non-coding regulatory 
RNAs in insects will be introduced in more detail in Chapter 2.3. 
In mammalian somatic cells, there is no evidence for the existence of endo-siRNAs. On the one 
hand, a recombinant overexpressed and purified human Dicer is able to process long fully 
complementary dsRNA into ~21 nt long siRNAs in an ATP-independent manner (Zhang et al., 
2002) in vitro, however, on the other hand, the transfection of mammalian cells with long dsRNA 
templates (38-1662 base pairs (bp)) does not result in efficient production of 21 nt long siRNAs 
(Caplen et al., 2000), but triggers interferon response by activation of protein kinase R (PKR) 
(Manche et al., 1992; Stark et al., 1998). Transfection of 21 nt long double stranded RNAs with a 
2 nt overhang on the 3’ end of each siRNA is able to overcome interferon response and leads to an 
effective knockdown of target genes in mammalian cells (Elbashir et al., 2001). Although 
containing the prerequisites to perform RNAi in general, mammalian somatic cells seem to react 
differently to long dsRNA species then shown in C. elegans or in Drosophila. Some exceptions, 
however, might exist in mouse oocytes and embryonic stem cells, where endo-siRNAs are 
generated upon viral infection, from transposable element-, bidirectional- or pseudogene-
transcription or from long hairpin structures (Dautry et al., 2007; Tam et al., 2008; Watanabe et 
al., 2008). 
 
2.2 Biogenesis of mammalian miRNAs 
The biogenesis of mammalian miRNAs starts in the nucleus, where PolII transcribes long primary 
transcripts (~ 1kb), which contain at least one local hairpin structure, where a mature miRNA 
sequence is embedded. In humans, many of the canonical miRNAs are located in introns of 
coding and non-coding genes. Other miRNAs are organized in clusters in which several miRNA 
loci follow each other, forming a polycistronic transcription unit (Lee et al., 2002). Each 
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pri-miRNA consists of a stem of ~33-35 bp in length, a terminal loop and single stranded RNA 
sequences at the 5’ and 3’ ends. This specific structural feature is recognized by the nuclear 
RNase III enzyme Drosha, which interacts with its cofactor DiGeorge syndrome critical region 8 
(DGCR8), the so called “microprocessor complex”  Figure 1.4, upper part) (Auyeung et al., 2013; 
Denli et al., 2004; Gregory et al., 2004; Han et al., 2004; Landthaler et al., 2004; Melo et al., 
2011). The complex further catalyzes a precise cropping of the stem loop, where Drosha cleaves 
the hairpin approximately 11 bp away from the “basal” junction, the lower end of the pri-miRNA 
stem, and 22 bp away from the “apical” junction, the upper end of the pri-miRNA stem, resulting 
in a smaller ~65 nts long hairpin-shaped RNA, the so called precursor-miRNA (pre-miRNA) (Lee 
et al., 2003). A recently published crystal structure of human Drosha (Kwon et al., 2015) suggest 
that Drosha alone is capable of recognizing the key structural features in the basal side of pri-
miRNA and measuring of the 11 bps for cleavage of the stem. DGCR8, on the other side, binds 
Drosha as a dimer and is required for the apical binding and positioning of the pri-miRNA. After 
positioning, one of the tandem RNase III domains  RIIID) cuts the 5’ strand and the other one the 
3’ strand, generating a two-nucleotide-long 3’ overhang forming the mature pre-miRNA (Han et 
al., 2006) (Figure 1.4, upper part). 
After nuclear processing of the pri-miRNA, the nuclear shuttling protein exportin 5 (Exp5) in 
complex with its cofactor the GTP-binding nuclear protein Ran (RanGTP) binds to the pre-
miRNA with its positive inner surface and forms the transport complex (Bohnsack et al., 2004; 
Lund et al., 2004; Okada et al., 2009; Yi et al., 2003). The tunnel like structure is able to strongly 
interact with the two-nucleotide-long 3’ overhang of the pre-miRNA and enables Exp5 to 
recognize dsRNA stems of >14 bps in length. After accurate assembly of Exp5, RanGTP and the 
pre-miRNA, the complex is translocated from the nucleus to the cytoplasm through the nuclear 
pore complex (NPC). In the cytoplasm, GTP bound to RanGTP gets hydrolyzed, initiating a 
disassembly of the complex and releases the pre-miRNA. 
In the cytoplasm (Figure 1.4, lower part), a second RNase III enzyme, called Dicer (Bernstein et 
al., 2001), binds to the pre-miRNA and cleaves the hairpin-structured RNA close to its terminal 
loop, liberating a small RNA duplex. As it is the case for Drosha, both Dicer RIIIDs form an 
intramolecular dimer, which creates the active center of the enzyme in a central cleft between 
both domains. The human Dicer anchors both the 3’ and the phosphorylated 5’ end within its PAZ 
domain and then recognizes the cleavage site by a predefined distance (∼22 nucleotides), starting 
from the 5' end of the pre-miRNA by the so called 5' counting rule (Park et al., 2011; Tian et al., 
2014). For hDcr it is shown that it is able to interact with the trans-activating response RNA-
binding protein (TRBP) and the interferon-inducible double-stranded RNA-dependent protein 
kinase activator A (PACT). However, the molecular details of theses complexes were not 
understood yet in detail. TRBP is shown to have an impact on the cleavage sites of Dicer by 
stabilizing the protein/RNA complex and enhancing the catalytic turnover of the pre-miRNA. 
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This leads to a preferential processing of certain miRNA isoforms compared to the processing of 
hDcr alone (Fukunaga et al., 2012) (Figure 1.4, lower part). 
The RISC loading step and the mechanistic details of miRNA-guided gene silencing are 
separately described in Chapters 2.4 and 2.5. 
 
 
Figure 1.4: Biogenesis of miRNAs in mammals. PolII starts transcription of pri-miRNA from the 
transcriptional start site (TSS) of miRNA genes. Pri-miRNAs contain single or clustered stem loop 
structures within their sequences and, like mRNAs, were capped and polyadenylated. The microprocessor 
complex, containing DGCR8 and Drosha, binds to a single stem loop and releases the pre-miRNA which is 
recognized by a complex of RanGTP and Exp5 that initiates translocation through the nuclear pore complex 
(NPC) form the nucleus to the cytoplasm. After hydrolysis of GTP bound to RanGTP, the pre-miRNA is 
released from the complex and bound by Dicer and its cofactors TRBP or PACT. After removal of the stem 
loop, the mature miRNA is loaded onto an Ago protein (Ago1-4) where the guide strand (miRNA) gets 
incorporated and the passenger strand (miRNA*) is removed and degraded. In complex with a protein from 
the TNRC6 family, miRNA loaded Ago forms the active miRISC. 
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2.3 Biogenesis of small regulatory RNAs in insects 
In contrast to the mammalian miRNA biogenesis machinery, where one single Dicer in complex 
with its dsRBP partner protein, is responsible to for the processing of miRNAs, there are two 
distinct isoforms of Dicer in the fruit fly Drosophila, dmDcr-1 and Dicer-2 (dmDcr-2). Both 
Dicer have distinct functions in the generation of small ncRNAs and were assisted by two 
different kinds of dsRBPs. DmDcr1 associates with Loqs and dmDcr-2 with R2D2 (Lee et al., 
2004; Liu et al., 2003; Tomari et al., 2004). For the loqs gene, there are four different splicing 
variants (Hartig et al., 2009) described (loqs RA, RB, RC and RD) which are derived through 
alternative splicing and encode for functionally different proteins (Loqs-PA, -PB, -PC and -PD) 
that differ in their C-terminal region succeeding the first and second dsRBDs (Figure 1.5). 
 
 
Figure 1.5: Loqs isoforms generated by alternative splicing. Left side: Different identified loqs mRNAs 
were depicted. Intronic sequences, which were removed upon splicing, were drawn as tin lines. 
Translational start sites were marked with green bars and stop codons were indicated with red bars. Right 
side: Protein sequence of different Loqs isoforms. Regions with a dsRBD fold were indicated as pentagons 
and alternative, unstructured and no dsRBD containing C-termini were highlighted in blue (Loqs-PC) and 
red (Loqs-PD). Figure adapted from (Hartig et al., 2009). 
 
Loqs-PA and -PB both contain a third dsRBD, which allows the interaction with dmDcr-1 and the 
processing of pre-miRNA in the miRNA biogenesis pathway (Förstemann et al., 2005; Jiang et 
al., 2005; Saito et al., 2005; Ye et al., 2007). Both isoforms were expressed in Drosophila cells, 
but only the Loqs-PB seems to be necessary and sufficient for embryonic development and the 
miRNA pathway (Park et al., 2007). The miRNA biogenesis pathway from Drosophila is mostly 
conserved to the mammalian biogenesis pathway (Figure 1.4) and therefore will not be introduced 
in more detail. The only differences in flies are Pasha, which is equivalent to DGCR8 (Giot et al., 
2003; Landthaler et al., 2004) and Loqs-PA and -PB, which are equivalent to TRBP and/or 
PACT. 
Loqs-PC lacks the dsRBD3 that is present in Loqs-PA and -PB and only little is known about this 
isoform and if it plays a physiological role in vivo at all.  
Isoform Loqs-PD, which has a different polyadenylation site in the third intron, contains an 
alternative 22 amino acid C-terminal sequence instead of the dsRBD3. Loqs-PD is highly 
expressed in Drosophila Schneider 2 (S2) cells but does not interact with the dmDcr-1 (Hartig et 
al., 2009). In earlier studies, proteins products from the loqs gene were thought to interact 
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exclusively with dmDcr-1. Therefore, it was surprising that a knockdown of the complete loqs 
gene also had an impact on the endogenous (endo)-siRNA processing pathway which, is made up 
mainly by dmDcr-2 and its dsRBP partner R2D2 (Czech et al., 2008). The dsRBP R2D2 consists 
of two dsRBDs  “R2”) and a rather unstructured C-terminus that is able to interact with Dicer2 
 “D2”). Loqs-PD, as R2D2, is able to interact with dmDcr-2 by its unique putatively unstructured 
C-terminal sequence and assists dmDcr-2 in the endo-siRNA pathway for a de novo response 
against invading selfish genetic elements in somatic cells. Both proteins have overlapping 
functions in targeting of transposons, however certain transposons display a preference for either 
dsRBP during production or loading (Mirkovic-Hösle and Förstemann, 2014). 
Besides its function in the endo-siRNA pathway, it has been shown, that R2D2 together with 
dmDcr-2 is able to direct innate immunity against viruses (Wang et al., 2006). The separation of 
the dicing processes into two different pathways might therefore result from a strategy, which 
allows a rapid counteracting to invading viral long dsRNA, which would, in the case of one Dicer, 
compete with the endogenous pre-miRNAs for processing and loading to an Ago protein 
(Ghildiyal and Zamore, 2009). It is also likely that an evolutionary pressure from rapidly evolving 
viral strategies to escape the RNAi-pathway lead to the specialization of dmDcr-2 and Ago2 
which is supported by the finding that dcr-2 and ago2 belong to the most rapidly evolving 
Drosophila genes (Obbard et al., 2006). 
In mammals, on the other side, the RNAi pathway for counteracting viral infection might have 
been substituted by the evolution of an elaborate, protein-based immune system (Vilcek, 2006; 
Williams, 1999). Notably, it has been shown that in mouse embryonic stem cells (mESCs), there 
is a RNAi response upon infection with an encephalomyocarditis virus (EMCV) or Nodamura 
virus (NoV), as ~22-nucleotide RNAs derived from viral dsRNA replication intermediates 
accumulate in the cell and were incorporated into Ago2 (Maillard et al., 2013), suggesting a 
possible active, Dicer-dependent, antiviral RNAi response in mammalian cells or at least in 
embryonic stem cells that lack an IFN response (Billy et al., 2001; Paddison et al., 2002). 
 
2.4 RISC loading 
After Dicer processing a dsRNA of ~22 nts with 2 nt 3’ overhangs on each side of the duplex is 
generated. The mature siRNA or miRNA is further transferred to a member of the Ago clade. 
Thereby, the dsRBP partner of Dicer and the thermodynamic properties of the duplex itself 
determine, which strand gets incorporated into the Ago protein, the so called “guide strand” 
(miRNA) and which strand is released and gets degraded, the so called “passenger strand” 
(miRNA*) (Schwarz et al., 2003). 
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2.4.1 RISC loading in Drosophila 
In Drosophila the molecular details of Ago loading were most extensively studied yet and many 
components involved in this process have been identified. Due to the existence of two Dicer, also 
RISC loading is performed separately, where miRNAs associate in miRISC and siRNAs in 
siRISC (Kawamata et al., 2009). For siRNA-loading, a RISC loading complex (RLC) consisting 
of dmDcr-2, R2D2, Ago2 and several auxiliary proteins is assumed. The nuclear TATA-binding 
protein-associated factor 11 (TAF11) has been identified by a genetic screen to be involved in 
siRISC formation. The mainly nuclear protein co-localizes with dmDcr-2/R2D2 in so called D2 
processing bodies in the cytoplasm. There a TAF11 tetramer facilitates dmDcr-2/R2D2 
tetramerization and enhances siRNA binding and RISC loading activities (Liang et al., 2015). In 
several studies it has been shown that Ago loading requires ATP and the help of a complex of 
chaperones which also can be observed in animals and plants (Iki et al., 2010; Iwasaki et al., 
2010). A recent study identified the proteins Ago2, dmDcr-2, R2D2, Hsc70, Hsp90, Hop, Droj2 
(an Hsp40 homologue) and p23 to be sufficient to reconstitute RISC loading in vitro (Iwasaki et 
al., 2015). Omitting any component leads to a deficiency of Ago loading. The chaperone complex 
is required to hold Ago2 in a productive state and extending the dwell time of the 
dmDcr-2/R2D2/siRNA complex on Ago2 for accurate 5’ phosphate recognition of the siRNA 
guide strand. Upon loading, R2D2 is required for sensing the siRNA duplex for thermodynamic 
asymmetry and promoting an orientation, where the 5’ phosphate of the guide strand is bound by 
Ago2 (Tomari et al., 2004). After loading, subsequent unwinding and passenger stand ejection has 
been shown to be ATP and chaperone independent for Drosophila Ago2 (Iwasaki et al., 2010; 
Kawamata et al., 2009; Yoda et al., 2010). DmDcr-2 in complex with R2D2 acts as a gatekeeper 
for the assembly of Ago2 complexes, where the loading of Ago2 with fully complementary 
siRNAs is favored (Tomari et al., 2007). 
For the assembly of miRISC, on the other hand, little is known. Efficient Ago1 loading is 
dependent on the occurrence of central and terminal mismatches and a 5’-Uracil, which are a 
typical structural features of most miRNA/miRNA* duplexes (Förstemann et al., 2007; 
Kawamata et al., 2009; Seitz et al., 2011). However, if dmDcr-1 and Loqs are also required for the 
miRNA loading process or if DmDcr-2 and R2D2 might additionally play a role within this 
process is not fully understood. 
 
2.4.2 RISC loading in mammals 
For mammalian RISC loading, many studies have been performed, to investigate the molecular 
details of the Ago loading step. However, many aspects are still not elucidated in detail and some 
are even contradictory. Ago2 is capable to bind to the miRNA-generating hDcr/TRBP complex 
(Chendrimada et al., 2005; Haase et al., 2005; Meister et al., 2005; Mourelatos et al., 2002). 
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Consistently, a ternary complex of Ago2, hDcr and TRBP can be associated in vitro and the 
structure could be resolved by cryo-electron microscopy (Wang et al., 2009). For a siRNA duplex, 
it is shown that, after processing of the dsRNA substrate, a repositioning along the helicase 
domain of the mature siRNA duplex takes place within the hDcr/TRPB complex and the strand is 
scanned for the thermodynamic less stable end by a putative second binding site in hDcr (Noland 
et al., 2011). By the biased arrangement of the dsRNA duplex a strand-selective RISC loading of 
Ago is accomplished. Additionally, it has been shown in a Dicer-knockout rescue assay with a 
dsRBP-binding deficient mutant of hDcr, that for a subset of 108 analyzed miRNAs there is a 
pronounced change in the proportion of guide versus passenger strand incorporation into Ago2 
(Wilson et al., 2015). However, there also exist sequencing-data from another miRNA screen in a 
TRBP and PACT knockout background, where no difference in strand selection and Ago loading 
could be observed in the absence of the Dicer partner proteins (Kim et al., 2014). Both studies 
commonly agree with the finding that in the absence of the Dicer partner proteins, the levels of 
several iso-miRNAs were altered. An iso-miRNA is derived from a mature miRNA, which can be 
altered by substitutions, insertions or deletions, 3' end non-templated additions, and 5' and/or 3' 
cleavage variations (Morin et al., 2008). Therefore, dsRBPs seem to have a relevant meaning on 
the positioning of the pre-miRNAs upon Dicer-cleavage, which on the other hand determines the 
length of the mature miRNA. 
As in flies, an effective loading and incorporation of small ncRNA into an Ago protein requires a 
heat shock protein. Hsp90 has been identified to stabilize Ago2 in an open state, allowing an 
accurate loading of the RNA duplex (Johnston et al., 2010). Hsp90 thereby is assisted by the co-
chaperones FKBP4 and FKBP5. A depletion of either co-chaperone leads to a strong decrease of 
Ago2 levels due to the instability of unloaded Ago within the cell (Frohn et al., 2012; Martinez et 
al., 2013). The chaperone complex keeps Ago in a loading-competent state until a mature miRNA 
is bound. 
Once bound to Ago, the guide strand gets incorporated and the passenger strand is removed by an 
unwinding of the duplex. The N-terminus of Ago itself has been suggested to contribute to the 
unwinding process through an active wedging process (Kwak and Tomari, 2012). Perfect 
complementarity in the middle of siRNAs and miRNAs allows catalytic active Ago proteins to 
position the RNA duplex within their catalytic DEDH motive, which activates the slicer activity 
and nicks the passenger strand. The endonuclease C3PO has been identified to interact with Ago2 
and degrades the Ago2-nicked passenger strand, contributing to an accelerated RISC formation 
(Ye et al., 2011; Zhang et al., 2016). Catalytic inactive Ago proteins, on the other side, were also 
efficiently loaded but the removal of the passenger strand is kinetically less favored (Dueck and 
Meister, 2014; Meister, 2013). Once incorporated into an Ago protein, the guide strand is tightly 
bound and cannot be exchanged between different members of the Ago protein family (Dueck et 
al., 2012). 
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2.5 Mechanisms of miRNA-mediated gene silencing 
Once incorporated into Ago, the miRNA guide strand directs Ago to its seed-complementary 
target mRNA allowing PTGS. To be able to mediate PTGS, a loaded Ago-protein binds to an 
effector protein from the GW182 protein family. GW182 proteins are mainly unstructured and 
contain multiple Trp residues, which are often flanked by Gly (GW repeats). Drosophila 
possesses one family member namely GW182 and mammals possess three paralogs namely 
trinucleotide repeat-containing protein 6 A, B, and C (TNRC6 A, B and C) (Baillat and 
Shiekhattar, 2009; Meister et al., 2005; Pfaff and Meister, 2013). These proteins are also 
commonly referred to as GW proteins. 
GW proteins comprise a modular composition and are able to act as scaffolds for a plethora of 
different regulatory proteins. The N-terminal part of GW proteins is Trp-rich and serves as an 
interaction platform for Ago proteins, the so called “Ago-hook” (Chekulaeva et al., 2009; Lian et 
al., 2009; Takimoto et al., 2009; Till et al., 2007). Thereby, two Trp residues with an exact 
spacing between each other were required, to specifically perform an high-affinity interaction 
with a hydrophobic pocket in the Piwi domain of Ago proteins (Hauptmann et al., 2015; Pfaff et 
al., 2013; Schirle and MacRae, 2012). The C-terminal silencing domain comprises a ubiquitin-
associated (UBA)-like domain, a glutamine (Q)-rich domain, a poly(A)-binding protein 
interacting motif 2 (PAM2) and an RNA-recognition motif (RRM) and is able to silence bound 
transcripts independently of Ago proteins (Lazzaretti et al., 2009). In this C-terminal part of the 
protein, Trp-based interactions with the deadenylation complexes CCR4-NOT and PAN2-PAN3 
take place (Chekulaeva et al., 2011; Christie et al., 2013; Fabian et al., 2012). A removal of the 
poly(A) tail, which is approximately 50–100 adenosines in length (Chang et al., 2014; Subtelny et 
al., 2014), by the deadenylation complex causes an initial destabilization of the mRNA. This 
destabilization is further enforced by the attraction of the decapping complex, containing the 
enhancer of decapping 3 (EDC3), EDC4, decapping protein 1 (DCP1) and DCP2 by the DEAD 
box protein 6 (DDX), which interacts with the decapping factors and the CCR4-NOT complex 
(Chen et al., 2014; Mathys et al., 2014; Tritschler et al., 2009). Once the 5’ cap is removed, the 
truncated mRNA is recogni ed by the 5’ to 3’ exoribonuclease 1  XRN1), which leads to the final 
degradation of the complete mRNA. The degradation of miRNA targets accounts for most of the 
miRNA-mediated repression at steady state levels in cultured mammalian cells (Jonas and 
Izaurralde, 2015). 
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3. The TRIM family 
The introduced miRNA biogenesis pathway is an example for a highly specialized cellular 
process that is responsible for small RNA mediated gene silencing. All components within this 
pathway have very specialized and limited functions. Proteins from the TRIM family, however, 
are involved in diverse cellular processes, including apoptosis, cell cycle regulation, neurogenesis, 
muscular physiology and innate immune responses. To establish this functional diversity, TRIM 
proteins possess a variety of different protein domains, where even some have been identified to 
be direct RBDs (Loedige et al., 2014). In the following, the main characteristics, which assign 
proteins to the TRIM family and their respective functional subclasses, will be introduced. 
The family of TRIM proteins can be characterized by the occurrence of a its eponymous 
characteristic motif, which consists of a “really interesting new gene” (RING) finger domain, at 
least one, in most cases two, B-Box-type zinc fingers (BB1 and BB2) and a Coiled-Coil (CC) 
domain. The TRIM motive is always located at the N-terminal part of the protein and the 
arrangement and the spacing between the individual domains is highly conserved among the 
family members (Reymond et al., 2001). 
The RING finger domain is an ubiquitin ligase (also referred to as E3). E3 ligases catalyze the 
attachment of polyubiquitin chains to their respective substrates. The domain architecture consists 
of a series of cysteine (Cys) and histidine (His) residues, in the order of Cys-X2-Cys-X9-39-Cys-X1-
3-His-X2-3-Cys-X2-Cys-X4-48-Cys-X2-Cys, where “X” represents any amino acid. Cys in position 
1, 2, 5 and 6 coordinate the first zinc ion and His 4 and Cys 3, 7 and 8 the second one (Barlow et 
al., 1994; Borden et al., 1995; Freemont, 1993). This cross brace arrangement, with the two zinc 
atoms coordinated by the conserved Cys and His residues at the center of the domain, is required 
for the domain architecture and for its E3 ubiquitin ligase (Joazeiro and Weissman, 2000). A 
mutation of a single Pro residue is sufficient to disrupt the ubiquitin transfer activity, as it is the 
case in the nematode protein Lin-41 (Budhidarmo et al., 2012; Tocchini et al., 2014). In certain 
uncommon TRIM family members, like the Drosophila proteins Brat and Wech, the RING 
domain is even missing. 
The B-box (BBs) domains also contain the structural element of cross brace coordinated zinc 
atoms that are also present in the RING, ZZ and U-box domains of E3 and E4 ubiquitin ligases 
(Massiah et al., 2007; Tao et al., 2008). There are two types of BB (BB1 and BB2), where BB1 
has the common motif Cys-X2-Cys-X6-17-Cys-X2-Cys-X4-8-Cys-X2-3-Cys/His-X3-4-His-X5-10-His 
and, if present, always is located N-terminal from BB2 with the motif Cys-X2-4-His-X7-10-Cys-X1-
4-Asp/Cys-X4-7-Cys-X2-Cys-X3-6-His-X2-5-His. Altogether there is little known about the function 
of BBs. The structural similarity of BB to the RING domains might support the hypothesis that 
these domains are able to act as E3 ubiquitin ligases by their own, or promote the E3 activity of 
the RING domain. This is supported by the finding that the B-boxes of TRIM18/MID1 are mono-
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ubiquitylated and B-box1 is able to enforce the E3 activity of the RING domain (Han et al., 
2011). 
The third part of the tripartite motif is the coiled-coil (CC) domain, which follows BB2 in all 
TRIM proteins (Reymond et al., 2001). The CC domain contains roughly a hundred, non-
conserved amino acids that form larger α-helical secondary structures, which are intertwined to a 
rope like structure, stabilized by hydrophobic contacts between helices, which are often mediated 
by leucines (Leu) (Woolfson and Alber, 1995). The CC domain allows the formation of homo- or 
heterodimers between TRIM proteins, promotes the formation of high molecular weight protein 
complexes and defines subcellular TRIM-specific compartments (Reymond et al., 2001; Sanchez 
et al., 2014). The dimer architecture is conserved among several TRIM family members. 
The occurrence of TRIM at the N-terminus dedicates a protein to the TRIM family. The 
functionality among certain family members however is achieved by a strong diversity of 
functional domains within the C-terminal part of the protein. Therefore TRIM proteins are 
assigned to certain classes according to their C-terminus (Short and Cox, 2006). 
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3.1 Classes of TRIM proteins 
A systematic arrangement of TRIM proteins was established by Short and Cox, (2006) where they 
used a bioinformatical approach for the sub-classification of the entire human TRIM ensemble, 
based on their variety within the C-terminal domain compositions. So far, 10 different C-terminal 
domains have been identified, which succeed the TRIM either alone or in combination of each 
other. Under consideration of the subcellular localization, the expression levels in different tissues 
and the respective functions, TRIM proteins can be divided into nine different subclasses (C-I to 
C-IX). Figure 1.6 shows an overview of different TRIM protein family members and their 
classification according to the modular arrangement of their TRIM and C-terminal domain(s). 
 
 
Figure 1.6: Schematic depiction of human TRIM protein family members. The classification of the 
TRIM families, depending on different carboxy-terminal-domain composition, was performed according to 
bioinformatics analysis of Short and Cox, (2006). Dotted lines indicate a variability of domain positions 
within the sequence. Domains are abbreviated in the following manner ARF: ADP ribosylation factor-like, 
BR: bromodomain, COS: C-terminal subgroup one signature, FN3: fibronectin type 3, FIL: filamin-type 
immunoglobulin, MATH: meprin and tumour-necrosis factor receptor-associated factor homology, MID: 
midline, PHD: plant homeodomain, PML: promyelocytic leukaemia. Adapted and modified from (Ozato et 
al., 2008). 
 
The C-terminal subgroup one signature (COS) was found to be present in subgroups C-I, C-II and 
-III. The COS domain is located directly after the CC sequence in a subset of TRIM proteins and 
could also be found in non-TRIM proteins containing a CC domain (Short and Cox, 2006). The 
COS domain is required for localization of the respective TRIM proteins with microtubules (Short 
and Cox, 2006) and plays a role upon retroviral infection (Uchil et al., 2008; Yap et al., 2004). 
The PRY domain with an average length of ~61 amino acids and the SPRY domain with ~140 
amino acids (Figure 1.6, subclass C-IV) are the most common protein domains among the TRIM 
family, where the SPRY domain alone can be found in a total number of 39 family members. Due 
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to their high conservation even in plants and fungi, the SPRY domain is thought to be 
evolutionary ancient. In 24 human TRIM family members, however, the SPRY domain is fused to 
a PRY domain, forming a PRYSPRY domain (also called B30.2). This fusion is derived from a 
more recent evolution by the formation of adaptive immune mechanisms and therefore is 
restricted to vertebrate species including humans, mice, chickens and frogs (Rhodes et al., 2005; 
Ruby et al., 2005). Structural data of the PRYSPRY domains revealed a rigid binding platform to 
mediate protein-protein interaction between donor and acceptor sequences, which resembles 
interactions reported for e.g. antigen-antibody contacts (Grütter et al., 2006; Woo et al., 2006). 
Additional structural work on the PRYSPRY domain of the autoantigen TRIM21 revealed a 
canonical binding interface comprised of two discrete pockets formed by antibody-like variable 
loops, which are able to specifically interact with the heavy chain of IgG (James et al., 2007; 
Keeble et al., 2008). For TRIM20 (also called pyrin) it is shown that mutations within its 
PRYSPRY domain affect the interaction with pro-interleukin-1β (pro-IL-1β), which leads to 
increased inflammation rates in the hereditary disease “familial Mediterranean fever (FMF)” 
(Aksentijevich et al., 1997; Weinert et al., 2015, 2009). 
The NHL-domain (Figure 1.6, subclass C-VII) was first described in the TRIM proteins NCL-
1/HT2A/LIN-41 and consists of a five- or six-bladed β-propeller, which is arranged in a barrel-
like assembly with a solvent filled cavity in the middle (Slack and Ruvkun, 1998). The NHL 
domain forms a rigid binding platform to meditate either protein-protein or protein-nucleic acid 
contacts. The NHL domain of TRIM32 for example is able to interact with the stress response 
factor p53, leading to apoptosis by its degradation (Liu et al., 2014). Consistently, an 
overexpression of TRIM32 strongly promotes oncogenic transformation and tumorigenesis in 
mice and it is also observed to be frequently overexpressed in different types of human tumors. 
TRIM3, on the other hand, has been identified as bona ﬁde tumor suppressor, where its RING- 
and NHL-domains, both were required to promote ubiquitination of p21, which is required for the 
proliferation of a subset of glioma cells (Raheja et al., 2014). Several TRIM-NHL proteins have 
been identified to interact with Ago proteins and other miRNP components with diverse 
functional implications. Mammalian TRIM32 and C. elegans NHL-2 are able to enforce miRNA-
mediated repression (Hammell et al., 2009; Schwamborn et al., 2009), whereas mammalian 
TRIM71 and Drosophila Mei-P26 negatively influence the miRNA biogenesis pathway 
(Neumüller et al., 2008; Rybak et al., 2009). Some NHL domains, however, show an 
accumulation of positively charged amino acids on the top surface of the β-propeller, whereas the 
bottom side is mostly negatively charged (Loedige et al., 2014). TRIM71 has been suggested to 
function as a direct translational regulator of many mRNA targets either independently or 
cooperatively with Ago proteins (Loedige et al., 2012). Consistently, TRIM71 has been found to 
directly interact with RNA in mouse embryonic stem cells (Kwon et al., 2013). 
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The filamin domain has a immunoglobulin-like structure with seven β-strands oriented in two 
antiparallel β-sheets (Bork et al., 1994) and is often associated with the NHL repeats at the C-
terminus of class C-VII TRIM proteins. 
The remaining C-terminal domains are the PHD domain, which is always in combination with a 
bromodomain (Figure 1.6, subclass C-VI) and supposed to be involved in chromatin-mediated 
transcriptional regulation (Friedman et al., 1996; Ivanov et al., 2007), the FN3 domain, which can 
contain binding sites for DNA and heparin, the ARF domain (Figure 1.6, subclass C-IX), which is 
involved in intracellular and vesicular trafficking and finally the MATH domain (Figure 1.6, 
subclass C-VIII), which is necessary and sufficient for self-association and receptor interactions 
by some TRAF proteins (Ozato et al., 2008). 
 
3.2 The Drosophila TRIM-NHL protein Brat 
Brat was first identified in a screen for lethal mutations in the dopa decarboxylase region (Wright 
et al., 1976) and was named after the phenotype, derived from inactivation of both alleles which 
leads to the production of a tumor-like neoplasm in the larval brain of Drosophila (Arama et al., 
2000). Brat contains a NHL-domain and is an atypical representative of the TRIM family because 
it only contains two BB domains and the CC domain and lacks the RING domain. The NHL-
domain contains a six bladed β-propeller, where each blade is composed of a highly twisted four-
stranded antiparallel β-sheet, which is similar to the WD40 fold (Edwards et al., 2003). Brat has 
been shown to have an regulatory influence on the segmentation gene hunchback (hb), which is a 
key gene for the early pattern formation process in the Drosophila embryo (Lehmann and 
Nüsslein-Volhard, 1987; Tautz et al., 1987). For the maternally provided hb mRNA, which is 
distributed equally in the embryo, this translational repression is active until specific translation of 
the mRNA at the anterior pole of the embryo, which defines the body axis and directs thorax head 
formation (Hülskamp et al., 1990; Tautz and Pfeifle, 1989). A dysregulated expression of the Hb 
protein at the posterior pole of the embryo causes deficiencies in the abdominal segmentation. 
Additionally, The bottom face of the NHL domain of Brat was identified to constitute an 
interaction platform for the cap binding protein d4EHP, which contributes to the inhibition of hb 
mRNA translation (Cho et al., 2006). 
Beside its function in the larval abdominal development of Drosophila early embryos, Brat has 
been identified to play a crucial role in the asymmetric cell division of neuronal stem cells (Brand 
and Livesey, 2011; Gómez-López et al., 2014; Knoblich, 2010). These stem cells are called 
neuroblasts (NBs) and the mechanisms underlying the processes of asymmetric stem-cell division 
are conserved among species. Upon the asymmetric cell division, the stem cell divides into a self-
renewing NB and an intermediate neuronal progenitor (INP) cell, which finally differentiates after 
several few more cell divisions. To be able to initiate differentiation, the INP needs to suppress 
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self-renewal processes. This is achieved during asymmetric cell division by segregation of the cell 
fate determinants Brat, Numb and Prospero to the differentiating daughter cell (Betschinger et al., 
2006; Knoblich et al., 1995; Rhyu et al., 1994). A disturbance of this process, where Brat is 
missing in the INP cell, causes an uncontrolled expansion of NBs and promotes tumor formation 
(Betschinger et al., 2006; Lee et al., 2006). In Brat mutant flies, the Brat targets Deadpan (Dpn) 
and Klumpfuss (Klu), which are involved in the self-renewal machinery, were strikingly increased 
in expression and lead to increased tumor formation. This tumorigenic phenotype, however, can 
be suppressed upon removal of either dpn or klu (Janssens and Lee, 2014; Xiao et al., 2012). In a 
genome-wide microarray expression study from brat homozygous mutant flies, which show a 
strong neoplastic adult brain phenotype, a large number of genes were identified, which showed 
highly significant changes in expression levels (Loop et al., 2004). Besides genes, which are 
relevant for asymmetric NB division, many genes involved in ribosome biogenesis, translation, 
and RNA processing could be identified, indicating also a contribution of these genes to the 
observed uncontrolled, tumor-like cell growth. Consistently, for the functional homolog of Brat in 
C. elegans, namely NCL-1, it is shown, that a loss of NCL-1 resulted in increased size of nucleoli, 
indicating higher levels of rRNA that promote ribosome biogenesis. This phenotype could be 
rescued by expressing Brat in the respective NCL-1 mutant worms (Frank et al., 2002; Frank and 
Roth, 1998). 
Coming back to hb-regulation and early development in Drosophila, it was initially thought that 
the core functional component for translational repression of target mRNAs was Pum, that binds 
to its 8-nucleotide consensus motive UGUANAUA, where N stands for any nucleotide (Gerber et 
al., 2006; White et al., 2001) and recruits Brat and Nanos (Nos) via protein-protein interactions 
(Sonoda and Wharton, 2001, 1999). However, it has been shown that Brat binds directly to the hb 
mRNA in a Pum-independent manner (Loedige et al., 2014), suggesting that there are targets, 
which could be regulated by Brat also in the absence of Pum. Recently, it has been shown that the 
Brat dependent repression of src64B mRNA, which is important for axon maintenance, is 
independent of Pum (Marchetti et al., 2014). The discovery of a Pum independent binding of Brat 
to several targets mRNAs raised the question, whether Brat possesses a sequence-specificity to 
recognize its own targets. In a genome-wide analysis of mRNAs associated with Brat, a RNA 
motif with the consensus NNUGUUDNN (D=A/G/U) could be identified (Laver et al., 2015). 
Brat and Pum associate with hundreds of mRNAs in early embryos, where only one third are co-
bound by both proteins. The occurrence of the Brat motif in proximity of the Pum motif lead to 
the assumption that Brat is able to interact with Pum by protein-protein interaction to allow a 
formation of a quaternary complex of Brat/Pum/Nos and the hb target mRNA (Edwards et al., 
2003; Sonoda and Wharton, 2001). However, it has been shown in gel filtration experiments that 
the isolated Brat-NHL and the Pumilio homology domains (Pum-HD), that is responsible for 
RNA binding (Wang et al., 2001), formed a stable complex only in the presence of RNA (Loedige 
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et al., 2014). Therefore the Pum motif might be required for an altered, more accessible RNA 
structure that would facilitate binding of the Brat-NHL domain. The association of either Pum or 
Brat alone or the simultaneous binding of both proteins to a target mRNA influences the 
translational status and the stability of the mRNA (Laver et al., 2015). 
For Pum, the molecular details for the interaction its Pum HD with a target RNA substrate are 
supported by several structural studies (Edwards et al., 2001; Gupta et al., 2008; Wang et al., 
2002, 2001), explaining the observed sequence-specificity in an atomic detail. Brat on the other 
side, has only recently been discovered to directly bind to RNA (Kwon et al., 2013; Loedige et al., 
2014) and the structural details for this interaction were still unknown when this PhD project was 
started. 
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Aims of this thesis 
RBPs play a central role in post transcriptional gene regulation mechanisms that act on the level 
of mRNA transcripts. The mechanisms of how RBPs are able to interact with their target 
sequences are diverse and differ among RBP families. 
Ago proteins associate with small ncRNAs that are generated by a complex cellular processing 
machinery where several proteins including Dicer and certain dsRBPs are involved. After loading, 
the small RNA provides Ago with “sequence-specificity” to identify distinct target RNAs. 
Thereby, some Ago proteins are endonucleolytically active and are able to cleave their targets, 
while others lack this feature. Ago proteins are able to recruit additional factors that mediate 
translational repression and target destabilization. 
The aim of the first part of this thesis was to investigate the mechanisms behind the cytosolic 
processing of miRNAs and their loading into Ago proteins. The cytosolic processing of pre-
miRNAs is performed by a complex of the RNase III enzyme Dicer and a dsRBP partner. Using 
structural biology and functional analysis, this thesis aimed to identify the molecular basis of the 
interaction platform between dmDcr1 and the dsRBD3 of Loqs and the implications on the 
processing of miRNAs. Furthermore an assay should be generated to be able to observe the 
downstream process of Ago loading with small fluorescently labeled ncRNAs using FCCS. 
TRIM-NHL proteins are conserved among multicellular eukaryotic organisms and control cell 
fate decisions in various stem cell linages. Drosophila Brat has been identified as an RBP that is 
able to repress translation of several mRNAs upon directly binding to a consensus motif. The aim 
of the second part of this thesis was to structurally characterize the molecular details of the 
interaction between the NHL domain of Brat and a consensus motif RNA target sequence to 
obtain information of how the sequence specificity is brought about. 
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II. Results 
1. Investigation of the human RISC loading complex 
1.1 FCCS-based Argonaute (Ago) loading assay 
During RISC loading small RNAs are generated by Dicer and transferred to a member of the Ago 
protein family. For the characterization of the binding of a small double stranded RNA (dsRNA) 
substrate to an Ago protein, a dual-color fluorescence cross-correlation spectroscopy (FCCS) 
assay was designed. FCCS is a confocal two-color spectroscopic method, where two laser lines 
were used to illuminate a microscopic detection volume in the range of one femtoliter (Bacia and 
Schwille, 2007). Fluorescently labeled molecules enter or leave this volume by diffusion and 
thereby generate a fluctuation in their fluorescence. From the fluctuation curves of each labeled 
component, various biophysical data such as molecular mobility, concentration and equilibrium 
and rate constants of molecular interactions can be extracted. To investigate Ago loading 
processes, green fluorescent protein (GFP) was fused N-terminally to Ago and the siRNA was 
labeled on its 3’end with a Cy5 fluorophore. After the initial characterization of the binding of one 
labeled siRNA to Ago, the affinity of any unlabeled siRNA can be determined in a competition 
reaction (see Figure 2.1 for schematic representation of the assay). 
To validate the hypothesis that knockdown efficiencies of siRNAs correlate at least partially with 
their binding affinity to an Ago protein, two different siRNA pairs targeting the serine/threonine 
kinase 1 (PLK1) mRNA were designed and characterized in preliminary experiments
1
. From these 
preliminary experiments, a pair of siRNAs was chosen whereby one siRNA had a high 
knockdown efficiency and a strong phenotype (si428) and the second one had lower knockdown 
efficiency together with a weak phenotype (si845). 
The single strands of the siRNAs were synthesi ed as a 3’ Cy5 labeled guide strand and an 
unlabeled passenger strand (Eurogentec) and the duplex was generated by an annealing reaction. 
Furthermore, a lysate was needed, where Ago adapted a native conformation and that was free 
from aggregates, to be able to investigate the binding of the labeled duplex in solution. For the 
generation of such a lysate, several conditions were tested resulting in one lysate that was suitable 
for the measurement. This lysate was based on a cytoplasmic fractionation (Dignam et al., 1983a) 
with cells from a stable and inducible overexpression human embryonic kidney (HEK) T-RExTM-
293 cell line and which was supplemented with 2 mM MgCl2, 100 mM KCl and 5 % glycerol for 
stabilization of the respective Ago protein (see Methods chapter 4.2). Taken these findings 
together, a lysate was generated where the binding of GFP Ago to a Cy5 labeled siRNA could be 
measured and that was also stable upon several freeze thaw cycles. 
                                                          
1
 See author-contribution page 
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Figure 2.1: FCCS based loading assay. Two laser-lines illuminate a microscopic detection volume and 
molecules entering or leaving this volume give rise to a fluctuation curve which contains various 
biophysical data of the involved components (left). For the FCCS assay, Ago was fused to GFP and the 
siRNA was labeled with Cy5 on its guide 3’ end  right). 
 
To further validate if the fluorescent labels of all components have an impact on the functionality, 
several experiments were performed. As an initial experiment the migration of GFP-Ago2 in a 15-
55 % sucrose gradient was investigated. As shown in Höck et al. (2007), Ago2 migrates in three 
distinct complexes, where each complex differs in Dicer and RISC activities. Therefore, a 
HEK293 lysate containing overexpressed GFP-Ago2 was loaded onto the gradient and samples 
from each fraction were analyzed via western blot with the anti-Ago2 11A9 antibody. As 
expected, the distribution of GFP-Ago2 resembles the wildtype protein, indicating that the GFP-
tag does not influence the formation of the different Ago complexes (Figure 2.2 A). 
In a second experiment
1
, the slicer activity of GFP-Ago2 has been investigated as described in 
Meister et al. (2004). FLAG/HA (FH)-tagged GFP (Figure 2.2 B lane 2) and GFP-Ago2 (lane 3) 
were immunoprecipitated with an anti-GFP antibody, FH-Ago2 (lane 5) with an anti-FLAG 
antibody and all samples were incubated with a radiolabeled target RNA fully complementary to 
endogenous miR-19b. Although the N-terminus together with the PIWI domain contributes to the 
slicing activity of Ago2 (Hauptmann et al. 2013) a GFP-tag in this region does not interfere with 
the cleavage efficiency of the RNA target as the cleavage product is generated in similar amounts 
compared to FH-Ago2. 
Finally the functionality of the labeled siRNAs was verified in a control knockdown experiment 
in order to exclude, that the Cy5 dye used for labeling of the 3’ end of the guide strand of the 
siRNA interferes with the incorporation into active RISC. Due to the strong regulatory 
involvement of PLK in the cell cycle, the knockdown was performed only for 24 h to prevent cell-
arrest or -death. As shown in Figure 2.2 C, the relative mRNA levels decrease upon siRNA 
knockdown, where Cy5-si428 has a high knockdown efficiency of ~92% and Cy5-si854 has a 
lower knockdown efficiency of ~60 % reduction of relative mRNA level, normalized to 
                                                          
1
 See author-contribution page 
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glyceraldehyde 3-phosphate dehydrogenase (GAPDH) mRNA expression and a control 
knockdown with an control siRNA. Therefore, the two labeled siRNAs were used to test if 
knockdown efficiencies of siRNAs correlate at least partially with their binding affinity to Ago 
proteins. 
 
Figure 2.2: Establishment of the FCCS assay (A) Sucrose density gradient for analysis of the migration 
of GFP-tagged Ago2 into different complexes (complexes I-III, lanes 3-18) confirmed by an Ago2 western 
blot. (B) In vitro Ago2 cleavage assay (lanes 2, 3 and 5). GFP-Ago2 was precipitated from a lysate of stable 
GFP Ago2 expressing HEK293 TRex cells using an GFP-specific antibody and incubated with a fully 
complementary radiolabeled target RNA to the endogenous miR-19b. As a marker a T1 digestion of the 
radiolabeled target was loaded (lane 1 and 4). The cleavage product is marked with an arrow (left panel) 
and FH-GFP (lane 6) and GFP-Ago2 (lane 7) on the loading control western blot (right panel) with an 
asterisk. (C) A knockdown of human PLK1 was used to validate the functionality of the Cy5 labeled 
siRNAs using quantitative real-time PCR. Samples were normalized to GAPDH mRNA expression and a 
control knockdown with a control siRNA. 
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In the FCCS binding assay, the Kd values of the Cy5 labeled siRNA were determined with a 
titration of the labeled siRNAs in GFP-Ago2 S100 lysate by serial dilutions. As expected, the 
siRNA gets incorporated into GFP-Ago2 and the Kd value for Cy5-si428 could be calculated as 
126 ± 15 nM (Figure 2.3 A) and for Cy5-si854 as 544 ± 1 nM (Figure 2.3 B), indicating a weaker 
affinity to GFP-Ago2 of the siRNA with the lower knockdown efficiency. This difference derives 
from a thermodynamic less stable U/A pair from 5’ end of the guide strand from Cy5-si428 
compared to a C/G pair of the guide strand from Cy5-si856 which has been shown to be important 
for efficient Ago loading (Khvorova et al., 2003; Schwarz et al., 2003). 
 
 
Figure 2.3: Binding of fluorescently labeled siRNAs to Ago2. (A) FCCS titration curves of Cy5-si428 
(high knockdown efficiency) and (B) Cy5-si845 (weak knockdown efficiency) indicating different affinities 
of both siRNAs to GFP-Ago2. 
 
Summarized, a lysate condition could be identified where the binding of a labeled siRNAs to GFP 
tagged Ago2 can be monitored. Due to its higher affinity to Ago2, the Cy5-si428 was used for the 
following binding studies. 
 
1.2 Loading of Ago1-4 
After the characterization of the binding of Cy5-si428 to GFP-Ago2, the FCCS loading assay was 
applied to the remaining Ago proteins. Therefore stable inducible monoclonal HEK T-REx
TM
-293 
cell lines were established expressing GFP-Ago1, -Ago3 and a polyclonal line for GFP-Ago4. As 
Ago1, Ago3 and Ago4 were not able to cleave the passenger strand, additionally to the GFP-Ago2 
cell line, a stable, polyclonal GFP-Ago2 H807R was generated where the catalytic DDH-motif is 
mutated to DDR abolishing the slicer activity of Ago2. This mutation was introduced to 
characterize the influence of the slicer activity to the binding of Cy5-si428 to an Ago protein by 
directly comparing slicer active and inactive Ago variants. After induction with tetracycline and 
expression for 24 hours, lysates were generated. The binding of Cy5-si428 to the different GFP-
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Ago constructs was measured in the FCCS assay and Kd values from the different Ago proteins 
were calculated based on the respective titration curves. 
First the affinity of Cy5-si428 to GFP-Ago1 was measured resulting in a Kd value of 288 ± 70 nM 
(See Figure 2.4). For GFP-Ago2 wt a Kd of 217 ± 4 nM and for the catalytic mutant H807R a Kd 
of 230 ± 12 nM could be obtained showing no difference in the affinity of the labeled Cy5-si428 
duplex to Ago2 in a slicer active compared to a slicer inactive Ago protein. In case of Ago3, 
FCCS measurements resulted in a Kd of 76 ± 14 nM, which was the strongest affinity measured 
for Cy5-si428. The measurement of GFP-Ago4 resulted in a Kd of 148 ± 31 nM. Taken together, 
these results show that the FCCS assay is applicable to all GFP-labeled Ago proteins and binding 
of each protein could be observed. Furthermore, all Ago proteins seem to have similar affinities to 
Cy5-si428 and variabilities of the measured Kd values could derive from the quality of the lysates 
(see Discussion chapter 1.3). 
 
 
Figure 2.4: Overview of the Kd values from GFP-tagged Ago proteins. Columns represent Kd values of 
different Ago proteins. Error bars were obtained from replicates of several measurements of each titration 
curves. 
 
1.3 Different siRNAs bind to Ago with different affinities 
To further validate the hypothesis whether differences in the affinities of siRNAs might be one 
determinant for an efficient siRNA knockdown, a competition assay was designed, to get access 
to the affinities of any desired siRNA. For this, increasing amounts of unlabeled siRNAs were 
mixed with a constant amount of Cy5-si428 and added to the sample to allow competition for 
GFP-Ago2 binding. A loss of cross-correlation between GFP-Ago2 and Cy5-si428 can be 
measured depending on the concentration of the added unlabeled siRNA. Using this approach, the 
Ki values, which are the Kd values for the competitor siRNA binding reflecting their respective 
affinity to GFP-Ago2, of eight different siRNAs (Figure 2.5 A) were determined. The siRNAs 
were designed against members involved in the human nuclear import pathway (Importin β 
36 
 
 Impβ), Importin 11 (Imp11), Ran-specific GTPase-activating protein (RanBP1) and Transportin-
1 (Tnpo1)) and already characterized concerning their knockdown efficiencies (Schraivogel et al., 
2015). The repetition of the knockdown experiment, using quantitative real-time PCR (Figure 2.5 
B), could confirm the efficiencies described in this publication. 
A comparison of the affinities derived from the FCCS assay with their respective in vivo 
knockdown efficiencies showed at least some correlation between both experiments. Imp si1 and 
si2, Imp 11 si1, Tnpo1 si1and RanBP1 si1 and 2 altogether led to a strong reduction of their 
respective target mRNA to less than 20% (Figure 2.5 B). Consistent with that, their respective Ki 
values showed a relatively high affinity to GFP-Ago with ~30nM (Figure 2.5 C). Tnpo1 si2, 
which comprised the most inefficient knockdown efficiency with a residual mRNA level of 73% 
(Figure 2.5 B), also had the weakest binding affinity to GFP-Ago2 in the FCCS assay with a Ki 
value of 76 nM (Figure 2.5 C), which was more than two times higher than the Ki values obtained 
for an efficient siRNA. Regarding only the Tnpo1 siRNA pair, which are designed against the 
same target mRNA, the difference of the knockdown efficiency might be influenced by the 
affinity of the siRNA to GFP-Ago2. However regarding the Imp11 si1 and 2 pair, Imp si2 has a 
lower knockdown efficiency of about 34 % residual mRNA level but a similar affinity to 
GFP-Ago2 with a Ki value that is similar to Imp11 si1 which has a knockdown efficiency of 
~15% residual mRNA level. 
Taken these findings together, a competition between Cy5-si428 and any unlabeled siRNA for 
GFP-Ago2 binding can be measured with the FCCS assay, resulting in the respective Ki values of 
each single unlabeled siRNA. For two different siRNAs targeting the Tnpo1 mRNA, a correlation 
between the knockdown efficiency and the affinity to GFP-Ago2 was measured, however for 
statistical validation of the hypothesis that the knockdown efficiency of a certain siRNA 
correlates, at least to some extent, with its affinity to Ago2, a dataset of several more siRNAs 
would be required. 
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Figure 2.5: siRNA competition screen. (A) Sequences of different siRNAs designed against members 
involved in the human nuclear import pathway. (B) Quantitative real-time PCR analysis of knockdown 
efficiencies from different siRNAs designed against members involved in the human nuclear import 
pathway, normalized to GAPDH mRNA levels. (C) Ki values from different unlabeled siRNAs derived 
from an FCCS competition screen with Cy5-si428 and GFP-Ago2. 
 
1.4 Influence of Ago phosphorylation on siRNA loading 
Many proteins in the cell are post-translationally regulated via dynamic phosphorylation of 
serines, threonines and tyrosines. Several phosphorylation (phospho)-sites have been reported for 
endogenous and overexpressed Ago2 (Rüdel et al., 2011) and (Sharma et al., 2014). As the FCCS 
assay has been shown to be a powerful tool for the investigation of the binding between GFP-
tagged Ago variants and the Cy5-labeled si428, the influence of two potential phospho-sites 
within the sequence of Ago2 were measured. Therefore, stable cell lines expressing GFP-tagged 
phospho-mimics were generated and lysates were titrated with Cy5-si428. 
In case of Y529 a phosphorylation affects the binding of endogenous miRNAs (Rüdel et al., 
2011). Y529 is located in the Mid domain of Ago2 and is required for binding of the 5’ end of a 
miRNA via its sidechain aromatic ring and hydroxyl group. The aromatic ring of Y529 has a 
parallel orientation to the first base of the miRNA with a distance of ~3.7 Å which allows π-
stacking interactions and stabili es the “kinked out” conformation of the first base (Figure 2.6 A). 
The Hydroxyl group further stabilizes this conformation via a hydrogen bond with the backbone 
phosphate of the first nucleotide (Figure 2.6 A). Mutations of Y529 to alanine, glutamate, 
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phenylalanine and glutamine were described in Rüdel et al. (2011). These findings were used as a 
proof of principle of the biophysical data generated in the FCCS assay. 
For this purpose, first the expression level of each single mutant in the S100 lysate was controlled 
using western blots against GFP and tubulin (Figure 2.6 B). All mutants and the wildtype Ago2 
were equally expressed indicating that the mutations have no influence on their respective 
expression level. 
Then the mutants were measured in the FCCS assay starting with a S100 lysate containing 
overexpressed GFP-Ago2 Y529E. Figure 2.6 B shows the titration curve where the concentration 
of the Cy5-si428 has been plotted in logarithmic scale. As expected, no binding at any Cy5-si428 
concentration and therefore no Kd value could be measured. The negatively charged side chain of 
glutamate repulses the 5’ phosphate of the siRNA and efficiently prevents binding into the 
binding pocket of Ago2. Thus, a phosphorylation at Y529 might have a post-transcriptional 
regulatory effect on Ago proteins. Therefore the observation of the FCCS assay is consistent with 
the findings described in Rüdel et al. (2011). 
If Y529
1
 was replaced by an alanine, the Kd value increases from 178 ± 1 nM measured for the wt 
GFP-Ago2 to 1.56 ± 0.36 µM (Figure 2.6 D). Y529 stabilizes the kinked conformation of the first 
nucleotide of the miRNA, where the base stacking with the second nucleotide is interrupted, via a 
hydrogen bond with the 5’ phosphate and π-stacking with the base. Alanine is not able to stabilize 
the 5’ end of the miRNA, which might explain the shift of the Kd values. 
A mutation of Y529 to glutamine introduces a bulky polar side chain into the 5’ binding pocket of 
Ago2. Consistent with that, the Kd is affected even stronger than in the Y529A mutant and is 
shifted to 2.61 ± 0.38 µM. The polar side chain of glutamine sterically interferes with the 5’ end 
of the miRNA and is also not able to stabilize the kinked conformation. But in contrast to the 
Y529E mutant, where a strong electrostatic repulsion of the negatively charged side chain and the 
5’ phosphate completely abolishes the binding, Y529Q is still able to bind the labelled siRNA, 
although with a very low affinity. 
A mutation of Y529 to phenylalanine has only a small influence on the affinity. The Kd could be 
determined as 209 ± 7 nM and is almost identical to the Kd of the wildtype Ago2 (178 ± 1 nM). 
As the 5’ phosphate of the miRNA is not only coordinated by Y529 but also via hydrogen bonds 
to K533, Q545, K566, K570 and R812, Y529 might contribute more via π-stacking to the binding 
then via its hydrogen bond. Thus Y529F, which lacks the contribution of the hydrogen bond, is 
still able to stabilize the kinked out conformation via π-stacking of its aromatic ring to the first 
base of the miRNA. 
Taken these findings together, the FCCS assay was able to reproduce findings on the potential 
phospho site Y529 (Rüdel et al., 2011) and kinetic data in terms of the respective Kd values could 
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be added within this study. Furthermore, the FCCS assay has proven to be suitable for the 
measurement of any potential phospho site within the sequence of an Ago protein. 
Thus another less characterized phospho site, which was additionally identified in the mass 
spectrometric analysis from Rüdel et al. (2011) was subjected to the FCCS assay to validate 
whether it could be a candidate for a possible phosphorylation site on Ago2 with a functional 
relevance on siRNA binding. S798 is located in a flexible loop region within the PIWI domain 
and contacts the RNA via a hydrogen bond to the phosphate group of nucleotide 5 within the 
miRNA sequence (Figure 2.6 A). To further validate the influence of S798 on the binding to 
dsRNA, the GFP-Ago2 mutants S798A and the phospho-mimic S798E were generated. 
For the S798A mutant a Kd value of 155 ± 27 nM could be measured indicating no effect on the 
binding of the labelled siRNA. The removal of one single hydrogen bond to the backbone 
phosphate of nucleotide 5 is not sufficient to reduce the affinity and is completely compensated 
by residual interactions of Ago2 to the siRNA. The phospho-mimic S798E with a Kd value of 206 
± 12 nM seems to have a small decrease of the affinity. However, this could also be explained by 
variations of the FCCS assay. The flexibility of the loop where S798 is located might also be 
responsible for the compensation of the negative repulsion from the phosphate backbone and the 
glutamate side chain. A phosphorylation at this residue alone thus has no post translational 
regulatory influence on the loading of Ago2. 
 
 
Figure 2.6: Ago2 phospho-mutants. (A) Overview of the 5’ miRNA-binding pocket of Ago2 in complex 
with miR-20a (PDB 4F3T). Sidechains of Y529 and S798 which have been mutated for the binding assay 
are shown as yellow sticks. (B) Loading and expression control of lysates from polyclonal phospho-mutants 
via western blot against GFP and tubulin. (C) Titration curve of the binding deficient GFP-Ago2 mutant 
Y529E. (D) Kd values of different phospho-mutants tested in the assay. 
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2. The fly miRNA biogenesis factor Loqs 
In the conserved miRNA biogenesis pathway, endogenous miRNAs have to pass several 
processing steps before they were loaded to their terminal Ago effector proteins. After passenger 
strand removal the miRNA single strand is able to perform translational repression of its target 
mRNA. The Dicer processing step, where the miRNA precursor is cleaved and the mature 
miRNA is released, directly precedes the Ago loading step and is assisted by a dsRBP partner. In 
flies, where two distinct Dicers exist, this step is carried out by dmDcr-1 and the Loqs-dsRBD3. 
Thereby the third dsRBD of Loqs has an identical fold from a classical dsRBD but functions as a 
protein interaction domain (Förstemann et al., 2005) instead of binding to RNA. To shed light on 
the molecular and functional details underlying the dmDcr-1-Loqs interaction, we structurally and 
functionally characterized important details of the dmDcr-1-Loqs interaction based on the crystal 
structure of Loqs-dsRBD3. 
 
2.1 Expression of Loqs-dsRBD3 
The boundaries of the Loqs-dsRBD3 crystallization-construct were determined according to a 
secondary structure prediction (PredictProtein) and a sequence coding for the isolated dsRBD3 
(residues 392-463) was cloned into expression vectors for initial expression- and solubility-
screening. The optimal expression of a soluble Loqs-dsRBD3 was achieved in E. coli BL21 
(DE3) with the expression vector pET32a by overnight expression at 18°C. Figure 2.7 shows the 
expression of the Loqs-dsRBD3 at different temperatures and time points. 
 
 
Figure 2.7: Expression of His6Trx-Loqs-dsRBD3. After induction with IPTG at OD600=0.6, cells were 
grown at 18, 25 and 37°C and samples were taken after 2h, 4h, 6h and overnight. Proteins were separated 
on a 10 % SDS gel and stained with Coomassie. 
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2.2 Purification of Loqs-dsRBD3 
E. coli BL21 (DE3) were transfected with the pET32 vector containing an N-terminal His6-
Thioredoxin (Trx) tag for affinity chromatography purification and an overnight culture was 
inoculated form these transfected cells. From that culture, lysogeny broth (LB)-medium was 
inoculated and grown overnight at 18°C after induction with IPTG (OD600=0.6). Cells were 
harvested and proteins were extracted using sonication. A lysate was obtained, containing large 
amounts of the overexpressed protein, which was affinity purified by immobilized metal ion 
affinity chromatography (IMAC) (Figure 2.8, A). Elution fractions were pooled and subjected to a 
TEV digestion while dialyzing against HisA buffer. Due to the inefficient cleavage of the TEV 
protease, which probably resulted from a steric hindrance between two folded protein regions, a 
linker of two additional glycines was introduced at the N-terminus of the construct and the 
cleavage activity was improved to ~60% of the total protein (Figure 2.8, B).  
 
 
Figure 2.8: First IMAC of His6Trx-Loqs-dsRBD3. (A) Chromatogram of the IMAC of His6Trx-Loqs-
dsRBD3. (B) 15 % SDS gel of the pooled fractions from the elution peak (~225 ml) of His6Trx-Loqs-
dsRBD3 and protein composition after TEV digestion of the respective pooled fractions. 
 
The uncut protein, the Trx-His6 tag and the TEV protease were removed with a second IMAC 
(Figure 2.9, A) and the flow through was concentrated by ammonium-sulfate precipitation (50% 
w/v) and centrifugation. The flow through of the second IMAC contained already high amounts 
of the isolated Loqs-dsRBD3 (Figure 2.9, B). However a minor proportion of the uncut protein 
and the isolated His6Trx-Tag co-eluted with the isolated dsRBD3. Therefore size exclusion 
chromatography (SEC) was applied after resuspension of the precipitated protein pellet. 
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Figure 2.9: Second IMAC of His6Trx-Loqs-dsRBD3. (A) Chromatogram of the second IMAC of TEV 
cleaved His6Trx-Loqs-dsRBD3. (B) 15 % SDS gel of the pooled fractions from the flow through peak (~5-
60 ml). 
 
After the SEC run, the Loqs-dsRBD3 with a molecular weight of ~8 kDa eluted at ~188 ml, 
which was unexpectedly early (See chapter 2.8 for further information) for a protein of the 
respective size (Figure 2.10, A). The shoulder from the elution peak was referred to the His6Trx-
Tag with a molecular weight of ~18 kDa, which eluted at a volume of ~174 ml. The peak 
fractions were pooled and separated from the shoulder and the purity of the respective fractions 
was confirmed with a 15 % SDS gel that was stained with Coomassie (Figure 2.10, B). After the 
first SEC, still a very little residual proportion of the His6Trx-Tag was present in the elution 
fractions. Therefore fractions were concentrated and subjected to another SEC. 
 
 
Figure 2.10: First SEC of Loqs-dsRBD3 (A) Chromatogram of the first SEC Loqs-dsRBD3. (B) 15 % 
SDS gel of the pooled fractions from the elution peak (~188 ml) and the shoulder (~174ml). 
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After the second SEC, highly purified Loqs-dsRBD3 was obtained which eluted in a single 
homogeneous peak at ~188 ml (Figure 2.11, A). The SDS gel from the pooled fractions showed a 
clear band for the isolated Loqs-dsRBD3 with no further contaminations (Figure 2.11, B). 
Therefore, the highly purified Loqs-dsRBD3 was used for crystallization experiments. 
 
 
Figure 2.11: Second SEC of Loqs-dsRBD3 (A) Chromatogram of the second SEC Loqs-dsRBD3. (B) 
15 % SDS gel of the pooled fractions from the elution peak (~188 ml). 
 
2.3 Crystallization of Loqs-dsRBD3 
After the final SEC, the buffer of Loqs-dsRBD3 was exchanged to crystallization buffer (20 mM 
Tris pH 7.5, 2 mM DTT) and the protein concentration was adjusted to ~15 mg/ml. Then 
screening was performed with commercially available crystal screens (See Table 4.11) using the 
“sitting drop” method (see Methods, chapter 7.1). However no condition for initial crystallization 
could be identified from all tested screens. 
Therefore another strategy was applied where the Loqs-dsRBD3 was chemically modified (Walter 
et al., 2006). As lysines can have a negative steric effect upon crystal contact formation due to a 
long positively charged sidechain, all free amino groups (Lysine side chains and the N-terminal 
amino group) were di-methylated within the sequence of Loqs-dsRBD3. The efficiency of the 
reaction was validated with a mass spectrometry analysis showing all four amino groups (3 
lysines and the N-terminus) being methylated. This is reflected by a shift of the full length Loqs-
dsRBD3 in the MS spectra, from a measured molecular mass of 8088.9 Da for the wildtype 
protein (Figure 2.12, A) and for the fully methylated protein to 8200.7 Da (Figure 2.12, B). To 
remove the chemical components from the protein methylation, the fully methylated construct 
was subjected in to another SEC, where a shift of the elution volume from 188 ml for the 
unmethylated protein to 181 ml for the fully methylated protein occurred (see Figure 2.12 C). The 
purity of the methylated Loqs-dsRBD3 was controlled by loading different amounts of the protein 
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onto a 10% Schägger gel and subsequent Coomassie staining (Figure 2.12 D). No additional 
bands were visible except of a faint band at ~16kDa which was identified by another MS-analysis 
(data not shown) as the dsRBD3 construct and might represent a SDS-stable dimeric form of the 
protein. 
In a last chromatographic step, the buffer was exchanged to crystallization buffer and immediately 
used for crystallization screening with commonly available crystal screens (Table 4.11). From 
crystal screening of the methylated protein, one single condition for crystallization could be 
identified consisting of 10 % poly ethylene glycol (PEG) 1000 and 10% PEG 8000. After 
refinement screening using the hanging drop method, the optimal mixture for crystallization of 
both precipitants could be identified as 2 % PEG 1000 and 12 % PEG 8000 supplemented with 
5 mM DTT which was crucial for the formation of the crystals. 2µL from the reservoir were 
mixed with 2 µL of a ~15 mg/mL protein solution and crystallized at 20°C. After 4-7 days, long 
and rod-shaped crystals grew within the drop (Figure 2.12, E). In most of the cases, crystals grew 
from a solid base with a cavity ranging from one side of the rectangle to the middle of the crystal. 
For further structural analysis, single crystals or single parts of the bases of one crystal were 
fished and briefly soaked in 20 % glycerol, 2% PEG1000 and 12% PEG8000 for protection 
against cryo-damage during freezing in liquid nitrogen. After the incubation with cryo buffer, the 
crystals were frozen and stored in liquid nitrogen. 
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Figure 2.12: Crystallization of methylated Loqs-dsRBD3. (A) MS spectra of unmethylated Loqs 
dsRBD3 (B) MS spectra of methylated Loqs dsRBD3 (C) Size exclusion chromatography of the 
unmethylated (dark blue (A280nm) and red (A260nm)) and the methylated (light blue (A280nm) and light 
red (A260nm)) dsRBD3 of Loqs. The protein elution shifts to a lower elution volume upon addition of 
methyl groups to the four amino groups present in the construct. (D) 10 % Schägger gel showing different 
amounts of the highly purified methylated protein with a molecular weight of 8.2 kDa and a SDS stable 
dimeric form of the protein at ~16 kDa. (E) Picture of a crystal obtained after refinement screening. 
 
2.4 Data collection and structure determination 
The data collection was performed at the Berliner Elektronenspeicherring-Gesellschaft für 
Synchrotronstrahlung m.b.H. (BESSY) on the beamline BL14.2 where native and 
selenomethionine (SeMet) substituted protein crystals (Methods chapter 7.2) were measured. 
SeMet incorporated Loqs-dsRBD3 was purified and crystallized in a similar manner as shown for 
the Loqs-dsRBD3. 
For the measurements, high energy synchrotron radiation was used, which is a prerequisite for 
X-ray crystallography. This radiation, like every electromagnetic wave, consists of an amplitude, 
that can be measured in form of the intensity of each spot on the detector and a certain phase, that 
is systematically lost upon diffraction at the electrons from atoms within the crystal. To overcome 
the phase problem, multi-wavelength anomalous diffraction (MAD) was performed. First, a 
fluorescence scan with the SeMet crystals was performed, for the detection of the optimal 
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wavelength for the three MAD measurements (peak, inflection and high remote, data not shown). 
Crystals from the SeMet protein diffracted up to 2.9-2.7 Å resolution and for the native protein up 
to 2.65 Å. The measured datasets were processed using XDS (Kabsch, 2010). Statistics of the 
MAD and the native datasets are given in Table 2.1. 
 
Table 2.1: Data collection statistics of Loqs-dsRBD3 crystals 
 peak inflection high remote native 
Wavelength (Å) 0.9798 0.9800 0.9082 0.9184 
Resolution range (Å) 50-2.9 (3.08-2.9) 50–2.7 (2.86-2.7) 50–2.9 (3.08-2.9) 50–2.65 (2.81-2.65) 
Space group P 21 21 21 P 21 21 21 
Unit cell, a b c 65.8 112.7 114.4 66.0 113.0 (114.1) 
Total reflections 285192 (45395) 347905 (51885) 143778 (22934) 188349 (30280) 
Unique reflections 36232 (5790) 44625 (6932) 36379 (5825) 25522 (4047) 
Multiplicity 7.9 (7.8) 7.8 (7.5) 4 (3.9) 7.4 (7.5) 
Completeness (%) 99.7 (99.1) 99.0 (95.1) 99.7 (99.4) 99.9 (99.9) 
Mean I/sigma(I) 23.0 (5.4) 27.7 (6.2) 21.2 (5.1) 33.8 (6.0) 
Wilson B-factor [Å2] 47.4 55.3 49.8 54.3 
Rsym-I [%] 8.9 (48) 6.5 (45) 5.6 (30.3) 4.6 (35.2) 
Values as reported by CORRECT. Values in parentheses refer to the highest resolution shells.  
 
Based on the Matthews coefficient, which allows an estimation of Loqs-dsRBD3 monomers that 
are present in the asymmetric unit by comparing the volume of the asymmetric cell with the 
molecular weight of the Loqs-dsRBD3 and the number of symmetry operators in the space group 
P212121, a number of 
~
8 monomers and a relatively high solvent content was obtained for the 
Loqs-dsRBD3 asymmetric unit cell. The high number of molecules within the asymmetric unit 
cell gave a reason why former attempts using molecular replacement, which is based on the 
correlation of a previously solved homologous protein structure with the data, obtained for the 
unknown structure, resulting in a solution for the phase problem, failed to calculate such a 
solution. However experimental phasing using AutoSHARP (Vonrhein et al., 2007) with the 
MAD data sets resulted in a total number of 9 selenium sites which was sufficient for the solution 
of the phase problem. 
Six of these sites could be assigned to the C-terminal methionine from each of the monomers 
resolved in the crystal. The remaining three positions were identified as alternative conformations 
from the C-termini showing some flexibility at this region. Starting from to the position of the 
respective SeMet in the N-terminal helix, model building was manually performed using COOT 
(Emsley et al., 2010). The refinement of the model was performed with the program 
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PHENIX.refine (Afonine et al., 2012) thereby using non-crystallographic symmetry (NCS) 
restraints and simulated annealing. 
Starting from the SeMet positions at the C-terminal helix of the Loqs-dsRBD3, a structural model 
of the complete asymmetric unit cell (Figure 2.13, A) was built into the electron density map 
obtained after experimental phasing. Thereby, half of the monomers in the crystal have undergone 
a domain swap where the β-strand β3 and the C-terminal helix α2 were exchanged between two 
monomers connecting both macromolecules by a physical bridge (Figure 2.13, B). Together with 
two “unswapped” monomers, this tetramer formed the building block for the crystal packing and 
two of these tetramers put up the asymmetric unit cell. It is likely that this domain swap was only 
required for crystallization as a compensation for lacking crystal contacts between each single 
monomer of Loqs-dsRBD3 and therefore can be seen as a crystal artifact which probably has no 
relevance for the function of Loqs in vivo. Consistent with that is also the fact, that during 
purification of the Loqs-dsRBD3, no species of higher molecular weight were observed, meaning 
that the tetrameric assembly was formed only upon crystallization. 
 
 
Figure 2.13: Asymmetric unit cell of Loqs-dsRBD3. (A) Beside the native monomers (blue) also 
monomers with swapped secondary structure elements (grey and orange) exist. Another dimer where the 
domain swap took place is only partly resolved (red and green) and the second half which is protruding in a 
large solvent channel could only be modeled as a poly alanine trace (magenta). (B) Detailed view of the 
domain swap between two monomers. 
 
One dimer of the building block protrudes into a large solvent channel and does not form any 
contact to other parts of the crystal. Therefore the electron density in this region is only weakly 
defined and this is reflected by the high B-factor averaged over all atomic positions within the 
structural model (Table 2.2). In these parts, the electron density was only partially defined for the 
main chain and completely missing for the side atoms. Therefore, the main chain was built as poly 
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alanine trace, as alanine possesses the smallest sidechain of all amino acids and therefore is 
commonly used, when electron density is missing for side chains (Table 2.2). 
 
Table 2.2: Model statistics and structure refinement 
Parameter Loqs-dsRBD3 
Rwork/Rfree 20.6/25.1 
Modelled polypeptides  
Monomers  
Chain A, C/B 391-462/392-463 
“Swapped” monomers  
Chain D/E/F/G 
391-463/389-463/429-463/390-
433 
Fragments  
Chain H 48 amino acids (Ala) 
No. of non-hydrogen atoms 3699 
macromolecules 3626 
water/ligands 67/6 
RMS(bonds) [Å] 0.009 
RMS(angles)  [°] 1.20 
Ramachandran favored (%) 97.2 
Ramachandran outliers (%) 0 
Clashscore 3.62 
Average B-factor [Å2] 65.40 
macromolecules 65.60 
ligands/solvent 79.10/ 52.80 
No. of TLS-groups 25 
 
2.5 The crystal structure of Loqs-dsRBD3 
Within the asymmetric unit there exist two states for the Loqs-dsRBD3 monomers. One half of 
the monomers swap secondary structure elements and were physically linked to each other and 
the other half that do not contain this domain swap and therefore were used for the following 
structure description. 
The Loqs-dsRBD3 has a classical ---- fold, which is a common feature among dsRBDs 
(Figure 2.14 A). In a superposition of the Loqs-dsRBD3 with other solved dsRBD containing 
structures (Staufen1, Dicer and RNase III), the atomic positions of the respective amino acids 
were almost identical with root-mean-square deviation (rsmd) values < 2 Å (data not shown) 
identified on the DALI server (Holm and Rosenstrom, 2010). 
Classical dsRBDs contact dsRNA via three different regions, which are located at one side of the 
dsRBD, representing the protein part of the RNA interface. Region 1 and 3 are made up by the N- 
and C-terminal helices and region 2 by the loop L2 between -sheets 1 and 2 (Figure 2.14 A, 
yellow). While the residues in region 1 are conserved, there are major differences among the other 
49 
 
two regions. In region 2, the GPxHxx motif is missing and in region 3 the KKxAK motif is 
mutated to an AAxAQ motif, which lacks the positive charges for the interaction with the major 
grove of the dsRNA backbone. 
The L2 loop, which represents RNA binding region 2 is not only lacking the motif for RNA 
binding but is also remarkably oriented away from the RNA interface in all monomers of the 
crystal. Additionally, the length of L2 is shorter compared to RNA binding dsRBDs, which makes 
it impossible for the Loqs-dsRBD3 to contact and anchor the protein to the minor groove of the 
dsRNA that is specifically bound by a histidine residue in dsRBD2 of TRBP (Yang et al., 2010). 
Figure 2.14 B shows a superposition of TRBP dsRBD2 (yellow), which was crystallized together 
with a dsRNA substrate (Yamashita et al., 2011), Staufen dsRBD5 (blue), which has no affinity to 
dsRNA and acts, similar to the Loqs-dsRBD3, as a protein interaction domain (Gleghorn et al., 
2013) and Loqs-dsRBD3 (green). Consistently, the L2 loop from Staufen1 dsRBD5 like L2 from 
Loqs-dsRBD3 is shorter and points away from the dsRNA interface, however in a more 
intermediate orientation (black arrow). Therefore, the orientation and length of the L2 loop might 
be crucial for either a protein-protein or Protein-dsRNA interacting dsRBD in general. 
Consistently, a reconstitution of the KKxAK motif in region 3 and the GPxH motif in region 2 is 
not sufficient to restore RNA-binding activity in gelshift assays, as the shorter L2 loop might 
prevent the histidine side chain to reach into the dsRNA minor groove (data not shown). In case 
of TRBP dsRBD2, L2 has exactly the right length, orientation and the GPxH motif and therefore 
is able to contact the minor groove of the dsRNA to anchor the dsRNA to the protein. 
 
 
Figure 2.14: Structure of Loqs-dsRBD3. (A) Monomer of the Loqs-dsRBD3. Regions which are 
responsible for RNA binding in functional dsRBDs were marked in yellow. The side chain of the solvent-
exposed phenylalanine (F419) within L2 is shown as sticks. (B) Superposition of the structures of TRBP 
dsRBD2 bound to RNA (PDB=3adl, yellow), RBD5 of Staufen1 (PDB=4dkk, blue), and Loqs-dsRBD3 
(green). An arrow highlights different orientations of the L2 loop pointing towards (TRBP) or away (Loqs) 
from a dsRNA substrate. 
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2.6 In vitro characterization of the Loqs-dmDcr-1 interaction interface 
For validation of Loqs-dmDcr1 interaction, glutahione-S-transferase (GST)-pulldown assay were 
performed. Thereby GST-tagged wt and mutants of Loqs were used as bait proteins and were 
incubated with a lysate of SF21 cells, containing overexpressed dmDcr-1. Figure 2.15 gives an 
overview of the GST tagged constructs used for the pulldown assays. 
 
 
Figure 2.15: Schematic overview of GST tagged Loqs constructs. Positions, where mutations were 
introduced, are indicated with red lines. 
 
Based on the structure of Loqs-dsRBD3, the most striking position for an amino acid is F419, 
which is located in L2 and is directly exposed to the solvent in all native species that present in 
the crystal (Figure 2.14 A). Thus, this residue was subjected to the GST-pulldown assay to 
validate its role in dmDcr-1 binding. A mutation of F419 to alanine had the strongest effect on the 
level of dmDcr-1 in the pulldown assay as the western blot signal for dmDcr-1 almost decreased 
completely (Figure 2.16 A, lane 4), while GST-Loqs-dsRBD3 efficiently precipitates dmDcr-1 
(Figure 2.16 A, lane 3). As a control for unspecific binding to the glutathione beads, GST alone 
was used, which also showed no western blot signal for dmDcr-1 (Figure 2.16 A, lane 2). F423, 
which is located near F419 at the beginning of 2, is only partly exposed to the surrounding 
solvent and has no direct influence on the binding of dmDcr-1 as shown by the F423A mutation 
(Figure 2.16 A, lane 5). This underlines the specificity of F419 as it might stack as a 
“hydrophobic finger” into a binding site located on the helicase domain of dmDcr-1. 
The A444K mutant, which partly restores region 3 as in a canonical dsRBD, has also no influence 
on the dmDcr-1 pulldown efficiency (Figure 2.16 A, lane 6). This finding indicates that dmDcr-1 
binding is not affected by the same region which is usually required for dsRNA binding in a 
functional dsRBD. 
It has been shown that Loqs can express four different splice isoforms in Drosophila cells (Hartig 
et al., 2009). These variants are referred to as Loqs-PA, -PB, -PC and -PD (Introduction, Figure 
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1.5). All four splice variants contain the first and second dsRBDs but differ in their C-terminal 
region. Loqs-PD and -PC have completely different C-termini and because of that they do not 
possess any affinity to dmDcr-1. Loqs-PA and -PB both contain the third dsRBD but differ in the 
linker region between dsRBD2 and dsRBD3. Both isoforms are able to interact with dmDcr-1 but 
the binding affinity is dramatically increased in case of Loqs-PB, which contains the complete 
interdomain-linker region between dsRBD2 and dsRBD3 (Förstemann et al., 2005; Ye et al., 
2007). To further identify the amino acids, which are responsible for this difference, truncations 
of GST-tagged Loqs constructs were made starting from the interdomain linker full length 
construct (Loqs-0), to the isolated dsRBD (dsRBD3), shortening the N-terminus step by step with 
an increment of around 10 amino acids (Figure 2.15). To directly identify amino acids that are 
responsible for the dmDcr-1 interaction within the sequence of the interdomain linker, the 
truncations were tested in the GST-pulldown assay. 
The Loqs-0 construct precipitated dmDcr-1 very efficiently (Figure 2.16 B, lane 3). The same 
observation was made for the truncation constructs Loqs-1, -2 and -3, which have a similar 
affinity as the full length linker construct, as the intensity of all dmDcr-1 signals, obtained after 
GST-pulldown, were almost identical (Figure 2.16 B, lane 4-6). This observation encloses the 
interaction surface between dmDcr-1 and Loqs to the region 337-368 within the Loqs interdomain 
linker. A further truncation of 11 amino acids resulting in a construct starting with aa 379 
however showed a strong effect on the pulldown efficiency of dmDcr-1 with a significant 
reduction of the western blot signal (Figure 2.16 B, lane 7). 
 
 
Figure 2.16: GST pulldown assay of Loqs-dsRBD3- and linker-constructs. (A) Pulldown assay of His-
dmDcr1 from SF21 cell lysate with GST-Loqs-dsRBD3 and point mutants as indicated (lanes 3-6). GST 
alone served as control (lane 2). Bound dmDcr1 is detected by immunoblot using a specific antibody and 
bait proteins were stained with Coomassie blue. (B) Pulldown assay as in (A) using Loqs constructs Loqs-
0-4 containing sequential truncations of the interdomain linker (lanes 3-7). 
 
GST-Loqs-3, which contains amino acids 368-463 of Loqs-PB, has been identified as the minimal 
construct, which contains the high affinity interaction site located in the interdomain linker 
between dsRBD2 and dsRBD3. A secondary structure prediction of the isolated linker region, 
using the program Jpred4 (Drozdetskiy et al., 2015), shows major parts of this linker to be 
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unstructured except for the region of the minimal construct Loqs-3 where a relatively high 
probability for a helix was predicted (Figure 2.17). Sequence analysis of this linker region reveals 
an alternating sequence of hydrophobic and hydrophilic amino acids with an increment of 3-4 
residues, which might form an amphipathic -helix. The hydrophobic side of the amphipathic 
helix consists of L371, N373, L379/80/82 and L387. 
 
 
Figure 2.17: Secondary structure prediction of the interdomain linker between dsRBD2 and 3. 
Potential secondary structure elements were marked as letters (H for helix) underneath the sequence of the 
interdomain linker. The minimal construct (Loqs-3) for the high affinity interaction with dmDcr-1 starts at 
residue number 368 (indicated above the sequence) within the sequence of Loqs. The last line stands for the 
reliability of prediction accuracy, which ranges from 0 to 9 and where high numbers indicate a strong 
confidence of the prediction for each respective residue. 
 
While mutations L371A and N373E in GST-Loqs-3 had no effect on dmDcr-1 binding (Figure 
2.18 A, lanes 4 and 5), there was a clear effect when L387 was mutated to alanine (See Figure 
2.18 A, lane 7). The mutation of K378 to glutamate also showed reduced dmDcr-1 binding 
(Figure 2.18 A, lane 6). Consistently with the findings described before, the mutation F419A 
showed an effect also in the presence of the complete interaction surface within the minimal 
construct Loqs-3. The contribution from the linker region (amino acids 368-463), however, is able 
to partly rescue the phenotype of the F419A mutation (compare lane 4 in Figure 2.16 A with lane 
8 in Figure 2.18 A). Hence, the double mutant L387A/F419A had the strongest effect in the GST-
pulldown assay (Figure 2.18 A, lane 9) due to the combined mutations in the linker region and in 
the dsRBD3. 
To further characterize the contributions of the linker- and the dsRBD3-interaction surface to the 
binding of dmDcr-1, GST-dsRBD3 and GST-Loqs-3 were used simultaneously in a GST-
pulldown assay and the signal from the dmDcr-1 was set into relation between the two constructs 
(see Figure 2.18 B, lane 2 and 3). The linker containing GST-Loqs-3 construct was able to 
precipitate roughly 10 fold more dmDcr-1 compared to GST-dsRBD3 indicating a strong increase 
of the affinity to dmDcr-1 when the interdomain linker is present. 
To quantify the difference of the dsRBD3 with and without the linker region in more detail, FCCS 
measurements were performed by our collaborators
1
 (See Figure 2.1). Affinity determination was 
performed for GFP-labeled dmDcr1 with an Alexa Fluorophore 647 (AF647) labeled dsRBD3 
(dsRBD3
AF647
) and Loqs-3 (Loqs-3
AF647
). For dsRBD3
AF647
 a Kd value of 191.5 nM ± 27.6 nM was 
                                                          
1
 See author-contribution page 
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measured. The Loqs-3
AF647
 construct dramatically increased the affinity resulting in a Kd value of 
6.7nM ± 2.2nM (data not shown) which reflects an increase of the affinity to dmDcr-1 of around 
30 fold. However both proteins were artificially modified with a fluorescent dye which could 
cause some deviations compared to the wt proteins. 
To eliminate the influence of the fluorescent AF647 protein dye, the measurement was repeated 
using the unlabeled dsRBD3 and Loqs-3 as competitors against Loqs-3
AF647
 for GFP-dmDcr-1 
binding. Loss of cross-correlation between the two fluorophores was measured, depending on the 
concentration of the added unlabeled protein (Figure 2.18, C). FCCS data provided an IC50 value 
of 104 nM for the dsRBD3 alone which corresponds to a Ki value of 43.6 nM. For the Loqs-3 
construct an IC50 value of 9.3 nM was obtained which corresponds to a Ki value of 3.6 nM. 
These data exactly correlate with the relative dmDcr-1 signals from the GST-pulldown, which 
showed a 10 fold higher affinity when the linker is present in the bait protein. 
Altogether, these observations indicate that two different binding sites in Loqs exist, which 
interact with dmDcr-1. The dsRBD3 has a lower affinity to dmDcr-1 but might provide specificity 
for the binding. The linker in contrast contributes with a high affinity to the binding but has a 
rather low specificity, as supported by a GST-pulldown assay whereby the linker alone fused to 
GST precipitated only a very low amount of dmDcr-1 but contained a strong background level of 
unspecific precipitated proteins (Figure 2.25 B, lane 8) suggesting misfolding and thus this 
control was not suitable for in vitro pulldown experiments. 
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Figure 2.18: The interdomain linker contributes to dmDcr-1 binding. (A) GST pulldown assay for the 
characterization of important aas within the minimal interacting construct Loqs-3 (lanes 3-9). The signal for 
the precipitated dmDcr-1 was normalized to the wt construct and related to the mutant-signals. (B) GST 
pulldown assay of in presence (Loqs-3, lane 2) or absence (dsRBD3, lane 3) of the interaction surface 
within the interdomain linker. (C) Fluorescently labeled Loqs-3
AF647
 was bound to GFP-dmDcr1 and 
subsequently competed with different amounts of unlabeled Loqs-3 or dsRBD3. IC50 values were obtained 
and Ki values were calculated according to Cheng-Prusoff. 
 
2.7 In vivo characterization of the Loqs-dmDcr-1 interaction interface 
To examine the influence of the residues identified by the in vitro GST-pulldown assay, an in vivo 
assay was designed where the wildtype- and mutant-constructs of Loqs and dmDcr-1 were co-
transfected into Dicer-deficient mouse embryonic fibroblasts (MEF Dcr
-/-
) (Chong et al., 2010; 
Frohn et al., 2012; Smibert et al., 2013) in context of the respective full length proteins. As 
dmDcr-1 alone cannot rescue mouse Dicer loss and requires the interaction with Loqs to process 
mammalian miRNA precursors (Bogerd et al., 2014; Förstemann et al., 2005), the detection of 
rescued let-7a levels gives a functional readout for the interaction between both proteins within 
the cell. Therefore several mutations were introduced within the sequence of full length Loqs-PB 
(Figure 2.19) and the rescue of mammalian miRNA precursor processing was tested in the rescue 
assay by analyzing of the level from rescued mature let-7a miRNA. 
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Figure 2.19: Schematic overview of full length Loqs. Mutations were marked with red lines. Double 
slashes indicate a change in the scale of the aa sequence. 
 
For the rescue assay, MEF Dcr
-/-
 cells were co-transfected with a modified pIRESneo eukaryotic 
expression vector (VP5), containing sequences of the different constructs and an N-terminal FH-
tag (see Results, chapter 1.1) for anti-FLAG western blot detection. The forward transfection of 
the “hard to transfect” MEF Dcr-/- cells was quite inefficient resulting in a low number of GFP 
positive cells (Figure 2.20 A). However, in a reverse transfection of the MEF Dcr
-/-
 cells, the 
efficiency could be increased to ~20 fold of additional GFP positive cells (Figure 2.20 B). 
Therefore all constructs used in the rescue assay were reverse transfected into MEF Dcr
-/-
 cells. 
 
 
Figure 2.20: Transfection of MEF Dcr
-/-
 cells. (A) Two random pictures of MEF Dcr
-/-
 cells transfected 
with VP5 GFP by forward transfection. (B) Two random pictures of MEF Dcr
-/-
 cells transfected with VP5 
GFP by reverse transfection showing higher transfection efficiency then in (A). 
 
After the transfection of MEF Dcr
-/-
 cells with the respective proteins, total RNA was isolated for 
the detection of let-7a by Northern blot analysis. To confirm the right size of the rescued let-7a 
miRNA, total RNA from MEF Dcr
+/+
 cells was loaded as a marker control (Figure 2.21 A, lane 1). 
As a negative control for let-7a processing and as an indicator for transfection efficiency, FH-
tagged GFP was used. As expected, no signal for a mature let-7a miRNA was detectable (Figure 
2.21 A, lane 2). As a second control, the human Dicer (hsDcr), which is able to efficiently process 
miRNA precursors also in the absence of its dsRBP partners TRBP and/or PACT (Kim et al., 
2014), was expressed in MEF Dcr
-/-
 cells (Figure 2.21 A, lane 3). As expected, the rescue of let-7a 
with the hsDcr resulted in the strongest signal for the mature miRNA. In case of the dmDcr-1 
alone, on the other side, the rescue of let-7a was quite inefficient, as only a faint band was 
detectable for the mature let-7a miRNA (Figure 2.21 A, lane 4). Upon addition of full length 
Loqs-PB to the dmDcr-1 mediated rescue of let-7a processing, there was a strong increase of the 
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signal from the mature let-7a miRNA (Figure 2.21 A, lane 5), which was sufficient to provide a 
direct readout for the interaction between both proteins. 
Therefore we addressed the functional relevance of the two identified Dicer-interaction modules 
in Loqs for miRNA processing by dmDcr1, introducing single and combined point mutations 
within the sequence of full length Loqs-PB. To identify differences between Loqs-PB wt and 
mutants, all signals from the let-7a northern blot were normalized to the wt rescue considering 
expression levels of each Loqs-PB construct. A mutation of L371 to alanine did not affect the 
interaction to dmDcr1 (Figure 2.21 A, lane 6), which is consistent with the findings from the in 
vitro binding experiments (Figure 2.18 A, lanes 3-9). Loqs N373E, however, which was able to 
precipitate dmDcr-1 with the same efficiency as the wt protein, rescued dmDcr-1 processing less 
efficiently (Figure 2.21 A, lane 7). Although the interaction is unaffected, the signal for the 
mature let-7a is only ~45% compared to wt, which might be due to technical differences between 
the two assays or between the truncated and the full length proteins. For Loqs K378E which 
showed a reduced binding to dmDcr-1, also the relative signal intensity of the rescue activity is 
decreased to ~55% (Figure 2.21 A, lane 8). Mutations of leucines 379, 380, 382 and 387, that 
might be part of the potential amphipathic -helix (Figure 2.17), had the strongest effect in the 
rescue assay, where triple mutant Loqs L379/380/382A comprised only a weak dmDcr-1 
activation with a relative signal intensity of ~20% compared to wt activation (Figure 2.21 A, lane 
9) and the single point mutation Loqs L387A to even less than 20% (Figure 2.21 A, lane 10), 
which means almost no activation at all. These findings emphasize the importance of the 
hydrophobic stretch of leucines as part of a possibly amphipathic helix for the interaction to 
dmDcr-1. Single point mutations of this interdomain linker binding module are sufficient to 
efficiently disturb the interaction of Loqs-PB and dmDcr-1. 
Furthermore the second binding module in the L2 loop within the dsRBD3 was investigated. 
Therefore a mutation of F419 to alanine was subjected to the in vivo and showed an effect on the 
processing from the let-7a pre-miRNA, where the relative signal intensity for the mature let-7a 
miRNA only reached ~30% of the signal from the wt rescue (Figure 2.21 A, lane 11). Consistent 
with the findings from the binding assay, this observation underlines the importance of the 
potential “hydrophobic finger” also in the context of the full length protein. 
Taken these findings together, our in vitro binding studies and in vivo dmDcr-1 activity assays 
provided evidence that dsRBD3 harbors a low and the linker region a high-affinity dmDcr-1-
binding site. Single point mutations within these modules were sufficient to disturb complex 
formation between Loqs and dmDcr-1 and directly affected dmDcr-1 activity in the in vivo rescue 
assay. 
To further address the influence from the high affinity interaction module to dmDcr-1 binding in 
the full length context, an expression vector of the naturally occurring splice variant Loqs-PA was 
generated. Loqs-PB contains both the high affinity interaction site within the interdomain linker 
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and the low affinity site of the dsRBD3, the high affinity site is almost completely missing in 
Loqs-PA due to alternative splicing (Figure 2.21 B upper panel). Therefore, we tested both 
isoforms in the activity assay and consistent with the results described before, only Loqs-PB 
(Figure 2.21 B, lane 1) was able to process pre-let-7a efficiently whereas in Loqs-PA experiments, 
the level of the rescued let-7a was only slightly increased (Figure 2.21 B, lane 2) compared to a 
rescue with dmDcr-1 alone (Figure 2.21 A, lane 4). Therefore Loqs-PA does not only bind 
dmDcr-1 with reduced affinity (Förstemann et al., 2005), but was also not able to reconstitute 
dmDcr-1 activity in our in vivo assay, indicating that interaction via the linker region binding 
module is crucial for efficient dmDcr-1 function. 
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Figure 2.21: An in vivo Dicer rescue assays for the functional analysis of Loqs-dmDcr-1 interactions. 
(A) FH-dmDcr-1 (lanes 4-11), wt Loqs (lane 5) as well as the indicated Loqs mutants (lanes 6-11) were co-
transfected into Dicer-deficient MEFs. Additionally, FH-GFP and FH-hsDcr (lanes 2 and 3) were 
transfected as controls. Endogenous let-7a from Dcr
+/+
 MEFs (lane 1) was loaded as a marker and 
processing in the deficient cells was analyzed by Northern blotting (upper panel). FH-dmDcr-1 (middle 
panel) or FH-Loqs (lower panel) expression was analyzed by Western blotting using anti-HA antibody. 
Loading of the Northern blot samples was controlled by EtBr staining and loading of Western blots via an 
actin blot. (B) Comparison of the Loqs-PB (lane 2) and Loqs-PA (lane 3) isoforms in the rescue assay. 
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2.8 Loqs-dsRBD3 forms homodimers in the crystal and in solution 
Loqs-dsRBD3 forms a tetrameric assembly in the crystal, where two monomers exchange 
secondary structure elements and are connected to each other (Figure 2.13 A and B). When the 
effect of the observed domain swaps was corrected, a dimeric assembly could be isolated. To 
analyze the protein contact interfaces of the isolated dimer in the crystal, a calculation was 
performed using the PISA-server (Krissinel and Henrick, 2007), which is an interactive tool for 
the exploration of macromolecular interfaces based on a structural model of a protein. The 
algorithm predicted a highly stable dimer in solution with a dimerization interface of about 700 Å
2
 
(Figure 2.22 A). Thereby, most of the dimerization interface is represented by hydrophobic 
contacts between the two monomers and a parallel orientation of aas 434-438 in each β3-strand, 
which forms an extended β-sheet in the middle of the dimer. 
To further support our structural model of the Loqs-dsRBD3 dimer, we performed a crosslinking 
experiment, using disuccinimidyl suberate (DSS) with a mixture of and HA-tagged Loqs-3 and 
recombinant dmDcr-1. As expected, HA-Loqs-3 can be readily crosslinked to a species migrating 
as a dimer in a denaturing SDS-PAGE and subsequent anti-HA western blot (Figure 2.22 B). 
Even with increasing amounts of crosslinker, the HA-Loqs-3 dimer did not form further 
homomeric aggregates indicating a specific crosslink within the solution-stable dimer. 
Furthermore, HA-Loqs-3 was crosslinked to dmDcr-1, where a clear shift was detectable for 
Loqs-3-HA (green) from ~13 kDa above the dmDcr-1 band (red) at ~255 kDa (Figure 2.22 B, 
upper panel), indicating a native interaction between both proteins. 
Also indicative for the existence of a stable dimer in solution is the running behavior of Loqs-3 in 
SEC (Figure 2.22 C). The column was calibrated with globular proteins of known molecular 
weight and respective elution volumes were indicated with arrows above the chromatograms. The 
wt Loqs-3 construct elutes at a relative size of ~26 kDa which is twice the MW of the monomer. 
As a control for the running behavior of a monomeric dsRBD, the isolated second dsRBD 
(dsRBD2) of Loqs was applied and elutes exactly at the predicted MW of ~14 kDa. In a further 
step, a mutant was designed, which was able to disturb the dimerization. Therefore L426 which is 
located in β2 and points towards the C-terminal helix of the second monomer was replaced 
against a bulky arginine which has a similar probability of occurrence in a β-sheet position (Smith 
et al., 1994) and thus does not disturb the formation of the secondary structure in β2. As expected, 
this mutant completely inhibits the formation of an intact dimer and the mutant elutes at the 
volume of a monomeric dsRBD (Figure 2.22 C, orange graph). 
Additionally to the L426R mutant that exhibited a rather severe phenotype, amino acids K460 and 
I461, located in the C-terminal helix, were mutated. When K460, which is supposed to form a salt 
bridge to E416 (located in L2), was exchanged to glutamate, this led to an intermediate elution of 
the Loqs-3 mutant in the gel filtration assay (Figure 2.22 C, red graph). Unlike the L426R mutant, 
60 
 
K460E is still able to form dimer contacts but interactions between the two monomers were 
attenuated. However K460 did not form a salt bridge to E416 in the crystal which is likely an 
effect of the hydrophobic di-methylation of the lysine side chain which reduces the overall 
positive charge. Additional mutation of I461, which is located next to K460 and forms 
hydrophobic stacking interactions within the dimer, even reinforced the effect (Figure 2.22 C, 
blue graph) as the elution volume was again shifted closer to the monomeric elution volume 
(Figure 2.22 C, orange and green graphs). 
 
 
Figure 2.22: Loqs dimerizes via its dsRBD3. (A) Structure model of a dimer from native Loqs-dsRBD3 
molecules. The side chain of residue L426 is shown as yellow sticks and I461 as red sticks. (B) 
Crosslinking assay of purified His-dmDcr-1 and HA-Loqs-3 (aa 368–463). Concentrations of DSS-
crosslinker are indicated on top. Both proteins are detected by immunoblot, Loqs by an anti-HA-antibody 
(green) and dmDcr-1 by a specific antibody (red). Positions of monomeric and dimeric Loqs-3 are indicated 
on the right. (C) Size-exclusion chromatography of Loqs-dsRBD2 (green), Loqs-3 wt (black), Loqs-3 
L426R (orange), Loqs-3 K460E (red), and Loqs-3 KI460/461EA (blue). Elution volumes of globular 
standard proteins are marked as black arrows above the chromatogram. 
 
 
 
 
 
61 
 
2.9 DmDcr-1 interaction in context of Loqs-dsRBD3 dimerization 
After the identification of a stable dimer of the Loqs-dsRBD3 in the crystal and in solution we 
addressed the question, how the dimerization of the Loqs-dsRBD3 affects its binding to dmDcr-1. 
Therefore, constructs with the mutations L426R, K460E and KI460/461EA were generated for the 
in vitro binding- and for the in vivo activity assays, respectively. First we used the GST-pulldown 
assay with mutations of the minimal construct Loqs-3 (Figure 2.23 A (top panel)). Thereby, the 
interaction with dmDcr-1 was completely abrogated in case of L426R (Figure 2.23 A(top), lane 
4). Due to the severe phenotype in the in vitro binding assay, L426R was subjected to an in vivo 
binding experiment with Loqs-PB full length variants in HEK 293 cells. To do so, we expressed 
FH-Loqs-PB wt and L426R together with myc-tagged dmDcr-1 and performed a myc-IP of 
dmDcr-1 (Figure 2.23 A (bottom)). The HA-western blot signal for the co-precipitated FH-Loqs-
PB gave a direct readout for the interaction between both proteins in the cell. As expected, the 
signal for FH-Loqs-PB L426R (Figure 2.23 A(bottom), lane 3) was strongly decreased compared 
to the signal for FH-Loqs-PB wt (Figure 2.23 A(bottom), lane 4), indicating a strong effect of 
L426R on both dimerization and dmDcr-1 interaction. Consistent with that, the interaction 
interface of the mammalian Dicer-TRBP complex has recently been published (Wilson et al., 
2015). The interface which Loqs uses for dimerization is, in case of the dsRBD3 of TRBP, bound 
to an α-helical insertion within the hsDcr helicase domain. Furthermore, to confirm this 
assumption, we subjected the L426R mutation in Loqs-PB to the dmDcr-1 activity assay. As 
expected, the dimerization mutant had also a reproducible effect in the dmDcr-1 activity assay, 
where the rescue with L426R led to no detectable increase of the signal for mature let-7a miRNA 
(Figure 2.23 B, lane 3) above the background level of a rescue where only dmDcr-1 was present 
(Figure 2.21 A, lane 4). 
To further test whether Loqs-PB binds to dmDcr-1 by its dimerization surface, mutation of K460 
or K460 and I461, which contribute to the dimer interface via a potential salt bridge and 
hydrophobic contacts and led to a destabilization of the dimer reflected by an intermediate elution 
in the SEC assay (Figure 2.22 C), were applied to the dmDcr-1 binding and activity assays, 
respectively. In TRBP, I361 participates in Dicer binding via hydrophobic interaction with L360 
on Dicer. K360 on the other hand is pointing away from the interaction site suggesting no 
relevance for the binding to hsDcr. Consistently, in the GST-pulldown assay, GST-Loqs-3 K460E 
had no influence on the binding to dmDcr-1 (Figure 2.23 A (top), lane 5) and also pre-let-7a 
miRNA processing activity was not influenced (Figure 2.23 B, lane 4). Therefore K460 
contributes rather to dimer formation then to the interaction surface with dmDcr-1. An additional 
mutation of I461 to alanine in the context of K460E, however, decreases the amount of 
precipitated dmDcr-1 in the GST-pulldown assay (Figure 2.23 A(top), lane 6) and also impairs 
miRNA procession activity in the rescue assay (Figure 2.23 B, lane 5). 
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Conclusively, residues which are responsible for the dimerization of Loqs-dsRBD3 were shown 
to have also an effect on the interaction with dmDcr-1. However, the results obtained so far, gave 
no information about the stoichiometry of both proteins in the Loqs-dmDcr-1 complex. 
 
 
Figure 2.23: GST-pulldown and Dicer-rescue assays for the functional analysis of the Loqs-dimer. (A) 
(Top) GST-Pulldown assay of His-dmDcr1 with GST-Loqs-3 and mutants as indicated. (Bottom) FH-
tagged wt Loqs (lanes 2 and 4) or FH-Loqs L426R (lanes 1 and 3) were co-transfected with myc-dmDcr-1 
into HEK 293 cells. Myc-dmDcr1 was immunoprecipitated using anti-myc antibodies and the 
immunoprecipitates were analyzed by Western blotting using anti-dmDcr-1 (upper panel) or -HA antibodies 
(lower panel). Lane 5 shows an IgG control. (B) Influence of the Loqs dimerization mutants L426R, 
K460E, and KI460/61EA on miRNA processing. 
 
To address the question, whether Loqs-dsRBD3 binds to dmDcr-1 as a monomer or a dimer, we 
used single molecule immunoprecipitation analysis
1
 (Figure 2.24 A). The single molecule pull-
down (SiMPull) assay that combines the principles of a common pull-down assay with single 
molecule fluorescence microscopy enables direct visualization of individual cellular protein 
complexes by immobilizing them on a quartz surface (Jain et al. 2011). This method is highly 
sensitive and can determine the stoichiometry of biomolecular complexes. Therefore we used the 
recombinant GFP-tagged dmDcr1 (See chapter 2.6) and Loqs-3
AF647
, that contained exactly one 
single AF647 label within the dsRBD3. A preformed complex of GFP-dmDcr-1 and Loqs-3
AF647
 
was immobilized on a passivated quartz slide, using a biotinylated GFP antibody (Figure 2.24 A) 
and fluorophores were exited using total internal reflection fluorescence (TIRF) microscopy. 
                                                          
1
 See author-contribution page 
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Single AF647 fluorescence spots were detectable in the dmDcr1 containing fraction and were 
mostly absent, when GFP-dmDcr-1 was omitted (Figure 2.24 B, C), indicating a relatively weak 
unspecific binding of Loqs-3
AF647
 to the surface and providing evidence to the specificity of the 
immobilization strategy. The photosystem of single fluorescent emitters is not permanently stable 
upon excitation and shows an abrupt decrease in fluorescence intensity, a process also known as 
photobleaching, which then can further be used to count the number of molecules present at an 
individual fluorescent spot. For the Loqs-3
AF647
/GFP-dmDcr-1 complex, one fraction (~90%) 
showed one single bleaching step and a minor fraction (~10%) showed two bleaching steps 
(Figure 2.24 D, E). This could rather be explained by an unspecific background binding of the 
labeled dimer then by a dimer bound to GFP-dmDcr-1. In summary these findings indicate that, 
although Loqs forms dimers in solution, it is bound as a monomer to dmDcr-1, which is consistent 
with the findings for the hsDcr-TRBP complex (Wilson et al., 2015). 
 
 
Figure 2.24: Single-molecule co-IP assay of the Loqs-dmDcr-1 complex. (A) Schematic overview of the 
assay (B) Total internal reflection fluorescence (TIRF) images of Alexa647-labeled molecules (Loqs-3
AF647
) 
pulled down via GFP-dmDcr-1. The GFP-dmDcr-1 fusion protein was immobilized on the quartz slide via a 
biotinylated anti-GFP antibody (scale bar: 10 µm). As a control, Loqs was flushed over the slide without 
prior incubation with GFP-dmDcr-1. (C) Average numbers of Loqs-3
AF647
 molecules per imaging area 
 6800 μm2). (D) Representative single-molecule fluorescence transients of Loqs-3AF647 molecules that 
exhibit one-step and two-step photo bleaching. (E) Photo bleaching step distribution for Loqs-3
AF647
 bound 
to dmDcr1 indicating a 1:1 stoichiometry for the Dicer–Loqs complex. Data were collected from four 
independent experiments from a total number of 1558 molecules. 
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2.10 Characterization of the TRBP-hsDcr interface for the analysis of 
post translational modifications on hsDcr 
For the characterization of the Loqs-dmDcr-1 interface, an in vitro binding assay was established 
(see chapter 2.6). Furthermore, this assay was adapted for the Loqs homolog TRBP, to 
characterize the binding between TRBP and hsDcr. To do so, we fused GST to different 
truncations of the interdomain linker between the dsRBD2 and dsRBD3 (aa positions 231-291) 
together with the dsRBD3. Interestingly one part of the linker region (aa 261-291) is required for 
the solubility of the dsRBD3 construct and truncations within this region led to insoluble proteins 
(data not shown), suggesting a requirement of residues within this region for the stability of TRBP 
in solution. 
In an initial GST-pulldown screen, the binding of the TRBP constructs, TRBP-1 (aa 231-363), 
TRBP-2 (aa 241-363), TRBP-3 (aa 261-363) and the interdomain linker alone (aa 231-291) to 
overexpressed FH-hsDcr were investigated (Figure 2.25 A). As expected, all constructs 
containing the interdomain linker connecting dsRBD2 and 3 were able to efficiently pulldown 
FH-hsDcr (Figure 2.25 A, lanes 10-12) except the linker alone or the GST-control (Figure 2.25 A, 
lanes 2 and 13). To test whether Loqs is able to interact with the hsDcr, truncations of Loqs were 
used in the binding assay to precipitate FH-hsDcr. However, all Loqs constructs used for the 
pulldown, only had a very weak affinity to FH-hsDcr (Figure 2.25 A, lanes 3-8). The interdomain 
linker of Loquacious (Figure 2.25 A, lane 8) comprised the highest level of precipitated FH-hsDcr 
which might be due unspecific binding caused by misfolding in the absence of the dsRBDs (see 
chapter 2.6). 
Interestingly, when dmDcr-1 was applied to the same a GST-pulldown assay, all truncations of 
TRBP (Figure 2.25 B, lanes 10-12), except the isolated interdomain linker between dsRBD2 and 
3 (Figure 2.25 B, lane 13), were able to efficiently precipitate dmDcr-1, in an equal or even higher 
level than the Loqs constructs (Figure 2.25 B, lanes 3-7). Taken these findings together there is 
some evidence that Loqs harbors a special feature, like its tendency to form dimers in solution 
(see chapter 2.8), to specifically recognize dmDcr-1 and not the human Dicer. As hsDcr has a 
higher sequence similarity to dmDcr-2 (data not shown) this feature might therefore be important 
for the discrimination between the two Drosophila Dicers. 
Due to the high pulldown efficiency of the TRBP dsRBD3, which was not only restricted to 
hsDcr, the binding assay was used for the enrichment of the hsDcr for MS analysis. Therefore 
TRBP-3 was used to precipitate either the endogenous or overexpressed FH-tagged human Dicer 
from HEK293 cells (Figure 2.25 C). The precipitation efficiency was assayed by western blotting 
using a Dicer-specific antibody. Additionally a western blot against Ago2 was performed to 
investigate if human Ago2 is co-precipitated in the GST-pulldown. As Ago2 is part also of the 
RLC, it is likely to be co-precipitated within the pulldown experiment and would provide 
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information about the phosphorylation status that is present in proteins within the RLC. From a 
lysate, containing the overexpressed FH-hsDcr, the pulldown worked quite efficiently with a 
strong signal for hsDcr (Figure 2.25 C, lane 6). The endogenous hsDcr was precipitated less 
efficiently but there was still a prominent Dicer band (Figure 2.25 C, lane 7), that looked 
promising for MS analysis. However, there was no band detectable for Ago2, that co-precipitated 
with the hsDcr in the GST-TRBP-3 pulldown and also in the Ago2 control-IP (Figure 2.25 C, lane 
3) there was no detectable band for hsDcr, indicating that a possible complex of Ago2 and hsDcr 
might not be stable under tested conditions. Thus MS analysis was performed on the precipitated 
endogenous hsDcr and overexpressed FH-hsDcr. As MS analysis required high amounts of 
proteins, a large scale GST-pulldown, using GST-TRBP-3, of either endogenous or overexpressed 
hsDcr was performed and loaded onto an 8 % SDS-gel which was stained with Coomassie (Figure 
2.25, D).  
 
 
Figure 2.25: GST-pulldown of the hsDcr. (A) GST-pulldown assay of overexpressed hsDcr with Loqs- 
and TRBP-linker constructs. (B) GST-pulldown assay of overexpressed dmDcr-1 with Loqs- and TRBP-
linker constructs. (C) Pulldown of endogenous and overexpressed FLAG/HA-tagged hsDcr with TRBP-3 as 
bait protein (upper panel). Control for co-precipitation of endogenous Ago2 with an Ago2 specific western 
blot (lower panel). (D) Coomassie gel of a large scale GST-pulldown for endogenous and FLAG/HA-
tagged hsDcr1. Bands used for MS analysis were marked with an asterisk. 
 
The bands containing hsDcr were excised from the gel and used for MS analysis after elution and 
tryptic digestion. Digestion with trypsin, which cleaves after lysines, generates a specific cleavage 
pattern with unique peptide composition for any protein. These peptides can be separated 
according to molecular weight and their overall charge and detected on the MS detector which 
results in their amino acid composition. Post-translational modifications alter the molecular 
weight and charge of peptides and therefore can be differentiated from unmodified peptides. For 
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this study, the digested hsDcr samples were analyzed for post translational modifications with the 
focus on phosphorylation sites. Thereby both samples comprised high sequence coverages with 
62.5 % for the endogenous and 56.3 % for the FH-hsDcr. 
In case of the endogenous hsDcr, only one phospho-site, Y1330 (Figure 2.26, bold), which is 
located in the RNase III domain, could be identified. This is probably due to the lower amount of 
precipitated protein (Figure 2.25 D). For the overexpressed FH-hsDcr, more protein was available 
for the MS-analysis and six additional phospho-sites were identified. Four were located within 
functional domains, Y153 in the helicase domain, S678 in the dsRBD, S1016 in the PAZ domain 
and S1470 in the RNase III domain of hsDcr (Figure 2.26). The remaining two sites were the 
adjacent S1252 and S1255 and are located in an interdomain region between the PAZ and RNase 
III domain (Figure 2.26). Phospho-sites S1016, S1252, S1330 and S1470 were already annotated 
on the PhosphoSitePlus® (www.phosphosite.org) databank. Y153, S678 and S1255, however, 
have not been annotated yet from any post-translational modification screen. 
Table 2.3 gives an overview of the type of amino acid, the respective position and the score of the 
identified phospho-sites within the hsDcr sequence. Sites of endogenous hsDcr are marked with 
bold letters. 
Taken these findings together, a fragment of the human TRBP (TRBP-3) can be used for an 
efficient hsDcr-isolation. The amount of precipitated hsDcr was sufficient to identify several 
phospho-sites within the sequence of the hsDcr. Furthermore, TRBP-3 was able to efficiently 
precipitate the dmDcr-1 and therefore might also be used for the isolation and characterization of 
Dicer-proteins from other species. 
To sum up the first part of this thesis, novel insights into the miRNA biogenesis pathway and 
RISC-loading process in flies and humans were obtained. Using X-ray crystallography the 
structure of Loqs-dsRBD3 was solved, providing evidence of an interaction surface that is either 
bound by dmDcr-1 as a monomer or dimerizes in the absence of dmDcr-1. Additionally, several 
residues within the interdomain linker region between dsRBD2 and 3 in Loqs-PB were identified 
which provide a high affinity dmDcr-1 binding site. Whereas Loqs-dsRBD3 comprised features 
that allowed a specific recognition of dmDcr-1, the dsRBD3 of TRBP was able to efficiently 
pulldown both, the dmDcr-1 and hsDcr and therefore might be used for the enrichment of Dicer 
proteins from different species in general. From the enriched hsDcr several phospho-sites were 
obtained by MS. 
After the processing of pre-miRNAs by the Dicer-dsRBP complex, the mature miRNAs were 
loaded onto an Ago protein. Therefore an Ago-loading assay using FCCS was established, 
resulting in a detailed kinetic observation of the loading process from different human wt and 
mutant-Ago proteins. 
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Figure 2.26: Schematic overview of the identified phospho-sites of the human Dicer 
 
Table 2.3: Identified phospho-sites of the human Dicer 
hsDicer aa position score location 
endogenous Tyrosine (Y) 1330 19.6 RNase III 1 
overexpressed 
(FLAG/HA) 
Tyrosine (Y) 153 31.9 Helicase (ATP-binding) 
Serine (S) 678 32.7 dsRBD 
Serine (S) 1016 14.2 PAZ domain 
Serine (S) 1252 24.3 Interdomain region (PAZ/RNase III 1) 
 Serine (S) 1255 15.9 Interdomain region (PAZ/RNase III 1) 
 Serine (S) 1470 71.9 Interdomain region (RNase III 1+2) 
 
In the miRNA biogenesis pathway, several RNA-binding proteins, that contain unique 
compositions of RNA-binding domains, are required for efficient substrate recognition and 
processing, to generate a mature miRNA, which allows an Ago protein to function as a post-
transcriptional regulator. Loqs thereby contains three dsRBDs, where two dsRBDs (dsRBD1+2) 
are able to specifically interact with the dsRNA-stem regions of pre-miRNA. Ago on the other 
hand is a RNA binding protein that binds to ssRNA by its PAZ and Piwi domains. The NHL-
domain of Drosophila Brat belongs to another family of RNA binding proteins, which is involved 
in the post transcriptional regulation of many mRNA targets that contain a specific Brat binding 
motive. In the second part of this thesis, the molecular details of the target-recognition of the Brat-
NHL domain were structurally characterized through crystallization of the Brat-NHL domain in 
complex with its consensus motif RNA. 
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3. Crystallization of the Brat-NHL domain in complex with its 
consensus motif RNA 
In previous studies, the NHL domain of Brat has been identified to contact the hunchback mRNA 
in a sequence-specific manner, which leads to translational repression (Loedige et al., 2012) and 
(Loedige et al., 2014). In follow-up experiments, that were performed by others in our lab, the 
consensus motif with the sequence 5’-UUGUUG-3’ was identified and showed a significantly 
high affinity for the Brat-NHL domain. To identify the molecular details behind the interaction 
between the Brat-NHL domain and its consensus front motif RNA, the complex was formed, 
isolated and applied to X-ray crystallography. 
 
3.1 Purification of the Brat-NHL-RNA complex 
For the generation of the Brat-NHL-RNA complex, the highly purified NHL domain of Brat (aa 
756–1037) as described in (Loedige et al., 2014) was used together with a 15 nucleotide long 
RNA, containing the consensus motif within the first 6 nucleotides of the sequence (consensus 
front RNA) followed by a stretch of 9 Us (5’-UUGUUGUUUUUUUUU-3’). The consensus motif 
was identified with multiple expectation and maximization for motif elicitation (MEME) (Bailey 
and Elkan, 1994) and a second method termed RNAcompete (Ray et al., 2009), in which the 
recombinant NHL domain of Brat together with a complex pool of short RNAs was used in vitro, 
to screen for high affinity sequence motifs. 
To analyze the complex formation, the Brat-NHL domain and the consensus front RNA, which 
were both provided by postdocs in the lab
1
, were loaded separately onto a Sepharose 75 10/300 
gel filtration column. The highly purified Brat-NHL domain eluted at 13.2 ml as a homogenous 
peak (Figure 2.27 A). The consensus front RNA however eluted at approximately 14.6 ml but 
contained a contaminant nucleic acid species, which eluted in front of the consensus front RNA 
peak at ~13.5 ml (Figure 2.27 B). This contamination might derive from a degradation of the 
hammerhead ribozyme system (Price et al., 1995), used for generating the RNA, as it increased 
after longer incubation for the autocatalytic cleavage (data not shown). If an equal amount of 
Brat-NHL is added to the consensus front RNA, a clear shift of the complex could be detected to 
~12.2 ml (Figure 2.27 C). The contaminant remained unaffected referred to its elution behavior 
(peak at 13.5 ml) upon addition of the Brat-NHL domain. 
 
 
 
 
                                                          
1
 See author-contribution page 
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Figure 2.27: Analytical gel filtration of the Brat-NHL-RNA complex. (A) Analytical gel filtration of the 
Brat-NHL domain alone. Absorption of the protein at 260 nm (red line) and 280 nm (blue line) was 
monitored. (B) Analytical gel filtration of the consensus front RNA alone. (C) Analytical gel filtration of 
the Brat-NHL domain in complex with the consensus front RNA. 
 
The complex preparation for crystal screening was scaled up and Brat-NHL was supplemented 
with an equal amount of consensus front RNA. The amount of RNA was adjusted according to 
the ratio between contamination and consensus front RNA. Fractions containing the complex 
were isolated after a first Sepharose 75 10/300 gel filtration column (Figure 2.28 A) and 
concentrated. A second gel filtration showed only a slight shoulder deriving from the 
contamination and a single peak for the purified and highly stable complex (Figure 2.28 B). 
Complex containing fractions were pooled, concentrated to ~2.3 mg/mL and used for 
crystallization studies. 
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Figure 2.28: Preparative gel filtration of the Brat-NHL-RNA complex. (A) First preparative gel 
filtration of the Brat-NHL-RNA complex (~12 ml). An RNA contamination included in the consensus front 
RNA sample could also be detected (~13.5 ml). (B) The complex containing fractions from the first gel 
filtration were concentrated and subjected to a second gel filtration column. The contamination was 
strongly reduced and the complex remained stable. 
 
3.2 Crystallization of the complex 
In an initial crystallization trial, the complex was subjected to the commercially available crystal 
screens JBScreen Classic 1-8, JBScreen Wizard I-IV and Natrix I and II (Table 4.11) in 96 well 
sitting drop plates (see methods, chapter 7.1). The complex crystallized after one day in a single 
condition containing 100 mM MES pH 6.5, 2 M ammonium sulfate, 5 % (w/v) PEG 400 at 20°C. 
The crystals grew as a tetragonal bipyramids with a size of less than 0.1 mm. 
For X-ray crystallographic measurements, conditions with initial crystals, in most cases, require 
further refinement to improve the quality of the crystals. Therefore refinement screens, using the 
“hanging drop” and the “sitting drop” method in 24 well crystallization plates, were performed, 
where the drop size, the pH, the concentration of the precipitant and from other components of the 
initial condition were altered. However, within these refinement screens, the crystals from the 
initial condition were hardly reproducible and only formed in two additional conditions (Data not 
shown). The crystals within these conditions did not differ from the initial crystals and thus, as 
refinement screening failed to optimize the crystals for X-ray crystallographic measurements, 
crystals from the initial sparse matrix screen were used. Therefore, crystals were either briefly 
soaked in cryo-buffer (20% glycerol, 5% PEG400 and 500 mM ammonium sulfate) or directly 
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taken out of the condition without further treatment and frozen in liquid nitrogen and stored for X-
ray crystallographic measurements. 
 
3.3 Data collection and structure determination 
The data collection was performed at the BESSY (Berlin) on the beamline BL14.2 where cryo-
buffer treated and untreated crystals were measured. The crystals, which were treated with cryo-
buffer, diffracted with a resolution range of ~3 Å in the highest resolution shell. The untreated 
crystals, however, showed a much better diffraction down to ~2.7-2.3 Å in the highest resolution 
shell. The reservoir solution from the initial sparse matrix screen was already sufficient to act as a 
cryo-buffer and was able to protect the crystals upon freezing as no ice rings were observed on the 
diffraction images of the dataset. Ice rings develop upon too early nucleation of ice crystals in the 
crystal-surrounding solution and therefore act as an indicator for insufficient cryo-protection of 
the crystal. 
Datasets were recorded from untreated crystals. The Brat-NHL-RNA complex crystallized in the 
tetragonal space group P4122 with a resolution of 2.3 Å. Table 2.4 shows some statistical 
parameters of the collected data. 
 
Table 2.4: Data collection statistics 
 native 
Wavelength (Å) 0.9814 
Resolution range (Å) 19.77-2.3 (2.4-2.3) 
Space group P 41 2 2 
Unit cell, a b c,  70.19 70.19 279.87, 90 90 90 
Total reflections 388255(46244) 
Unique reflections 32238 (3769) 
Multiplicity 12 (12.3) 
Completeness (%) 99.99 (100.00) 
Mean I/sigma(I) 11.77 (2.42) 
Wilson B-factor [Å2] 26.99 
CC½ [%] 99.5 (74.2) 
Values as reported by CORRECT. Values in parentheses refer to the highest resolution shells.  
 
Phasing of the Brat-NHL-RNA crystal was performed using molecular replacement with the 
program Phaser (McCoy, 2007). The crystal structure from the apo Brat-NHL domain (pdb entry 
1Q7F) was used as a search model (Edwards et al., 2003). Two monomers of Brat-NHL with high 
Z-scores were placed into the asymmetric unit cell (Figure 2.29 A). The Z-score judges the quality 
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of the in silico solution of the phase problem and values above 8, which was the case for Brat-
NHL, imply an unambiguous solution. 
Model building was performed in COOT (Emsley et al., 2010) and refinement of the model 
against the density was performed with PHENIX.refine (Afonine et al., 2012) using simulated 
annealing and non-crystallographic symmetry restraints (NCS). If the refinement was performed 
without consideration of hydrogen atoms, there was a gap between Rwork and Rfree of more than 
five percent, which indicates a strong model bias, which derives from the search model that was 
used for molecular replacement. The refinement under consideration of the hydrogen atoms 
resulted in a much lower gap with a Rwork value of 0.188 and Rfree value of 0.219 (Table 2.5) and 
is therefore more reliable. 
Two monomers of the Brat-NHL domain and one molecule of the consensus front RNA were 
built into in the asymmetric unit cell, where the Brat-NHL monomers were bound to one RNA 
molecule simultaneously (Figure 2.29 A). 
 
 
Figure 2.29: Asymmetric unit cell of the Brat-NHL-RNA complex. (A) Overview of the asymmetric unit 
cell where two Brat-NHL domains bind to one molecule of the consensus front RNA. (B) B-factor plot of 
single nucleotides from the consensus front RNA. High Bav values indicate a strong flexibility and weak 
binding whereas low values indicate less flexibility and strong binding to the protein backbone. 
 
For an estimation of temperature-caused vibrational motion of different parts of the structure, the 
B-factors were used. Thereby, atoms with low B-factors can be assigned to parts of the structure 
that is well ordered, whereas atoms with large B-factors generally belong to parts of the structure 
that are flexible. The B-factor of the protein chains was 29.67 Å
2
 for chain A and 31.85 Å
2
 for 
chain B indicating a relatively rigid and well-ordered binding platform for the RNA. Only in a 
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small loop region of chain A, there was only poor electron density and therefore S825 could not 
be built into in the structural model.  
Regarding the bound consensus front RNA on the other side, the distribution of the B-factors 
varies strongly between each single nucleotide position (Figure 2.29 B). A plot of the B-factors 
for each nucleotide against its position within the RNA sequence clearly highlighted the strongest 
binding or the lowest flexibility, respectively. The minima of the B-factor plot occurred at 
positions G3, U4 and U5 in monomer A and positions U11, U12 and U13 in monomer B. 
Nucleotide U7, which is located between the monomers showed the highest flexibility and the 
pyrimidine base therefore was not resolved in the electron density. U15 at the 3’ end of the 
consensus front RNA could also not be built because of poor electron density, which was 
additionally split to two possible conformations. All building attempts to place the terminal 
nucleotide into the electron density, lead to an increase of the Rwork and Rfree values and therefore 
U15 was omitted from the structural model. Model statistics and structure refinement data are 
given in Table 2.5. 
 
Table 2.5: Model statistics and structure refinement 
Parameter Brat-NHL/RNA complex 
Rwork/Rfree 0.188/0.219 
Modelled polypeptides  
Chain A/B 758-824,826-1036 / 758-1035 
Modeled RNA  
Chain C Nts 1-14, 15 not resolved 
No. of non-hydrogen atoms 5133 
macromolecules 4697 
water/ligands 338/98 
RMS(bonds) [Å] 0.003 
RMS(angles)  [°] 0.75 
Ramachandran favored (%) 96.7 
Ramachandran outliers (%) 0 
Clashscore 1.28 
Average B-factor [Å2] 31.72 
Protein (Chain A/B) 29.67/31.85 
RNA 46.27 
ligands/solvent 43.90/33.50 
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3.4 The crystal structure of the Brat NHL-RNA complex 
To illustrate the molecular details behind this sequence specificity, the crystal structure of the 
Brat-NHL domain in complex with a 15 nt long consensus front RNA has been solved at a 
resolution of 2.3 Å (Figure 2.29 A). The Brat-NHL domain assembles as a six-bladed β-propeller, 
which surrounds a solvent filled channel at the center of the domain. The top surface of the NHL-
domain contains mainly positively charged amino acids, which are mostly forming a platform for 
the interaction with the backbone of nucleic acids. This conformation remains mainly unchanged 
upon substrate binding. The bottom surface, however, mainly has a negative overall charge and 
was not involved in RNA binding in the crystal structure. The binding of the consensus front 
RNA is mediated via three different binding regions, which are responsible for specific base 
recognition (Figure 2.30 B). U1 and U2 stack against each other and are bound between blades II 
and III of the β-propeller. G3 is bound between blades IV and V flipped out from the π-stacking 
interaction with the residual RNA strand. The last three nucleotides from the consensus motif U4, 
U5 and G6 stack against each other and were coordinated between blade VI and I (Figure 2.30 A). 
The pyrimidine base of U1 from the consensus motif interacts with the protein backbone via π-
stacking to Y829 and the base forms two hydrogen bonds from O2 to R847 and one hydrogen 
bond from N3 to N800. However, the electron density was weak for the base of U1 and also the 
high B-factors indicate some flexibility within this region. N2 from the second U is coordinated 
by E782 and the base stacks against U1 (Figure 2.30 C, panel 1). 
The 5’ phosphate of G3 is bound by K891 and R875, which also contact the 5’ phosphate of the 
neighboring U4 and thus enabling a conformation whereby G3 can flip out of the π-stacked RNA 
strand to form specific contacts with the protein backbone. Thereby, the aromatic ring of G3 is 
stacked onto F916 which enables the purine base to form two hydrogen bonds with peptide bonds 
of the protein main chain. Ring position N1 forms a hydrogen bond with the peptide carbonyl 
group of E915 and O6 with the peptide amine of K891 (Figure 2.30 C, panel 2). The rigid 
assembly of the protein backbone specifically enables a guanosine to form a maximum of possible 
interactions explaining the binding preference for a G at position 3 within the consensus motif. 
Nucleotide U4 and the adjacent U5 form most of the interactions with the Brat-NHL domain and 
were tightly bound to the protein backbone. This is reflected by the minima of the B-factor plot 
(Figure 2.29 B). The 2’O  of the ribose attached to U4 forms hydrogen bonds to the side chains 
of N933 and R934 and therefore represent contacts that are specific for an RNA template, as 
DNA, on the other side, lacks this 2’O  group. Ring positions O2 and O4 of the uracil base from 
U4 make specific hydrogen bonds to the side chain amide of N933 and the peptide N-H of C1004. 
In addition, N3 forms a hydrogen bond to a water molecule that is coordinated by the protein 
backbone via the peptide carbonyl of Y959 and the peptide N-H of N976. U5 stacks to the base of 
U4 and contacts the protein backbone via hydrogen bonds of ring positions N3 to the peptide 
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carbonyl of N976 and O4 to its side chain amide. The coordinated water, which binds to U4, also 
contacts U5 at ring position O2 (Figure 2.30 C, panel 3). 
G6 is the last nucleotide of the consensus motif and extends stacking interactions with U4 and U5. 
N1 binds to the peptide carbonyl of H1001 and N2, which is specific for guanosine is also able to 
make hydrogen bonds to the backbone carbonyls of H1001 and N978 (Figure 2.30 C, panel 4). 
The RNA, which was used for the crystallization contained the consensus motif within the first 
six positions followed by a stretch of nine uracil bases. This stretch is bound by a second Brat-
NHL domain allowing a direct comparison of the complete versus an incomplete binding motif. 
U9 and U10, which were equivalent with U1 and U2, show the same coordination in both 
monomers. U11, which is equivalent with G3, is also flipped out of the RNA strand and stacks 
against F916. However the pyrimidine base is only able to form one single hydrogen bond to the 
backbone N-H of K891, which might explain why poly(U) also exhibits a relatively strong 
affinity to the Brat-NHL domain (data not shown). U12 and U13, which are equivalent to U4 and 
U5, also show the same coordination in both monomers. The G6 equivalent U14 is not able to for 
similar hydrogen bonds as the guanine base and therefore the electron density is only weakly 
defined at this position. 
Taken these findings together, the crystal structure of the Brat-NHL domain bound to its RNA 
consensus binding motive reveals how sequence specificity is brought about. Thereby, three pairs 
of neighboring β-blades from the β-propeller form three specific binding clefts, which allow a 
perfect accommodation of the six bases from the consensus motif through a network of base-
specific hydrogen bonds. 
Within this thesis, novel insights into Dicer processing and Ago loading concerning the miRNA 
biogenesis pathway could be obtained. Furthermore the molecular details behind the interaction of 
a consensus RNA motif and the Brat-NHL domain could be identified at atomic resolution. In the 
following section these results will be discussed under consideration of the recent scientific 
background. 
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Figure 2.30: Structure of the Brat-NHL domain bound to its consensus motif RNA. (A) Structure 
model of the Brat-NHL domain bound to RNA. Top: model of the six-bladed β-propeller of the NHL 
domain viewed from the top surface. The individual blades are numbered, and the bound RNA is shown as 
a stick representation. Center: electrostatic surface representation of the Brat-NHL top side with bound 
RNA. Bottom: side view of the complex with the electrostatic potential shown for the protein domain. (B) 
Schematic representation of the protein/RNA contacts. Side chains forming stacking interactions to RNA 
bases are shown in red. Ionic interactions with the phosphate backbone of the RNA are indicated in green. 
Hydrogen bonds with the bases or sugars of the RNA are shown in black. (C) Close-up view of the RNA 
binding pockets. RNA is shown in cyan, and protein residues are shown in yellow. Hydrogen bonds are 
marked by dashed lines. Side chains not interacting with the RNA are drawn as thin lines, and interacting 
side chains and backbone atoms are shown as thick lines and labeled. All chain cuts are marked with halos. 
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III. Discussion 
In eukaryotic cells, gene expression is highly regulated by processes, which require a large set of 
different RBPs, of which each displays specific RNA- and protein-protein interactions. The 
interaction with target RNA can be either mediated directly by RBP-RNA interactions or 
indirectly via base paring with an RBP-bound complementary guide RNA strand. In this thesis, 
X-ray crystallography and single molecule spectroscopy have been used for the characterization 
of representatives from both groups. 
MiRNAs are small RNAs of 21-24 nts in length and are endogenously expressed as pri-miRNAs 
by PolII in the nuclei of eukaryotic cells. Two RNase III enzymes, nuclear Drosha and cytosolic 
Dicer, are responsible for the generation of mature miRNAs including their correct ends. During 
the last several years, many novel insights into the mechanisms underlying the processing of 
miRNAs could be obtained. However, lots of molecular details of the interaction between Dicer 
and its dsRBP partners during pre-miRNA processing as well as strand selection during Ago 
loading are still unclear. Therefore, one aim of this thesis was to structurally and functionally 
characterize interactions between Dicer and associated dsRBPs as well as further investigating 
determinants of strand-specific Ago-loading processes following pre-miRNA processing. 
TRIM proteins belong to one of the largest protein families and are conserved among many 
different species. Thereby, TRIM family members containing the NHL-domain have been 
identified as key regulators of developmental transitions. In progenitor stem cells, for example, 
TRIM family members promote differentiation, while inhibiting cell growth and proliferation. 
The NHL-domain of the Drosophila TRIM-NHL protein Brat has recently been identified as a 
novel RNA-binding domain (Loedige et al., 2014) classifying TRIM-NHL proteins as direct 
RBPs. Therefore, the aim of the second part of this thesis was to crystallize the NHL domain of 
Brat together with its consensus RNA motif, to elucidate how binding specify and selectivity is 
achieved. 
 
1. RISC loading in mammals 
The mammalian RISC loading follows a cytosolic procession step where Dicer, in complex with 
its dsRBP partners, removes the stem loop from the pre-miRNA and produces the second end of 
the mature miRNA. Thereby, the miRNA duplex has a 2 nt overhang at both 3’ ends and a 
phosphate group at each 5’ end. Regardless of the sequence of each strand, the overall shape of 
the duplex is symmetric and the ends are chemically equal. One strand of the duplex, however, is 
recognized as the guide strand and is incorporated into an Ago protein while the passenger strand 
is rapidly degraded. About the loading of the duplex strand and the determination of the correct 
incorporation of the guide strand little is known so far. In fact, the small RNA duplex itself 
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already represents one determinant for the selection of the guide. Base pairing at both ends of the 
duplex strongly contributes to guide strand selection. Following the so called asymmetry rule, the 
strand with the thermodynamically less stably paired 5’ end is preferentially loaded into Ago 
proteins and becomes the guide strand (Khvorova et al., 2003; Schwarz et al., 2003). 
For knockdown experiments of any gene of interest in the cell it is therefore important to design 
siRNA duplexes with an effective guide strand loading into Ago. The asymmetry rule thereby 
needs to be considered. Until today neither sequence specificity nor any influence of the siRNA 
structure on guide incorporation into Ago could be shown. X-ray crystal structures of human 
Ago2 in complex with a single-stranded guide RNA revealed sequence-independent interactions 
between amino acids and guide RNA backbone phosphates (Elkayam et al., 2012; Schirle and 
MacRae, 2012). Further X-ray crystal structures of ternary hAgo2-guide-target complexes 
revealed a binding pocket for position 1 of the target RNA which specifically binds adenosine 
(Schirle et al., 2015, 2014). 
Based on these observations, it seems that additionally to the thermodynamic asymmetry, at least 
one part of the sequence of the guide strand could be important for the efficiency of the guide 
strand incorporation. Therefore, one aim of this thesis was to analyze sequence-specific effects of 
siRNA duplexes on loading efficiencies. Thus an FCCS assay was designed to monitor binding of 
Ago to a set of different guide RNAs. 
 
1.1 Ago loading resolved by FCCS 
FCCS was chosen to monitor Ago-loading processes, because it is a highly sensitive method 
detecting molecular interactions on a nanomolar level (Schwille et al., 1997). One other advantage 
of this assay is its application in a high-throughput scale allowing screening of various siRNAs in 
parallel. To enable detection and characterization of the binding partners, both species need to be 
fluorescently labeled. Therefore, Ago was fused to an N-terminal GFP-tag, whereas the siRNAs 
were synthesized with a Cy5 label at the 3’ end of the predicted guide strand. To circumvent 
variability of different transient transfections, stable HEK TREx-293 cell lines were generated 
using a vector encoding GFP-tagged Ago protein. 
To detect Ago-loading events, a lysate of respective GFP-tagged Ago proteins was generated 
using hypertonic swelling of the cells (Dignam et al., 1983b). Unfortunately, freezing of the lysate 
resulted in the formation of aggregates, which interfered with the FCCS measurements. Addition 
of supplements according to Martinez et al. (2002) stabilized the lysate enabling freezing without 
a major loss of activity. The amount of glycerol was adjusted from 10 % to 5 % because higher 
concentrations of glycerol (>10%) alter the refraction index of the solution and thus hampers the 
detection of the fluorescently labeled particles within the measurement chamber. To remove Ago 
containing aggregates and higher MW complexes (Figure 2.2, A), centrifugation of the lysate at 
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100.000 x g was necessary because these particles caused inhomogeneity in the fluctuation curve 
of the FCCS measurements. 
Introducing all these modifications, a lysate was generated that enabled the observation of binding 
events between a Cy5 labeled siRNA and active GFP-Ago protein, more or less uninfluenced by 
the fluorescent labels (Figure 2.2, B,C and D). Furthermore the lysate was stable for several 
freeze-thaw cycles without the loss of Ago loading activity. 
 
1.2 siRNA-loading into Ago proteins 
Following the optimization of a binding competent lysate for the FCCS assay, measurements with 
3’ Cy5 labelled siRNAs were performed. These measurements are essential to allow further large 
scale screening attempts with different unlabeled siRNAs and to validate whether the efficiency of 
a siRNA-mediated knockdown is influenced by its affinity to an Ago protein. 
Based on a functional knockdown screen that was performed by Michael Hannus (siTOOLs 
Biotech GmbH), where several siRNAs against PLK were tested, two siRNA candidates were 
randomly chosen. For the FCCS assays, both carried a Cy5 label at their 3’ ends. For both siRNAs 
the correlation between knockdown efficiency and incorporation efficiency into Ago was 
determined. The Kd value of the less effective siRNA (si856, Kd ~544 ± 1 nM) is about fivefold 
increased, compared to the more efficient siRNA (si428, Kd ~126 ± 15 nM). To exclude variations 
in the lysate quality, both siRNAs were measured in a lysate from the same batch. Both siRNAs 
display thermodynamic asymmetry but whereas in case of si428 the first base pair is an U/A pair 
which is less stable base pairing than the 5’ G/C pair of si856. This difference in the 5’-end 
explains the less efficient binding of si856 to Ago2. Compared to literature the Kd values of the 
binding from Ago2 to a guide 3’ Cy5 labeled 21-mer siRNA duplex were slightly increased 
compared to 21-mer siRNA duplex with a guide strand that is labeled with fluorescein at position 
14 (counted from the 5’ end) with a Kd value of ~48 nM (Deerberg et al., 2013). This difference 
of the Kd values might derive from an influence of the fluorescent label on the binding of the 3’ 
end of the guide strand at the PAZ domain of Ago2 but still lies in a rage of a certain error 
between both methods of measurement. 
Due to this potential effect of the Cy5 label on the 3’ end binding of the siRNA guide strand and 
to circumvent high costs for the synthesis of labeled siRNA strands, a competition assay with the 
already characterized Cy5 labelled si428 was established, which can further be applied to any 
unlabeled siRNA. Thereby the Kd values of the unlabeled inhibitor siRNAs, the Ki value, can be 
obtained. Notably it was essential to make serial dilutions of the unlabeled siRNA duplex, 
containing constant concentration of the labeled si428 duplex, prior adding the mixture to the 
lysate. If the lysate was incubated with the labeled si428 before the addition of the unlabeled 
siRNA, no competition of si428 could be observed due to a tight binding of the labeled strand. 
80 
 
This strong binding affinity might be caused by a processing of the siRNA duplex by Ago2 within 
the cellular lysate. After the passenger strand is removed, the single stranded guide strand 
comprises a higher affinity to Ago then the duplex strand (Deerberg et al., 2013). This effect has 
also been shown by other groups, which tried to compete endogenously loaded siRNAs in 
Drosophila Ago2 upon addition of an exogenous let-7 siRNA (Iwasaki et al., 2015). Thus the 
competition of loaded Ago with a siRNA duplex is strongly impaired and a pre-incubation with 
the labelled siRNA duplex is not advisable for the competition assay. 
When the competitor siRNA duplex was added simultaneously with the labelled si428, a 
competition of both duplexes for the binding to Ago2 could be measured resulting in Ki values, 
which represent the Kd of the competitor. A set of 8 unlabeled siRNAs against different members 
of the import family was used. All siRNAs showed an efficient knockdown activity except for one 
pair of siRNAs designed against the Transportin-1 (Tnpo) mRNA. As the Kd values for siRNAs 
with high knockdown efficiencies distributed of ~30 nM, the Tnpo si1, which had a quite 
inefficient knockdown efficiency, comprised a remarkably and reproducible shift of its Kd value 
to ~76 nM. This observation might be indicative that the affinity of the Tnpo si2 to Ago2 is 
decreased and that this correlates with the decrease of the knockdown efficiency. 
For characterization of the data obtained from the FCCS screen, further experiments should be 
performed to collect more details of the Ago loading process. First, all siRNAs which were used 
in this assay were added to the lysate without a 5’ phosphate. This phosphate has been shown to 
be critical for efficient Ago loading (Elkayam et al., 2012; Ma et al., 2005; Nykänen et al., 2001; 
Schirle and MacRae, 2012). It has been shown, that siRNAs are phosphorylated by cellular 
kinases upon addition to cellular lysates, however this process and further downstream loading 
processes require ATP. To exclude deviant measured Kd and Ki values, these experiments should 
be repeated with siRNA duplexes that contain a phosphate group at their 5’ends. 
Second, the FCCS assay as conducted can only resolve the binding of siRNA duplexes to Ago, 
whereas further downstream events like passenger strand removal and/or cleavage (Leuschner et 
al., 2006; Matranga et al., 2005; Rand et al., 2005) are hidden from view. Therefore a GFP-Ago-
IP should be performed after loading of the siRNA duplex under conditions of the FCCS assay. 
Northern blot analysis of the RNA extraction would further provide evidence which one of the 
two strands is incorporated as the guide and which one is removed as the passenger after loading 
or if both strands are detectable, which would be indicative for an incomplete unwinding of the 
duplex. Alternatively, a double labeled siRNA with a second fluorescent label at the passenger 
strand could also provide information about the fate of the siRNA duplex, once it is bound to an 
Ago protein. 
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1.3 Loading of human Ago 1-4 
Besides GFP-Ago2, other stable cell lines expressing GFP-Ago1, GFP-Ago2 H807R a slicer 
inactive mutant of Ago2, GFP-Ago3 and GFP-Ago4 were generated. Lysates from each cell line 
were titrated with the Cy5 labeled si426 and Kd values were obtained using FCCS. Disregarding 
of the kinetics from each loading event to the respective Ago proteins, loading could be observed 
in any tested lysate. However, with different Kd values for each Ago protein. For Ago1, the 
weakest binding affinity was measured. For Ago2 and the slicer deficient mutant Ago2 H807R, 
almost identical Kd values were measured. For Ago3 the strongest and for Ago4 the second 
strongest affinity could be measured. 
The monoclonal cell line of GFP-Ago3 and the polyclonal line of GFP-Ago4 expressed each 
respective protein less efficiently after induction with tetracycline and yielded in a lower amount 
of overexpressed protein after lysate preparation. Therefore, the effect of a higher affinity to the 
si428 duplex might rather derive from a better availability of other Ago endogenous loading 
factors like Hsp90, FKBP 4/5, Dicer and TRBP, which were included in the total cellular lysate, 
then from protein specific properties, which promote a stronger binding of si428. Additionally, 
lysates from high expressing cells were diluted with lysate from uninduced HEK-293 cells to 
adjust equal particle counts for the measurements of all Ago proteins. The lysate from the 
uninduced HEK-293 however was produced earlier and might therefore stronger be depleted from 
ATP which has been shown to be important for siRNA 5’ phosphorylation and unwinding of the 
duplex for RISC activation (Nykänen et al., 2001). 
To exclude an effect from the quality of different lysates, new lysates should be generated and 
measured directly after lysis. Additionally the expression from all GFP-Ago proteins should be 
adapted, that all constructs were equally expressed at the time point of cell lysis. Additionally, 
ATP should be added to the lysis buffer and measurements should be repeated with 
phosphorylated 5’ ends of the siRNAs as already mentioned above. 
 
1.4 Ago 2 phosphorylation 
Ago proteins are specialized RNA binding enzymes and play a key role in small RNA-mediated 
gene silencing. About their regulation, however, little is known up to date. MS data from 
endogenous proteomic screens or from overexpressed Ago proteins identified several potential 
phospho-sites (Rüdel et al., 2011; Sharma et al., 2014) but for most identified phospho-sites, no 
functional relevance has been assigned. 
The FCCS assay is a powerful tool to obtain information about the binding behavior of Ago to a 
dsRNA substrate. Thereby, the binding of any GFP-tagged mutant that mimics a potential 
phosphorylation within the sequence of Ago to a CY5-tagged siRNA can be monitored. To 
control the functionality of the assay in general, mutants of the putative phospho-site Y529, which 
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have been characterized earlier (Rüdel et al., 2011) have been generated with an N-terminal GFP 
tag and mutations of Tyr to Ala, Phe, Gln and Glu. Consistent with the results obtained in the 
paper, a mutation of Tyr to Glu had the strongest effect on the loading of Ago2 (Figure 2.6, B). 
As in the case of a potential phosphorylated Y529, the side chain from the Glu mutant sterically 
blocks the entry of the siRNA duplex into the 5’ binding pocket, which is additionally enforced by 
repulsion of a negative charge from the Glu carboxyl group and the also negatively charged 5’ 
phosphate. Furthermore, the Ago 2 Y529E mutant can be used as a negative control for the FCCS 
assay because the binding of small RNA duplexes is strongly impaired (Figure 2.6, B) as no 
correlation between GFP-Ago2 and the Cy5-tagged dsRNA could be measured even in conditions 
with high concentrations of the labeled siRNA. 
A second mutant, where Y529 is exchanged to Gln, shows a similar phenotype in the FCCS assay 
as the Glu mutant, however a weak residual binding affinity could be measured. This observation 
is consistent with the findings in Rüdel et al., (2011), where this mutant, together with the mutants 
Y529A and F, were still loaded with endogenous miRNAs after FH-Ago2 FLAG-IP and 
subsequent northern blot analysis and which was not shown in the case of Y529E. The Gln side 
chain has identical space-filling properties as the Glu side chain and is able to sterically block the 
entry of the 5’ phosphate into the 5’ binding pocket, however the effect of a strong electrostatic 
repulsion is reduced in the polar, uncharged side chain of Gln. This might explain the observed 
shift of the Kd value of the Y529Q mutant (Figure 2.6, D). 
A mutation of Y529 to Ala, compared to Gln and Glu, does not block the 5’ binding pocket and 
allows an entry of the 5’ phosphate into the 5’ binding pocket of Ago2. In the wildtype protein, 
the first nucleotide of the siRNA guide strand forms π-stacking interactions with Y529, which 
stabilizes a conformation of the first nucleotide in a kinked out conformation. The base stacking 
with the second nucleotide of the guide strand thereby is interrupted. In the Y529A mutation, the 
5’ binding pocket is accessible for the siRNA strand, however there are no π-stacking of the first 
base which could stabili e an optimal 5’ nucleotide binding. Therefore this might explain the shift 
of the Kd value to ~1.5 µM which is indicative for a low total affinity of the respective Ago2 
mutant to the dsRNA duplex (Figure 2.6, D). 
Consistent with the observations described above, a mutation of Y529 to Phe has the closest 
similarity to the binding behavior of the wt protein. The aromatic ring of the Phe side chain is able 
to stack against the first base of the siRNA and allows an optimal binding of the first nucleotide of 
the siRNA guide strand. Therefore the Kd value of the Y529F mutant is almost identical with the 
respective Kd of the wildtype Ago2 (Figure 2.6, D). Taken these findings together, the stacking 
interaction of the first nucleotide to Ago2 seems to be crucial for an efficient binding of the 
siRNA guide strand. 
From a MS screen performed with overexpressed FH-Ago2, S798 could be identified to be 
phosphorylated in the respective overexpressed background. Within this study, the mutants 
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S798A and S798E were applied for cleavage assay and controlled for loading with an endogenous 
miR-19b (Rüdel, 2010). For a Glu substitution, the cleavage activity was strikingly reduced 
compared to an Ala substitution. This effect did not derive from an altered guide strand binding 
behavior as both mutants were still equally loaded with endogenous miR-19b. Due to a lack of 
structural information at the time of this study, this effect could not be explained in detail. 
However after the determination of the structure from human Ago2 (Elkayam et al., 2012; Schirle 
and MacRae, 2012), it has been shown, that S798 is directly involved in the binding of miRNA by 
a hydrogen bond with the phosphate backbone from nucleotide 5. To examine whether mutations 
S798A and E of GFP Ago2 have an impact on the binding of Cy5 si428, lysates from both 
mutants were measured in the FCCS assay. The FCCS assay showed no detectable difference of 
the Kd values from both mutants (S798A and S798E) and both Kd values were identical to the one 
which was measured for the wildtype protein (Figure 2.6, D). 
The putative phospho-site S798 is located inside a flexible loop region ranging from residues 787-
800 within the PIWI domain ~10 Å away from to the catalytic DDH motif. An electrostatic 
repulsion caused by a mutation of Ser to Glu, which mimics the phosphorylated state from the 
sidechain of S798 might induce a movement of the flexible loop towards the catalytic core of 
Ago2. A movement in other directions is blocked by the protein backbone (Figure 3.1). This 
movement might further cause a disturbance within the catalytic DDH motif or simply interfere 
with the orientation of the target strand prior cleavage could explain effects which are observed in 
the thesis of Rüdel, (2010). The affinity to a siRNA strand however is generally unaffected by the 
S798E mutation, indicating an overall intact binding pocket for the RNA duplex and a relatively 
weak contribution of the hydrogen bond from S798 to the backbone of a siRNA. Therefore a 
phosphorylation of S798 might be required for regulation of Ago2 in general or in other Ago 
related processes which are independent of Ago slicer activity, e.g. during dsDNA break repair 
(Gao et al., 2014; Wei et al., 2012) or during Ago/RNA-mediated interaction with chromosomal 
DNA (Hall et al., 2002; Janowski et al., 2006), where the slicer activity might be disturbing and 
only RNA binding activity is needed. However further experiments would be required to clarify 
the mechanistic details behind this speculation. 
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Figure 3.1: Phosphorylation of S798 in human Ago 2. Left: The PIWI domain of Ago2 (PDB-ID: 4F3T) 
is shown in grey. S798 is located in a flexible linker region (orange) which is in close proximity (~10 Å) of 
the catalytic DDH motive. Amino acid side chains were shown as yellow sticks. Right: Mutation of S798 to 
E or a potential phosphorylation of the endogenous Ser causes sterical and electrostatic repulsion (red 
braces) at this position within the flexible loop. This repulsion might cause a shift of the loop towards the 
catalytic center (black arrow), which then further interferes with the catalytic slicer activity of Ago2. 
 
Taken these findings together, the FCCS assay is a powerful tool to study binding of a labeled 
dsRNA duplex to GFP-Ago in solution on a single molecule level. It is likely that co-localized 
particles refer to GFP-Ago and the Cy5 labeled single strand, however, control experiments (e.g. 
northern blot or binding study with a dual labeled siRNA duplex) still need to be performed. All 
GFP tagged Ago proteins were integrated into stable inducible cell lines. Therefore other potential 
candidates, which were implicated with Ago loading, could be either overexpressed or knocked 
down and the FCCS assay. This would provide a direct readout for potential effects on Ago 
loading. Furthermore a protocol needs to be established for the FCCS assay, where cells can be 
transiently transfected instead of generating stable cell lines, as this process is rather time 
consuming and not applicable for screening of high amounts of different mutants. 
 
2. Processing of miRNAs by a dsRBP/Dicer complex 
In flies, the processing of pre-miRNAs into mature miRNAs requires a functional complex of an 
RNase III enzyme which collaborates in complex with a dsRBP. In Drosophila, two different 
RNase III enzymes, namely dmDcr-1 and dmDcr-2, are responsible for the generation of small 
ncRNAs from long double-stranded precursor species. Thereby, dmDcr-1 in complex with Loqs-
PB and to some minor extend with Loqs-PA is able to process pre-miRNAs (Förstemann et al., 
2005). In humans, there exists only one Dicer (hDcr), which interacts with the Loquacious 
homologs TRBP and PACT. Disruption of the complex in both species has been shown to 
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interfere with the processing of pre-miRNA substrates as well as for a subset of miRNAs strand 
selection processes (Fukunaga et al., 2012; Wilson et al., 2015). However for mammalian Dicer, 
processing of pre-miRNAs in general seems to be rather independent of its dsRBP-partners, 
however the processing of several iso-miRs, which derive from the same pre-miRNA but were 
alternatively cleaved by Dicer, resulting in distinct seed regions, is affected by a complete loss of 
the human dsRBPs PACT and TRBP (Kim et al., 2014). Furthermore, in the absence of TRBP 
and/or PACT, strand selection by Ago2, where Ago2 is loaded with the guide strand and the 
passenger strand is removed and degraded, seems not to be altered in any of the miRNAs 
identified by small RNA sequencing (Kim et al., 2014). 
In Drosophila, the processing of miRNAs, however, is dependent of a functional complex of 
dmDcr-1 and Loqs (Bogerd et al., 2014; Fukunaga et al., 2012). So far, little is known about the 
molecular details of the dmDcr-1-Loqs interaction. For the characterization of the molecular 
details of this interaction, the crystal structure of Loqs-dsRBD3 has been solved at 2.65 Å 
resolution in this thesis. Furthermore, two different assays have been established to identify 
critical residues within the interaction surface by a screen of different point mutations in vitro and 
in vivo. 
 
2.1 Purification, crystallization and structure determination of Loqs-
dsRBD3 
For the crystallization of Loqs-dsRBD3, folded secondary structure elements of the dsRBD3 have 
been identified by in silico secondary structure prediction (PredictProtein). After the rigid core of 
the dsRBD3 has been identified and flexible unfolded regions at both sides of the dsRBD3 were 
omitted, a construct that contained residues 392-463 of Loqs-PB was recombinantly 
overexpressed. Purification of the protein yielded in a high grade of purity, which was required 
for X-ray crystallography. Subsequent crystallization screens with the wt protein failed to identify 
conditions, which resulted in initial crystals. Therefore the solubility of the construct was altered 
by methylation of Lysines, which lead to an increase of the hydrophobicity of the protein. Only 
one condition was identified, which resulted in crystals with an impaired crystal growth behavior. 
Regardless of the crystal growth behavior, the structure of Loqs-dsRBD3 could be solved 
comprising an arrangement of two domain swapped monomers packed against up to 4 single 
monomers within the asymmetric unit cell. This uncommon arrangement is supposed to originate 
from lacking crystal contacts and therefore might explain the macroscopic observation of the 
crystal growth behavior. The domain swap of two monomers might rather be required to 
compensate for lacking crystal contacts then having a functional meaning of this assembly in vivo. 
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2.2 The dmDcr-1-Loqs-dsRBD3 complex 
The interaction between dmDcr-1 and its cofactor Loqs is mediated by the dsRBD3 which is only 
present in isoforms Loqs-PA and –PB (Förstemann et al., 2005). When not associated with his 
dsRBP partner, dmDcr-1 has some weak processing activity for pre-miRNA substrates which is 
drastically increased upon binding to the isoform Loqs-PB (Fukunaga et al., 2012; Jiang et al., 
2005). Additionally, it has been shown that a 46 aa extension of the Loqs-PB specific interdomain 
linker region could enhance affinity of Loqs to dmDcr-1 (Ye et al., 2007). In this study, the 
molecular details of the interaction between the dsRBD3 and the Loqs-PB specific interdomain 
linker to dm-Dcr-1 were investigated. By truncation of the linker region between dsRBD2 and 
dsRBD3, a stretch of 24 aa together with the dsRBD3 was identified, which contains all residues 
that are required for the interaction with dmDcr-1 (Figure 2.16). Using different technical 
approaches, the interaction surface with dmDcr-1 was identified to be separated into two different 
binding modules. One module is the dsRBD3 itself, which has a rather low affinity to dmDcr-1. 
The solvent exposed F419 in the loop region L2 from the dsRBD3 thereby plays an essential role 
(Figure 2.16 A). A point mutation at this positon strongly affects the interaction with dmDcr-1 
and the activity in the in vivo reconstitution assay. 
Another module is located within the dsRBD2/3 interdomain linker within a putative amphipathic 
helical folding, where one side is made up by several unpolar Leu residues and the other side 
contains mainly charged residues (Figure 2.17). Several point mutations within this region were 
identified to have an impact on dmDcr-1 binding and pre-miRNA processing activity of the 
complex. Altogether these residues make up a strong contribution to the interaction surface which 
leads to a tenfold increase of the affinity between the Loqs and dmDcr-1 when the Loqs-PB 
specific linker region is present (Figure 2.18 B). This increased affinity is furthermore required 
for an effective complex formation and functionality in vivo, as only isoform Loqs-PB and 
not -PA led to a rescue of the mature let-7a miRNA in the rescue assay (Figure 2.21 B). 
Taken these findings together, two specific dmDcr-1 contact sites located in the linker region as 
well as in the dsRBD3 were identified. While the low affinity interaction of the dsRBD3 might be 
important for specificity, the linker region strongly contributes to a high binding affinity. This 
twostep model for dmDcr-1 binding gives further rise to the speculation, that a proof reading 
mechanism might take place during pre-miRNA positioning for an accurate processing and/or 
strand selection upon Ago1 loading. Such a model, however, needs further experimental 
verification, for example by solving the crystal-structures of either Loqs-3 alone or the dmDcr-1 
helicase surface in complex with Loqs-3. These structural data would provide further insights into 
cooperative pre-miRNA processing and the involvement of the interdomain-linker region. 
For the human Loqs homolog TRBP, there exist structural data about the TRBP/Dicer interface 
(Wilson et al., 2015). The TRBP construct contains most of the dsRBD2/3 interdomain linker and 
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a helical insertion of the Dicer helicase domain. The linker region is rather flexible and almost 
completely not resolved. However there exists a small helical part that is packed against the 
dsRBD3, which is supposed to originate from the dsRBD2/3 interdomain linker region. It is 
therefore tempting to speculate that there might also be an additional binding site where this part 
of TRBP contacts Dicer, which is not present within the Dicer construct that was used by this 
group for crystallization. 
To identify the potential interaction surface of the dmDcr-1 site, a limited proteolysis of dmDcr-1 
Loqs-3 complex coupled with MS analysis could be performed. Having identified such a minimal 
interaction construct, crosslinking of the respective dicer helicase fragment with Loqs-3 could be 
repeated as crosslinking with the full length dmDcr-1 with Loqs-3 did not result in reliable inter-
crosslinks which might be caused by the predominant amount of peptides from dmDcr-1 intra-
crosslinks. From the full length dmDcr-1-Loqs-3 crosslink, one peptide could be identified with a 
relatively weak score, where K391 is crosslinked to K673 of the dmDcr-1 site. These two Lys 
were located within the interdomain region between the helicase domain and the dsRBD on the 
dmDcr-1 surface and in front of the dsRBD3 in the Loqs-3 construct. However these observations 
require further experimental replicates and optimization. 
 
2.3 Dimerization of Loqs-dsRBD3 
After solving the crystal structure of Loqs-dsRBD3, the asymmetric unit cell of the crystal 
revealed an unexpected assembly of the dsRBD3 monomers. Two monomers exchange secondary 
structure elements and were physically coupled to each other through an exchange of secondary 
structure elements. The overall folding of the single domain swapped dsRBD3s, however, is 
identical to the folding observed for each of the three unswapped monomers, which are 
additionally present in the asymmetric unit cell. The domain swap occurred in loop region L3 and 
generates two monomers with the topologies α1β1β2β3’α2’ and α1’β1’β2’β3α2 (Figure 2.13 A 
and B). To each domain swapped monomer a second native monomer is assembled generating a 
symmetric dimer. As the domain swap might rather be an artefact due to lacking crystal contacts 
that are required for the formation of the macroscopic crystal, the dimeric assembly, however, was 
identified to be highly stable in solution according to in silico calculations with the PISA-server 
(Krissinel and Henrick, 2007). Consistent with the observations from the data, the purified Loqs-
dsRBD3 eluted at a volume that corresponds to twice as much as the molecular weight calculated 
for one single monomer and could also be readily detected by chemical crosslinking of two Loqs 
monomers with DSS (Figure 2.22, B and C). A mutation of L426 to Arg, which introduces a 
charged and bulky sidechain into the mostly hydrophobic surface for dimerization, was able to 
completely abolish dimer formation in vitro and in vivo (Figure 2.23, A and B). 
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The crystallized Loqs-dsRBD3 dimer uses a high confidence surface for the interaction of both 
monomers when dmDcr-1 is not present for binding. Interestingly, this surface is conserved in 
several other protein-interacting dsRBDs among different species (Figure 3.2, A). And in fact for 
the dsRBD3 of TRBP and PACT it has been shown by several other groups that there exists a 
tendency for the formation of homo- and heterodimers (Hitti et al., 2004; Kok et al., 2007; 
MacRae et al., 2008). A sequence alignment of the dsRBD3 from dsRBPs acting in small RNA 
processing pathways in various organisms shows a strong conservation of structural elements that 
were required for the formation of the Loqs-dsRBD3 dimers (Figure 3.2, A). It is therefore likely 
that dimerization might either be required for stabilization of a Dicer unassociated dsRBP and/or 
for any yet unknown physiological processes in the cell which require a Dicer unassociated form 
of the dsRBP (See working model in Figure 3.3). 
The Drosha dsRBP partner DGCR8 from the microprocessor complex has been shown to 
dimerize and act together with Drosha as a Dimer (Faller et al., 2007; Herbert et al., 2016; 
Senturia et al., 2012, 2010). To determine the stoichiometry of the dmDcr-1 Loqs-PB complex, 
single molecule analysis was applied. Bleaching steps of Loqs-3
AF647
 bound to dmDcr-1 were 
counted and revealed a clear 1:1 ration between dmDcr-1 and Loqs-3 (Figure 2.24). Consistent 
with this finding, the interaction surface between the dsRBD3 of TRBP and a helical insertion of 
the Dicer helicase domain also reveals a 1:1 complex of both proteins (Wilson et al., 2015) 
indicating a dissociation of the dsRBP Dimer upon binding to its respective Dicer partner. A 
superposition of Loqs-dsRBD3 with TRBP dsRBD3 shows an almost identical folding of both 
proteins and the single dsRBDs can easily be aligned on top of each other in both structural 
models (Figure 3.2, B; C and D). Thus it is conceivable that TRBP and PACT might form homo- 
and/or heterodimers in a similar manner then Loqs and that the interaction surface between Loqs 
and dmDcr-1 might comprise an analogy to the one from TRBP in complex with the human 
Dicer. 
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Figure 3.2: The dimerization interface of Loqs-dsRBD3. (A) Sequence alignment Loqs-dsRBD3 with 
functional homologs of the TRBP and PACT protein families from different organisms. (B) Superposition 
of Loqs-dsRBD3 (cyan) and TRBP dsRBD3 (blue, PDB ID: 4WYQ) (C) Superposed structure of 
Loqs/TRBP dsRBD3 packed against a second Loqs monomer (orange). (D) Superposed structure of 
Loqs/TRBP dsRBD3 packed the human Dicer helicase interface. 
 
Furthermore it has been shown by other groups (Fukunaga et al., 2012; Ye et al., 2007) that the 
affinity of the dmDcr-1 interacting isoforms from Loqs, Loqs-PA and –PB, strongly differs 
between these variants. Both isoforms were generated by alternative splicing and Loqs-PB 
contains an extended interdomain linker region. In this thesis, it has been shown by FCCS 
measurements that this region is able to increase the affinity around 10 fold compared to the 
dsRBD3 alone (Figure 2.18, B and C). In the in vivo dicer reconstitution assay, the rescue of let-
7a miRNA was inefficient when dmDcr-1 was co-transfected with Loqs-PA. Consistent with that, 
a recent study identified Loqs-PB as the predominant isoform that interacts with dmDcr-1, 
however which is only required for ~40% of all endogenous miRNAs which are expressed in flies 
(Lim et al., 2016). 
Considering the dimer formation of Loqs-dsRBD3, it is therefore possible that an alternative 
function of the Loqs dimer might exist in vivo when it is not associated with dmDcr-1 (See 
working model in Figure 3.3). The mRNA expression of loqs-RA and loqs-RB strongly differs 
among tissues and developmental stages in Drosophila somatic cells (Fukunaga et al., 2012). The 
expression of loqs-RA is in general lower at earlier stages of development and increases with 
progressing time of development. The germ cells from male and female flies also comprise 
different expression of both isoforms. In adult male flies, testes predominantly express loqs-RA, 
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whereas female ovaries express loqs-RB in higher levels then loqs-RA (Fukunaga et al., 2012). If 
these differences in the expression of the two isoforms originate from a need of different miRNA 
isoforms during developmental processes or from potential Dicer unrelated functions in the cell is 
unclear. For the Loqs homolog TRBP it has been shown that besides its involvement in the 
generation of cellular miRNAs, it has a function in cell cycle regulation, where TRBP undergoes 
hyperphosphorylation during mitosis by the c-Jun N-terminal kinase (JNK), which then enhances 
the inhibitory activity of TRBP on PKR (Kim et al., 2014). 
If there are further Loqs-mediated functions besides its implication in the miRNA processing 
pathway, needs to be experimentally verified. An IP of either endogenous or overexpressed Loqs-
PA and -PB in different tissues or cell lines from Drosophila combined with MS analysis might 
provide information about other protein interactors and a potential contribution of the Loqs dimer 
in other cellular processes. Consistent with this assumption, Loqs has been identified in a MS 
coupled GST pulldown of Sex-lethal (SXL), which is responsible for the female-specific 
repression of male-specific-lethal-2 (msl2) mRNA (Graindorge et al., 2013). However if the 
findings of this study are specific and Loqs actually comprises a function within the msl2 
repression needs to be further experimentally tested. 
If there exist a free Loqs dimer with Dicer-independent functions, Loqs-PA might be stronger 
implicated within these processes because of its lower affinity to dmDcr-1 (Figure 3.3 upper part, 
bold arrow) and Loqs-PB on the other side is rather responsible for the generation of miRNAs in 
flies (Figure 3.3 middle part, bold arrow). Figure 3.3 summarizes a hypothetical working model of 
both Loqs isoforms. 
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Figure 3.3: Working model for Loqs dimerization and dmDcr1 binding. In the absence of dmDcr1, 
Loqs forms homodimers via the dimerization interface located on dsRBD3 (green) and might be involved in 
dmDcr-1 independent processes. DsRBD1 and 2 are indicated as orange circles. In the presence of dmDcr1, 
Loqs-PB preferentially binds to the helicase domain of dmDcr1 (left, indicated with bold arrow) via the 
dimerization interface of dsRBD3 and a high-affinity binding site located in the linker preceding dsRBD3 
(highlighted in red) leaving Loqs-PA to exercise putative dmDcr-1 independent processes (right, indicated 
with bold arrow). 
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2.4 Post-translational modifications of human Dicer 
 
GST-pulldown of the human Dicer with the dsRBD3 of TRBP  
For the phosphorylation analysis of human Dicer, a pulldown with a C-terminal part of TRBP was 
used. The construct contained the dsRBD3 together with a fragment of the dsRBD2/3 interdomain 
linker (residues 261-364), which was indispensable for the solubility of the protein. A complete 
truncation of the interdomain linker led to aggregation of the dsRBD3 which further localized into 
inclusion bodies upon expression in E. coli. Therefore, aas from position 261-292 from TRBP 
have a substantial influence on the stability of the dsRBD3 and presumably of the full length 
protein. The molecular details behind this stability effect however require further experimental 
validation. To characterize the structural details of the dsRBD3 and the interdomain linker from 
TRBP, a crystallization approach was performed within this study. Therefore, TRBP dsRBD3 
together with the interdomain linker from position 261 were used and crystal screening and 
refinement resulted in macromolecular hexagonal protein 3D-crystals (Condition 1: 10% PEG 
10000, 100 mM Tris pH 7.8-8.7; Condition 2: 18 % PEG 20000, 100 mM Tris pH 7.8-8.7). These 
crystals diffracted only to ~3.5 Å resolution and no symmetry could be assigned, which ruled out 
a solution of the crystal structure. In further experiments, the crystallization conditions could be 
varied to obtain another crystal, which might be suitable for X-ray crystallography. Additionally 
nuclear magnetic resonance (NMR) measurements could be performed to characterize the 
structure of the interdomain linker in solution and its contribution to the solubility of the protein. 
Consistently with that, the published crystal structure of the Dicer/TRBP interface (Wilson et al., 
2015) contains major parts of the interdomain linker and an unknown electron density which 
might derive from this interdomain linker located next to one TRBP monomer comprising a 
helical structure element, that might derive from the putative amphipathic helix that contains 
several identical residues as in Loqs-PB. 
 
Analysis of post-translational modifications on hDcr 
For the precipitation of either the endogenous or a FLAG/HA tagged overexpressed hDcr, a GST-
tagged TRBP truncation (261-364), containing the 3
rd
 dsRBD and a part of the dsRBD2/3 
interdomain linker was used. The GST-pulldown of hDcr was suitable to obtain sufficient sample 
for MS analysis, which could not be obtained by Dicer-IP or other strategies used for the 
enrichment of hDcr so far. The MS data from one single measurement resulted in several 
phospho-sites for the overexpressed FLAG/HA hDcr with reliable scores and one single site for 
the endogenous hDcr reflecting the amounts of precipitated protein that was used for the 
measurements and which was higher in the case of the overexpressed hDcr. To further validate 
the identified phospho-sites, more replicates of the pulldown experiment are required to confirm 
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the biological relevance of these sites. Additionally for endogenous hDcr, the pulldown needs to 
be further optimized, to obtain more material for the identification of additional endogenous 
phospho-sites. 
All identified phospho-sites were located within or in close proximity of domains from the hsDcr, 
which were involved in the binding and processing of dsRNA. Thereby, Y153 is located in the 
helicase domain, S678 in the dsRBD, S1016 in the PAZ domain, Y1330 and S1470 in the RNase 
III domain. The S1252 and the adjacent S1255 are located in the interdomain region between the 
PAZ and RNase III domain und thus might also have an effect on the hsDcr function. For the 
characterization of the identified phospho-sites, a similar rescue assay, which was used for the 
analysis of different Loqs-PB mutants, could be applied. The mutations on the hsDcr sequence 
could be introduced by site directed mutagenesis and the putative phospho-site should be mutated 
to Glu, which mimics a phosphorylation at the respective position, or to Ala which cannot be 
phosphorylated by cellular kinases and mimics the unphosphorylated state of the protein. The 
amount of rescued miRNAs in MEF Dcr
-/-
 cells would provide evidence on the regulatory effects 
of a certain mutation on the processing activity of hsDcr. Especially phospho-sites Y153 and 
S678 have not been annotated yet on the PhosphoSitePlus® (www.phosphosite.org) databank 
from any screens for post-translational modification and therefore might be some interesting 
candidates for further validation. However, also from the annotated phospho-sites, most data is 
derived from more globular phospho-proteomic screens and no data based on site-specific 
methods, e.g. site directed-mutagenesis, are available to date. 
Furthermore it has been shown that the GST-tagged TRBP truncation (261-391) is not only able 
to precipitate the hsDcr, but also has a quite strong affinity to the fly homolog dmDcr-1 (Figure 
2.25, B). Therefore the dsRBD3 construct of TRBP can also be used to precipitate other Dicer 
homologs from different cellular lysates in a similar manner as described in Hauptmann et al., 
(2015) for a TNRC6 fragment that is able to precipitate several Ago homologs in different 
organisms. In an MS analysis, the different phospho-sites then could be directly compared to 
obtain information about the conservation of each site. Additionally, lysates from different tissues 
can be analyzed to obtain information about the phosphorylation pattern within these tissues. 
 
 
 
 
 
 
 
 
 
94 
 
3. The crystal structure of Brat-NHL in complex with its 
consensus RNA motif 
In post-transcriptional gene regulation processes, many RBPs interact with target RNA sequences. 
Thereby the specificity and selectivity of this interaction is of high relevance for the correct 
biological function in the cell. To elucidate the molecular interactions between the NHL domain 
of Brat and its RNA consensus sequence, the crystal structure of the RNA bound complex has 
been solved at 2.3 Å resolution. The six-bladed β propeller of the N L domain has a diameter of 
~47 Å and a modular shape that provides a rigid binding platform for the interaction with its 
target RNA. The binding cavity runs along the complete positively charged top surface and forms 
three binding pockets to specifically interact with the six bases of the consensus motive. This is 
achieved by base-specific hydrogen bonds to the protein main chain and several side chains 
within the NHL domain. By the arrangement of the six-bladed β propeller, bases 1 and 2 of the 
consensus motif were coordinated between blades II and III, base 3 between blades IV and V and 
bases 4-6 between blades I and VI. Thus, it is tempting to speculate, that the arrangement of the β 
blades and their loop- and sidechain-composition within the propeller might be crucial for the 
generation of sequence specificity and substrate recognition. 
The β propeller folding of the Brat NHL domain is also a common structural feature in WD40 
domains, which are highly abundant in the eukaryotic proteome (Stirnimann et al., 2010). Based 
on our findings it is tempting to speculate that WD50 might also be a widespread RNA-binding 
domain. In the past, this domain was mainly regarded as a mediator of protein-protein contacts 
and only few candidates were shown to interact directly with RNA substrates as the WD40 
domain of Gemin5 that interacts with snRNAs (Lau et al., 2009). From recent large-scale 
proteomic screens, the number of new candidates containing a WD40 domain that directly 
contacts RNA could be increased (Baltz et al., 2012; Castello et al., 2012; Gerstberger et al., 
2014; Kwon et al., 2013). Based on the solved structure of the NHL domain of Brat in complex 
with its consensus motif, structural homology modeling could be performed to obtain information 
how sequence specificity is achieved in other WD40 or NHL-domain containing proteins. 
Additionally to the structure of the NHL domain of Brat bound to its consensus motive, there 
exits another monomer which is bound to a stretch of poly U that directly succeeds the consensus 
motive. The poly U stretch adapts a similar conformation as the consensus motif and can undergo 
most of the respective interactions. However uracil is unable to form any of the hydrogen bonds, 
observed for the guanine base, which affects mostly the binding of U14 that is equivalent with G6 
from the consensus motif, as the electron density for this nucleotide is only very weakly defined. 
The orientation of the two Brat NHL monomers within the crystal seems rather influenced by the 
simultaneously bound RNA, as the little protein contacts within the crystal are not indicative for a 
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stable interaction between both monomers. However, as the full length Brat contains a CC, which 
is used for dimerization by proteins from the TRIM family, it is not excluded that this orientation 
of both NHL domains has function in the Brat-mediated translational repression in vivo. This 
possibility could be addressed in further experiments with the full length protein. 
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IV. Material and Methods 
1. Material 
1.1 Chemicals and enzymes 
If not denoted separately, chemicals were ordered from Amersham Biosciences 
(Buckinghamshire, UK), Applichem (Darmstadt, Germany), Biorad (Hercules, USA), Merck 
(Darmstadt, Germany), Roth (Karlsruhe, Germany) and Sigma Aldrich (Munich, Germany). DNA 
oligonucleotides were ordered and synthesized from Metabion (Martinsried, Germany), RNA 
oligos from Biomers (Ulm, Germany) and Eurogentec (Liège, Belgium). All enzymes which were 
used for cloning and modification of DNA or RNA were purchased from Thermo Fisher 
Scientific (Waltham, USA) or New England Biolabs (Ipswich, USA). 
 
1.2 Laboratory equipment 
All instruments which were used in this were listed in the following table. 
Table 4.1: Instruments 
Instrument Distributor (alphabetical) 
Ultraspec 3300 pro Amersham Biosciences (Little Chalfont, UK) 
GeneAmp PCR System 9700 Applied Biosystems (Foster City, USA) 
Avanti J-20 XP Centrifuge Beckman Coulter (Krefeld, Germany) 
Geiger Counter LB123 EG&G Berthold (Bad Wildbad, Germany) 
CFX96 Real-Time-System Bio-Rad (Hercules, USA) 
PowerPac HC Power Supply Bio-Rad (Hercules, USA) 
Screen Eraser-K Bio-Rad (Hercules, USA) 
Trans-Blot SD Bio-Rad (Hercules, USA) 
Power Supply EV233 Consort (Turnhout , Belgium) 
Thermomixer compact Eppendorf (Hamburg, Germany) 
Centrifuge 5415D Eppendorf (Hamburg, Germany) 
Polymax 2040 Heidolph (Schwabach, Germany) 
Vortexer REAX top Heidolph (Schwabach, Germany) 
Branson Soniﬁer 450 Heinemann (Schwäbisch Gmünd, Germany) 
Biofuge pico Heraeus (Hanau, Germany) 
Hybridization oven T 5042 Heraeus (Hanau, Germany) 
Incubator Model B6200 Heraeus (Hanau, Germany) 
Megafuge 40 Heraeus (Hanau, Germany) 
Centrikon T-1170 Kontron 
Microscope Diavert Leica (Wetzlar, Germany) 
AT200 Mettler (Gießen, Germany) 
Milli-Q PLUS Millipore (Billerica, USA) 
Innova 44 New Brunswick Scientific (Eppendorf) 
Quantum gel-doc. system Peqlab (Erlangen, Germany) 
LC 4801 P Satorius (Göttingen, Germany) 
Cytoperm Thermo Scientiﬁc  Rockford, USA) 
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HeraCell 240i CO2 Incubator Thermo Scientiﬁc  Rockford, USA) 
Nanodrop Thermo Scientiﬁc  Rockford, USA) 
 
1.3 Plasmids 
The following vectors were used in this thesis. 
Table 4.2: Plasmids for bacterial expression 
Plasmid Resistance Description 
pGEX4T-1 AMP N-terminal GST 
pET32a AMP N-terminal His6-Trx 
pColdI AMP N-terminal His6, Cold shock inducible 
pETDuet-1 AMP His-(MCS1) and S-tag(MCS2), co-expression of two target genes 
pHis.TEV AMP Expression vector for His6 TEV-protease 
pGEX.TEV AMP Expression vector for GST TEV-protease 
 
Table 4.3: Plasmids for eukaryotic expression 
Plasmid Resistance Description 
VP5-FAME AMP,Neo 
Modified pIRES neo, N-terminal FLAG and HA, FseI-AscI 
cassette added 
pCS2-FAME AMP N-terminal myc6-tag, FseI-AscI cassette added 
pGTO-b AMP 
Modified pCDNA3/TO, eGFP inserted for the generation of 
stable HEK T-REx-293 cell lines 
 
Table 4.4: Plasmids for insect expression 
Plasmid Resistance Description 
pMT/V5-A AMP Copper inducible expression vector for Drosophila derived cells 
pFastBac-1 AMP Expression in SF21 cells with Bac-to-Bac
®
 expression system 
 
1.4 Oligonucleotides 
All DNA- or RNA-oligonucleotides that were used for this thesis are listed in the following 
tables. 
 
1.4.1 DNA oligonucleotides 
All DNA oligonucleotides, which were used in this thesis, were ordered from Metabion 
international AG (Munich). 
Table 4.5: List of different DNA oligos. 
Primer name  Sequence 5’->3’ 
Loquacious  
Loqs-PB_338-463for GCTAGGATCCGAAAACCTGTATTTTCAGGGACCCCGCAGTAGTGAAAATTATTATGG 
Loqs-PB_348-463for GCTAGGATCCGAAAACCTGTATTTTCAGGGATTGAAAGATATCTCTGTGCCG 
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Loqs-PB_358-463for GCTAGGATCCGAAAACCTGTATTTTCAGGGAACGCAGCACAGTAACAAAGTATCC 
Loqs-PB_368-463for GCTAGGATCCGAAAACCTGTATTTTCAGGGACATAAGACCCTAAAAAATGC 
Loqs-PB_379-463for GCTAGGATCCGAAAACCTGTATTTTCAGGGACTGCTTAAGTTACAGAAGACTTGC 
L-PBf Gly2 Linker for CCAGGATCCGAAAACCTGTATTTTCAGGGAGGAGGAATTGATTACATCAAGCTGCTGG 
Loqs-PB_392-463 rev CCAGTCGACTTAGGTCATGATCTTCAAGTACTCG 
L-PB-463-HA rev 
CCAGTCGACTTAAGCGTAATCTGGAACATCGTATGGGTAGGTCATGATCTTCAAGTACTC
G 
L-PBLink338-391rev CTAGGTCGACTTACTTGTTGTTCTTCAAGCAAGTC 
L-PB_k FseI for GCTAGGCCGGCCATGGACCAGGAGAATTTCC 
Loqs-PB_392-463 rev TAGCGGCGCGCCTTAGGTCATGATCTTCAAGTACTCG 
  
Dicer  
GFP_pFB_f 
GCTAGAATTCACCATGCATCACCATCACCATCACGGCGGCAGCAAGGGCGAGGAGCTGT
TCACC 
GFP_pFB_EcoRI_r CTAGGAATTCCTTGTACAGCTCGTCCATGCC 
Dicer1_FseI for GCTAGGCCGGCCATGGCGTTCCACTGGTGCG 
Dicer1_AscI rev TAGCGGCGCGCCTTAGTCTTTTTTGGCTATCAAGCC 
  
TRBP  
TRBP_231-End for GATCGGATCCGAAAACCTGTATTTTCAGGGAGATGCCCGGGATGGCAATGAGG 
TRBP_241-End for GATCGGATCCGAAAACCTGTATTTTCAGGGAGATGATGACCACTTCTCCATTGG 
TRBP_251-End for: GATCGGATCCGAAAACCTGTATTTTCAGGGATCCCGCCTGGATGGTCTTCG 
TRBP_261-Gly2 for 
GATCGGATCCGAAAACCTGTATTTTCAGGGAGGAGGACCAGGTTGCACCTGGGATTCTCT
ACG 
TRBP_271-End for GATCGGATCCGAAAACCTGTATTTTCAGGGATCAGTAGGAGAGAAGATCCTGTCC 
TRBP_231-291 rev GATCGTCGACTTAGCCCAGGGCACCCAGGGAGCC 
TRBP_292-364 rev CCAGTCGACTTAGCCTGCCATGATCTTGAGGTACTGC 
TRBP_k FseIfor GCTAGGCCGGCCATGCTGGCCGCCAACCCAGGC 
TRBP_k AscIrev TAGCGGCGCGCCTCACTTGCTGCCTGCCATGATCTTGAGG 
  
Ago  
Ago1 (EcoRI) for CCAGAATTCATGGAAGCGGGACCCTCG 
Ago1 (HindIII) rev CCAAAGCTTTCAAGCGAAGTACATGGTGC 
Ago2 (EcoRI) for ATCTGAATTCATGTACTCGGGAGCCGGCCCCGC 
Ago2 (HindIII) rev ATCTAAGCTTTTATCAAGCAAAGTACATGGTGC 
Ago3 (EcoRI) for CCAGAATTCATGGAAATCGGCTCCGCAGG 
Ago3 (HindIII) rev CCAAAGCTTTTAAGCGAAGTACATTGTGC 
Ago4 (EcoRI) for CCAGAATTCATGGAGGCGCTGGGACCC 
Ago4 (ClaI) rev CCAATCGATTCAGGCAAAATACATCGTGTGC 
  
Mutagenesis  
L-PB F419A f CATAGAGGAGAAGACCGCGTCTGGCCAGTTCCAG 
L-PB F419A r CTGGAACTGGCCAGACGCGGTCTTCTCCTCTATG 
99 
 
L-PB F423A f GAAGACCTTCTCTGGCCAGGCGCAGTGCCTGGTTCAACTG 
L-PB F423A r CAGTTGAACCAGGCACTGCGCCTGGCCAGAGAAGGTCTTC 
L-PB A444K f CAGCGGACCAACAAAGGCCGATGCCCAGC 
L-PB A444K r GCTGGGCATCGGCCTTTGTTGGTCCGCTG 
L-PB L371A f CAGGGACATAAGACCGCAAAAAATGCAACGGGC 
L-PB L371A r GCCCGTTGCATTTTTTGCGGTCTTATGTCCCTG 
L-PB N373E_for GGACATAAGACCCTAAAAGAAGCAACGGGCAAAAAACTG 
L-PB N373E_rev CAGTTTTTTGCCCGTTGCTTCTTTTAGGGTCTTATGTCC 
L-PB K378E_for CTAAAAAATGCAACGGGCAAAGAACTGCTTAAGTTACAGAAGAC 
L-PB K378E_rev GTCTTCTGTAACTTAAGCAGTTCTTTGCCCGTTGCATTTTTTAG 
L-PB L379/380/382A f CAACGGGCAAAAAAGCAGCTAAGGCACAGAAGACTTGCT 
L-PB L379/380/382A r AGCAAGTCTTCTGTGCCTTAGCTGCTTTTTTGCCCGTTG 
L-PB L387A f TAAGTTACAGAAGACTTGCGCCAAGAACAACAAGATTGATTAC 
L-PB L387A r GTAATCAATCTTGTTGTTCTTGGCGCAAGTCTTCTGTAACTTA 
L-PB KI460_61EA_FAf GAATGCCCTCGAGTACTTGGAGGCCATGACCTAAGGCGC 
L-PB KI460_61EA_FAr GCGCCTTAGGTCATGGCCTCCAAGTACTCGAGGGCATTC 
L-PB KI460_61EA_SalIf CAGAATGCCCTCGAGTACTTGGAGGCCATGACCTAAGTCGAC 
L-PB KI460_61EA_SalIr GTCGACTTAGGTCATGGCCTCCAAGTACTCGAGGGCATTCTG 
L-PB K460E_FAf GAATGCCCTCGAGTACTTGGAGATCATGACCTAAGGCGC 
L-PB K460E_FAr GCGCCTTAGGTCATGATCTCCAAGTACTCGAGGGCATTC 
L-PB K460E_SalIf CAGAATGCCCTCGAGTACTTGGAGATCATGACCTAAGTCGAC 
L-PB K460E_SalIr GTCGACTTAGGTCATGATCTCCAAGTACTCGAGGGCATTCTG 
L-PB C386S_for CTTAAGTTACAGAAGACTTCTTTGAAGAACAACAAGATTG 
L-PB C386S _rev CAATCTTGTTGTTCTTCAAAGAAGTCTTCTGTAACTTAAG 
L-PB C425S_for GGCCAGTTCCAGAGCCTGGTTCAAC 
L-PB C425S_rev GTTGAACCAGGCTCTGGAACTGGCC 
L-PB C437S_for CCCGTTGGCGTTAGCCACGGCAGCG 
L-PB C437S_rev CGCTGCCGTGGCTAACGCCAACGGG 
TRBP251_-Bam f CCTGTATTTTCAGGGTTCCCGCCTGGATGG 
TRBP251_-Bam r CCATCCAGGCGGGAACCCTGAAAATACAGG 
Ago2 S798A for GCACACGCTCCGTGGCCATCCCAGCGCCAGC 
Ago2 S798A rev GCTGGCGCTGGGATGGCCACGGAGCGTGTGC 
  
Northern probes  
let-7a AACTATACAACCTACTACCTCA 
  
Q-PCR oligos  
pRT GAPDH fwd TGGTATCGTGGAAGGACTCATGAC 
pRT GAPDH rev ATGCCAGTGAGCTTCCCGTTCAGC 
pRT PLK1 Primer1 fwd AGCAAGAAAGGGCACAGTTT 
pRT PLK1 Primer1 rev GGTTTGCCCACTAACAAGGT 
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pRT PLK1 Primer2 fwd ACAGTGTCAATGCCTCCAAG 
pRT PLK1 Primer2 rev CTGATACCCAAGGCCGTACT 
 
1.4.2 RNA oligonucleotides 
RNA oligonucleotides were ordered from biomers.net GmbH (Ulm, Germany) or synthetized at 
the Max Planck Institute (Martinsried, Munich). 
Table 4.6: : List of different RNA oligos 
siRNA  Guide sequence 5’->3’ Passenger sequence 5’->3’ 
Si428 UCAUAUUCGACUUUGGUUGdCdC-Cy5 CAACCAAAGUCGAAUAUGAdTdT 
Si856 CUUGCCCGCGAACACCUCCdTdT-Cy5 GGAGGUGUUCGCGGGCAAGdTdT 
Impβ si1 UUUCCCUUAGCUCAUUCAGUdT CUGAAUGAGCUAAGGGAAAUdT 
Impβ si2 UUACUAGGCUCUUCUUUCCUdT GGAAAGAAGAGCCUAGUAAUdT 
Imp11 si1 UAAUUCUAAACCAUCUUCCUdT GGAAGAUGGUUUAGAAUUAUdT 
Imp11 si1 UAUCUCUACACACAUUAUCUdT GAUAAUGUGUGUAGAGAUAUdT 
Tnpo1 si1 UAAGGCUGCAUCUCUAUACUdT GUAUAGAGAUGCAGCCUUAUdT 
Tnpo1 si2 AUAAAUGAAUACCUGUGGCUdT GCCACAGGUAUUCAUUUAUUdT 
RanBP1 si1 UUGGUCUCCUCCUUCACCGUdT CGGUGAAGGAGGAGACCAAUdT 
RanBP1 si2 UUGUUUUGAAUUUCUGUGCUdT GCACAGAAAUUCAAAACAAUdT 
 
1.5 Antibodies 
All commonly used antibodies were diluted in TBS-T supplemented with 5 % milk powder (Roth) 
and 0.02% Sodium azide (Sigma Aldrich). 
Table 4.7: Antibodies 
Antibody Description Dilution 
Primary antibodies:   
Mouse anti-αTubulin  monocl, clone DM1A, Sigma Aldrich 1:10000 
Mouse anti-βActin monocl, clone AC15, Abcam 1:10000 
Mouse anti-HA monocl, clone 16B12, Covance 1:1000 
Mouse anti-GFP Monoclonal, clones 7.1 and 13.1, Roche  1:1000 
Rabbit anti-c-Myc  polycl, C3956, Sigma Aldrich 1:1000 
Rabbit anti-dmDcr-1 Polycl., ab4735, Abcam 1:1000 
Rabbit anti-hsDcr Polycl., A301-937A, Bethyl 1:5000 
Rat anti-Ago2 Monoclonal, hybridoma Ab (clone 11A9, Rüdel et al.,2008) 1:10 
Secondary antibodies: 
Goat anti-rat 680 secondary antibody, Li-Cor Biosciences 1:10000 
Goat anti-rabbit 680  secondary antibody, Li-Cor Biosciences 1:10000 
Goat anti-mouse 680  secondary antibody, Li-Cor Biosciences 1:10000 
Goat anti-rat 800  secondary antibody, Li-Cor Biosciences 1:10000 
Goat anti-rabbit 800  secondary antibody, Li-Cor Biosciences 1:10000 
Goat anti-mouse 800  secondary antibody, Li-Cor Biosciences 1:10000 
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1.6 Bacterial strains and cell lines 
Table 4.8: Bacterial strains 
Strain genotype distributor 
BL21 (DE3) F
–
 dcm ompT lon hsdSB(rB
-
 mB
-) gal λ(DE3) Invitrogen 
Rosetta (DE3) F
–
 dcm ompT lon hsdSB(rB
-
 mB
-) gal λ(DE3) pRARE (CamR) Novagen 
DH10B 
F
–
 endA1 deoR
+
 recA1 galE15 galK16 nupG rpsL Δ(lac)X74 
φ80lacZΔM15 araD139 Δ(ara,leu)7697 mcrA Δ(mrr-hsdRMS-
mcrBC) Str
R
 λ– 
Invitrogen 
XL1 blue 
F
–
 recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac F’[proAB+ 
lacI
q
 ZΔM15 Tn10 (TetR)] 
Stratagene 
 
Table 4.9: Eukaryotic cell lines 
Cell line specification 
HEK 293T Human embryonic kidney cells 
MEF Dcr 
-/-
 and 
+/+
 Mouse embryonic fibroblasts 
d.mel-2 Insect cells derived from Drosophila melanogaster 
Sf21 Insect cells derived from Spodoptera frugiperda 
 
1.7 Culture media 
Standard cell culture medium for human cells: 
Dulbecco’s Modified Eagle Medium  DMEM)  Sigma Aldrich, Munich, Germany) 
Supplemented with: 
10 % fetal bovine serum (FBS) (Sigma Aldrich, Munich, Germany) 
1 % penicillin/streptomycin (Sigma Aldrich, Munich, Germany) 
 
Standard cell culture medium for insect cells: 
Gibco SF900 medium (Thermo Scientific) for Sf21 cells and Express Five® SFM medium 
 Thermo Scientific) supplemented with GlutaMAX™  Thermo Scientific) for d.mel-2 cells. 
 
Standard cell culture medium for bacteria cells: 
Antibiotics for selection of positively transformed bacteria cells were added from 1000 x stock 
solutions to the final concentrations of 50 µg/ml Ampicillin (Amp), 30 µg/ml Kanamycin (Kan) 
and 25 µg/ml Chloramphenicol (Cam). 
 
LB-Medium: 
1 % NaCl 
0.5 % Yeast-Extract 
10 % Bacto-Trypton 
 
LB-Plates: 
LB medium supplemented with 1.5 % Agar 
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1.8 Buffers and solutions 
Common buffers and solutions 
Coomassie staining-solution 30 % EtOH 
10 % Acetic acid 
0.25 % Coomassie brilliant blue R250 
Coomassie destaining-solution 30 % EtOH 
10 % Acetic acid 
Easy Prep 10 mM Tris/HCl pH 8.0 
1 mM EDTA 
15 % (w/v) saccharose 
2 mg/mL lysozyme 
0.2 mg/mL RNase A 
0.1 mg/mL BSA 
EDC (1-ethyl-3-(3-dimethyl-aminopropyl)-
carbodiimid) crosslinking solution 
160 mM EDC 
130 mM 1-methylimidazole 
12.5 mM HCl 
Gradient Buffer 25 mM Tris/HCl pH 7.5 
150 mM KCl 
2 mM EDTA 
HEPES buffered saline (HBS) (2x) 54,6 mM HEPES/NaOH pH 7.1 
274 mM NaCl 
1,5 mM Na2HPO4 x 2 H2O 
IP-lysis 25 mM Tris/HCl pH 7.5 
150 mM KCl 
2 mM EDTA 
0.5 % NP-40 
IP-wash 50 mM Tris/HCl pH 7.5 
300 mM NaCl 
5 mM MgCl2 
0.05 % NP-40 
Laemmli loading dye (5x) 300 mM Tris/HCl pH 6.8 
10 % SDS 
62.5 % Glycerin 
0.025 % bromophenol blue 
10 % -mercaptoethanol 
Northern blot hybridization 20 mM Na2HPO4 pH 7,2 
15 mM Trinatriumcitrate-dihydrate 
150 mM NaCl 
7 % SDS 
0,02 % Albumin fraction V 
0,02 % Polyvinylpyrrolidon K30 
0,02 % Ficoll 400 
Northern blot wash I 75 mM Trinatriumcitrate-dihydrate pH 7.0 
750 mM NaCl 
1 % SDS 
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Northern blot wash II 15 mM Trinatriumcitrate-dihydrate pH 7.0 
150 mM NaCl 
1 % SDS 
PBS 12 mM Na2HPO4/NaH2PO4 pH 7.5 
137 mM NaCl 
2.7 mM KCl 
RNA sample buffer (2x) 99.9 % Formamide 
0.05 % Xylene cyanol 
0.05 % Bromophenol blue 
Roeder A 10 mM HEPES/NaOH pH 7,9 
10 mM KCl 
1,5 mM MgCl2 
0,5 mM DTT 
1 mM AEBSF 
SDS running buffer 25 mM Tris 
192 mM Glycine 
0.1 % SDS 
siRNA annealing buffer (2x) 60 mM HEPES/NaOH pH 7,4 
4 mM MgAc 
200 mM KAc 
TBE 90 mM Tris pH 8.0 
90 mM Boric-acid 
2 mM Na2-EDTA 
TBS 10 mM Tris/HCl pH 8.0 
150 mM NaCl 
TBS-T 10 mM Tris/HCl pH 8.0 
150 mM NaCl 
1 % Tween 
  
Towbin blotting buffer  25 mM Tris/HCl pH 8.6 
192 mM glycine 
(10 % MeOH for semi-dry blotting) 
  
Buffers for protein purification 
GST-A 50 mM Tris/HCl pH 8.0 
200 mM NaCl 
GST-B 50 mM Tris/HCl pH 8.0 
200 mM NaCl 
10 mM glutathione 
HisA 50 mM Tris/HCl pH 8.0 
300 mM NaCl 
10 mM imidazole 
HisB 50 mM Tris/HCl pH 8.0 
300 mM NaCl 
300 mM imidazole 
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SEB1 20 mM Hepes/NaOH pH 7.5 
150 mM NaCl 
1 mM DTT 
SEB2 20 mM Tris/HCl pH 7.5 
200 mM NaCl 
1 mM DTT 
SEB3 20 mM Tris/HCl pH 7.5 
1 mM DTT 
SEB4 20 mM Tris/HCl pH 8.0 
200 mM NaCl 
 
1.9 Columns for protein purification 
Columns for affinity chromatography 
Column Material h [mm] Ø [mm] V [mL] 
IMAC I IMAC Sepharose
TM
 6 Fast Flow (GE) 25 16 5 
IMAC II IMAC Sepharose
TM
 6 Fast Flow (GE) 200 16 11 
IMAC III Profinity
TM
 IMAC (Biorad) 200 26 45 
GSTrap Glutathione Sepharose
TM
 4 Fast Flow (GE) 25 16 5 
GST II Glutathione Sepharose
TM
 4 Fast Flow (GE) 200 16 18 
 
Columns for size exclusion chromatography 
Column Material Mr [kDa] Ø [mm] Vt [mL] 
S75 10/300 (GE) Crosslinked agarose and dextran 3-70 10 24 
S75 16/600 (GE) Crosslinked agarose and dextran 3-70 16 120 
S75 26/600 (GE) Crosslinked agarose and dextran 3-70 26 320 
S200 10/300 (GE) Crosslinked agarose and dextran 10-600 10 24 
S200 26/600 (GE) Crosslinked agarose and dextran 10-600 26 320 
Superose6 10/300 
(GE) 
Composite of crosslinked 
agarose 
5-5000 10 24 
HiPrep Desalt 26/60 
(GE) 
Sephadex G-25 Fine 1-5 26 53 
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2. Molecular biological methods 
2.1 Agarose gel electrophoresis 
For the detection, separation and analysis of DNA fragments, agarose gel electrophoresis was 
performed on 0.6-2% (w/v) agarose gels supplemented with ethidium bromide (EtBr) (3µL / 100 
mL agarose gel) for staining of the DNA bands. Prior loading to the gel, 6x DNA loading dye 
(Fermentas) was added to the DNA sample. The separation was performed in TBE buffer for 20-
40 min (RT) with a constant current of 120 V. For size determination of DNA bands, a marker 
(GeneRuler, Fermentas) was loaded. The DNA bands were visualized with a gel documentation 
system (Quantum ST4, PeqLab (Erlangen, Germany)) and images were stored locally. 
 
2.2 Preparation, purification and sequencing of plasmid DNA 
Plasmid-DNA was extracted from chemically competent E. coli XL1 blue cells, which were 
prepared and transformed as described in (Inoue et al., 1990). The DNA was isolated using either 
the Nucleobond Plasmid Kit for Mini- or the Nucleobond Xtra Midi Kit (both Macherey-Nagel, 
Düren, Germany) for Maxi-preparations. The quality and concentration of the DNA was 
determined using NanoDrop 1000 Spectrophotometer (Thermo Scientific, Rockford, USA). For 
sequencing, samples were prepared according to companies protocols and sent to GATC Biotech 
(Cologne, Germany) or Macrogen (Amsterdam, Netherlands). 
For screening of lager amounts of clones, a fast DNA extraction method was applied according to 
(Berghammer and Auer, 1993). Therefore 2 mL an overnight culture were resuspended in 40 µL 
EasyPrep buffer for high copy vectors or 20 µL for low copy vectors and incubated for 1 min at 
99°C. After an incubation of 1 min on ice, the supernatant was cleared by centrifugation at 15000 
g for 15 min (RT). 5-10 µL of the plasmid containing supernatant was used for an analytical 
digestion (see 4.2.1.3). 
 
2.3 Restriction analysis 
Analytical digestion 
For the analytical restriction analysis the following digestion mix was used: 
12 µL 10x reaction buffer 
8 µL H2O 
1 µL of respective restriction enzyme(s) 
 
2 µL of digestion mix was added to a total volume of 10 µL DNA sample and incubated at 37°C 
for 1 h followed by agarose gel electrophoresis. Plasmid DNA from positive clones was isolated 
via Mini-prep purification and stored at -20°C. 
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Preparative digestion 
For preparation and further ligation of DNA from a PCR fragment or a circular plasmid, the 
following preparative digestion mix was prepared: 
2-5 µg Template DNA 
5 µL 10x reaction buffer 
ad 50 µL ddH2O 
The reaction mix was incubated for 1 h at 37°C and digested DNA was purified from agarose gel 
using the NucleoSpin Gel and PCR Clean-Up Kit (Macherey-Nagel). 
 
2.4 Molecular cloning 
DNA sequences for cloning were amplified via polymerase chain reaction (PCR) either from 
template vectors or from cDNA of Drosophila Melanogaster embryonic cells using the Phusion 
High-Fidelity DNA Polymerase  Thermo Scientiﬁc). The PCR mix and the 2-step reaction were 
performed as below: 
 
PCR-mix  Temperature program 
50 ng Template DNA  time temperature cycles 
2.5 µL Fwd. primer (10µM)  30 sec 98°C 1x 
2.5 µL Rev. primer (10µM)  10 sec 98°C 
35x 
10 µL 5x HF buffer  30 sec/1kb 72°C 
1.5 µL DMSO (100%)  10 min 72°C 
1x 
1 µL dNTPs (10mM)  store 4°C 
1 µL Phusion (2 U/µL)     
Ad 50µL dd H2O     
 
After the PCR the mixture was subjected to agarose gel electrophoresis and bands containing the 
PCR-product were cut out and purified with the NucleoSpin Gel and PCR Clean-Up Kit and 
preparative digested together with the respective vector for insertion. To prevent re-ligation of the 
lineari ed vectors, the 5’ and 3’ ends were dephosphorylated using the FastAP Thermosensitive 
Alkaline Phosphatase  Thermo Scientiﬁc) which was directly added to the digestion  30 min, 
37°C). The digested DNA fragments were purified for a second time with the NucleoSpin Gel and 
PCR Clean-Up Kit.  
For ligations, 50 ng of the template vector were mixed with a 2-5 fold molar excess of insert-
DNA. After the addition 0.1 U/µL T4 DNA Ligase and the respective buffer (both Thermo 
Scientiﬁc), the reaction was performed at RT for 1 h. For higher efficiency of the ligation 
reaction, PEG4000 was additionally added in some minor cases. The reaction mixture was heat-
inactivated at 65°C for 10 min and transformed into XL1 blue and plated onto agarose plates 
containing the selection antibiotic(s). Positive clones were identified by an analytical digestion 
and sequenced after plasmid isolation. 
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2.5 Mutagenesis PCR 
For site directed mutagenesis, primers were generated using a web-based program designed to 
automate the design of mutagenic PCR (PrimerX). The mutagenesis PCR reaction was performed 
as below: 
PCR-mix  Temperature program 
50 ng Template DNA  time temperature cycles 
10 µL 5x HF buffer  30 sec 98°C 1x 
1 µL Fwd. primer (10µM)  10 sec 98°C 
20x 1 µL Rev. primer (10µM)  20 sec 55°C 
1.5 µL DMSO (100%)  30 sec/1kb 72°C 
1 µL dNTPs (10mM)  10 min 72°C 
1x 
1 µL Phusion (2 U/µL)  store 4°C 
Ad 50µL dd H2O     
 
After the PCR, the sample was purified with the NucleoSpin Gel and PCR Clean-Up Kit and 
eluted with 44 µL ddH2O. The template vector was removed by DpnI digestion. Therefore 1µL of 
the Enzyme and 5 µL of the 10 FD buffer (both Thermo Scientific) was added to the elution and 
incubated for 3-24 h at 37°C. 5 µL of this mix was used for transformation in XL1 blue. After 
plating onto agarose plates containing the selection antibiotic(s), positive clones were identified 
by an analytical digestion and sequenced after plasmid isolation. 
 
3. RNA-based methods 
3.1 RNA isolation 
For quantitative real time PCRs (qRT-PCR) and Dicer rescue assays, RNA was extracted directly 
from transfected cells, which were pelleted prior lysis. Therefore an adequate amount of TRIzol® 
(Thermo Fisher Scientific) was added to the cell pellets, according to the manufacturer’s 
guidelines. Purified RNA pellets were resuspended in nuclease free water (5 min at 65°C while 
shaking) and stored at -80 °C for further appilactions. 
 
3.2 RNA separation and Northern blot analysis 
RNA samples were prepared by adding equal amounts of 2x RNA sample buffer the respective 
RNA-dilutions. 12 % urea polyacrylamide gels (Urea Gel Systems, National Diagnostics) were 
prepared according to the manufacturer’s instructions. To allow a complete separation of RNA 
species on the gel, the gels were run for 30 min at 400 V in TBE buffer. Prior loading of the RNA 
samples, pockets were washed thoroughly. After addition of ~30µL samples to the respective 
pockets, gels were run at 400 V for about 1.5 hours. 
To control the quality of the RNA extraction and the loading of each lane, urea gels were stained 
with EtBr in TBE buffer for 10 min. After documentation, blotting was performed using three 
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Whatman papers on top and below an Amersham Hybond-N membrane (GE Healthcare) and the 
urea gel. All components were briefly soaked in MilliQ water upon building of the blotting-
sandwich. Transfer of the RNAs was conducted at 20 V for 30 min. Then, the miRNA 5’ ends 
were crosslinked to the membrane, using an EDC crosslinking at 50 °C for 1 h. Therefore, the 
membrane was placed on another EDC-soaked Whatman paper with the RNA side facing up and 
wrapped in cling film together with the paper. After crosslinking, the membrane was gently 
washed with water and dried. Northern blots were hybridized with respective radiolabeled probes 
overnight at 50°C. After the incubation, the blots were washed twice with Northern blot wash I 
buffer and once with Northern blot wash II buffer. Signals were detected by exposure to a screen 
and scanning with the phospho-imaging system PMI (Biorad). 
 
3.3 qRT-PCR 
DNA contaminants after RNA isolation were removed from qRT-PCR samples upon digestion 
with DNAse I for 30 min at 37 °C. For each sample, 1 µg of total RNA was used. Then, DNase I 
was inactivated by EDTA-addition and 10 min incubation at 65 °C. The cDNA was synthesized 
according to protocols from the First Strand cDNA Synthesis Kit (Thermo Scientific).  
qRT-PCR was performed using Sso Fast Eva Green Mix (Biorad) 0,4 µM forward and 0,4 µM 
reverse primer and cDNA from 50 ng RNA as template. qRT-PCR were run on a CFX96 cycler 
(Bio-Rad, Hercules, USA) using standard program as given in the SsoFast EvaGreen SuperMix 
manual with denaturation and annealing/extension times of 5 sec, 40 cycles and a 65-95 °C melt 
curve.  
qRT-PCR data were assessed, using the ΔΔCt method (Livak and Schmittgen, 2001) with 
GAPDH as reference mRNA. Error bars were calculated from respective technical and biological 
replicates. 
 
4. Protein-biochemical methods 
4.1 Determination of protein concentration 
For the determination of protein concentrations in solutions containing a mixture of several 
different proteins (e.g. cellular lysates), a Bradford Protein Assay (Biorad) was used and 
performed according to the protocol of the distributor and as described in (Bradford, 1976). 
The concentration of a homogenous protein solutions (e.g. after protein purification) was 
determined by the measurement of the total A280 using the NanoDrop ND-1000 UV-Vis 
spectrophotometer (Peqlab). The extinction coefficient regarding the absorption from Tryptophan, 
Tyrosine and non-reduced Cysteine and the molecular weight were calculated in silico using the 
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program Protparam (www.expasy.org/tools/protparam.html). The final protein concentration 
could be obtained with equation 4.1. 
 
 [
  
  
]  
      
 
                  
  
    
                  
  Mass concentration 
A280  Absorption at 280 nm 
Mr  Relative molecular weight 
d  Thickness of cuvette 
280  Molecular absorption coefficient 
 
Protein specific factors of proteins, which were recombinantly purified in this thesis, were 
calculated with Protparam (http://web.expasy.org/protparam) and listed in Table 4.10: 
Table 4.10: Protein specific factors 
Protein Mr [kDa] 280[M
-1
cm
-1
] f 
Loqs dsRBD3 8.031 4470 0.557 
GST-dsRBD3 35.118 48820 1.390 
GST-Loqs-0 41.204 51800 1.257 
GST-Loqs-1 40.020 48820 1.220 
GST-Loqs-2 38.952 48820 1.253 
GST-Loqs-3 37.795 48820 1.292 
GST-Loqs-4 36.844 48820 1.325 
GST-Loqs-linker 33.305 47330 1.421 
GFP-dmDcr-1 276.291 238140 0.862 
dmDcr-1 256.564 226220 0.882 
TRBP-3 38.302 52830 1.379 
TRBP-2 40.572 52830 1.302 
TRBP-1 41.655 52830 1.268 
Brat-NHL 31.797 16390 0.515 
 
4.2 Preparation of eukaryotic cellular lysates 
For the lysis of mammalian cells, three different protocols were used. 
 
Detergent based lysis 
For the detergent based lysis, cells from a 15 cm culture plate were washed with PBS and pelleted 
(500 x g, 5 min, 4 °C). The pellet was resuspended in 1 mL of a detergent based lysis buffer (see 
Material Chapter 1.8) supplemented with 1 mM AEBSF, 1 mM DTT and 1 mM NaF and 
incubated for 20 min on ice. The lysate was cleared by centrifugation (17,000 x g, 20 min, 4 °C) 
and the supernatant was collected for further applications. 
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Lysis by hypertonic swelling 
To generate the lysate for the FCCS loading assays, a modified protocol from Dignam et al., 
1983b and Martinez et al., 2002 was used. Therefore cells were harvested and pelleted (500 x g, 5 
min and 4 °C) after washing with PBS. After washing, the cells were gently resuspended in 
Roeder A buffer (5 mL per 1 mL of packed cell volume) and incubated for 10 min on ice. Cells 
were pelleted for a second time and resuspended in 2mL Roeder A buffer per 1 mL cell pellet and 
transferred to a glass dounce homogenizer (B type pestle) and homogenized with ten strokes. The 
lysate was then pre-cleared by centrifugation (2000 x g, 10 min, 4°C) and the supernatant was 
applied to a 5 mL polycarbonate tube and mounted to a TST 55.5 rotor (Kontron Instrumnets) and 
centrifuged for 60 min at 100,000 x g at 4°C (Kontron Centrikon T-1170). Prior freezing in liquid 
nitrogen, 2 mM MgCl2, 100 mM KCl and 5 % glycerol were added. 
 
Lysis by sonication 
For the lysis via sonication cell were harvested from the culture plate and washed with PBS. After 
pelleting of the cells (500 x g, 5 min, 4 °C) cells were resuspended in an appropriate volume of 
PBS supplemented with 1 mM AEBSF, 1 mM DTT and 1 mM NaF. Cells were lysed via 
sonication (Pulse 50, Intensity 7, 30 strokes) lysate was clarified via centrifugation (20800 x g, 15 
min, 4 °C).  
 
4.3 GST-pulldown assay 
For each pulldown sample, 40 µL of Glutathione 4 Fast Flow Sepharose (GE Healthcare) were 
washed with PBS twice. Recombinant GST-bait proteins (300 µg each) were added to the beads 
and incubated for 1 h at 4 °C. Then the supernatant was removed and beads were washed three 
times with PBS and 1 mL of SF21 lysate containing the respective Dicer protein. For the 
dsRBD3-only constructs, a threefold more concentrated lysate was applied to the coupled beads. 
After incubation for 3 h at 4°C while rotating, the supernatant was removed and the beads were 
washed once with PBS supplemented with 1 mM DTT and 1 mM AEBSF and then three times 
with a wash buffer containing 25 mM Tris, pH 7.5, 350 mM NaCl, 1 mM MgCl2, 1 mM DTT, 1 
mM AEBSF and 0.1 % NP40. Samples, used for MA-analysis, additionally contained 1 mM NaF 
as an inhibitor for phosphatases. The elution was performed with 40 µL elution buffer (GST B) 
for 30 min at RT and the eluate was supplemented with Laemmli sample buffer (5 fold 
concentrated). Pulldown samples for MS were directly eluted with 2x Laemmli buffer at 95 °C for 
10 min. Proteins were separated on an 8 % SDS-poly-acrylamide gel and Western blotting was 
performed as described below. As a loading control, 1% of each elution sample was separated on 
a 10% SDS–polyacrylamide gel and Coomassie-stained. 
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4.4 Dicer rescue assay 
For the dicer rescue assay, 800,000 Dicer
-/-
 MEF-cells were seeded to a 6-well plate and grown 
overnight. Then cells were transfected with Lipofectamine LTX, using 0.5 µg of VP5-Loqs and 2 
µg of VP5-dmDcr-1 as described in Methods Chapter 5.1. For the Loqs-L429R mutant, 1 µg of 
plasmid was transfected due to a lower expression-level. Cells were transfected in a 6 well plate 
and incubated for 6 h. Then cells were split to a 10 cm cell culture dish and after incubation for 2 
d, cells were harvested. Sixty-five percent of the cells were used for Western blot analysis and 
35% for RNA extraction. Cells for Western samples were resuspended in 80 µL PBS 
supplemented 20 µL 5x Laemmli buffer and lysed via sonication. Western blotting was performed 
as described below. For Northern blotting analysis, 10 µg of extracted total RNA from the rescued 
Dicer
-/-
 cells was used and 0.5 µg of the Dicer
+/+
 total RNA as a wt control for let-7a. 
 
4.5 Co-immunoprecipitation assay 
HEK293-T cells co-transfected with myc-tagged and FLAG/ HA-tagged constructs. Then cells 
were harvested and lysed for co-immunoprecipitation (co-IP) 48 h after transfection. For each co-
IP, transfected cells from one 15-cm plate were lysed in 1 mL IP-lysis buffer. To exclude an 
indirect RNA-mediated interaction, 100 µg/mL RNase A (Thermo Scientific) into relevant 
samples. Lysates were cleared by centrifugation after an incubation time of 15 min at 4°C 
(additionally 10 min at room temperature upon RNase A treatment). As input samples 1.6 % of 
the cleared lysates were taken. The residual input was applied to 50 µL Protein-A-Sepharose 
beads (GE Healthcare), pre-coupled with 2.5 µg anti-c-myc antibody (Sigma Aldrich). The Co-IP 
was performed for 3 h at 4°C. As control, rabbit IgG (Santa Cruz) was used. After incubation, 
beads were washed five times with IP wash buffer and once with PBS buffer. The elution of the 
precipitated protein complexes was performed by adding 50 µL SDS-PAGE loading buffer to the 
beads followed by heating to 95°C for 5 min. For analysis via Western blot, 40% of each IP-
eluate was taken for PAGE. 
 
4.6 SDS PAGE and Western Blot 
Samples for SDS-PAGE were mixed with Laemmli Buffer and incubated at 95°C for 5 min. 
Proteins were separated on SDS-polyacrylamide gels with different percentages (8, 10 and 15%) 
with constant current (50 mA for normal gel, 30 mA for mini-gel) until the running front reached 
the bottom of the gel. 
For western blotting, proteins were transferred to a Hybond ECL (GE Healthcare) nitrocellulose 
membrane via semidry- (for low MW proteins) or wet-blotting (for high MW proteins) 
respectively (2 mA/cm
2
 of membrane area, 1 min per 1kDa from protein of interest). After the 
transfer, the membrane was blocked for 1 h using 5 % milk powder in TBS-T while shaking. For 
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Immuno-detection primary antibody was diluted in TBS-T (5 % milk, 0.02 % NaN3) and 
incubated for 3 hours at RT or o/n at 4 °C. After washing three times with TBS-T, the secondary 
antibody (5 % milk, 0.02 % NaN3) was applied for 1 h. After washing (3xTBS-T) the membrane 
was scanned with the Odyssey IR detection system (Licor). Antibodies used for western blot 
analysis were listed in Table 4.7. 
 
4.7 Sucrose gradients 
Sucrose gradients for separation of different proteins and protein complexes by centrifugation 
were generated using 15 % to 55 % sucrose in gradient buffer in 14x89 mm polyallomer 
centrifuge tubes (Beckman, Palo Alto, USA) using the Gradient Master 107ip system (Biocomp, 
New Brunswick, Canada) and cooled to 4 °C. Then, lysate that was clarified from cell debris by 
centrifugation at 17000 g for 10 minutes at 4 °C was applied on top of the gradient. Lysates were 
separated by centrifugation at 30000 rpm in a SW41 rotor for 18 h at 4 °C in an Optima L-90K 
ultracentrifuge (Beckman Coulter GmbH). A “low” acceleration rate and no brakes were used 
within the centrifuge-settings. 500 μl fractions were taken manually and used for western blotting 
in order to check for protein distribution. 
 
5. Cell culture of eukaryotic cells 
5.1 Cell culture of mammalian cells 
HEK 293T and MEF (Dcr
+/+
 and Dcr
-/-) cells were cultured in Dulbecco’s modified Eagle’s 
medium (DMEM, Sigma-Aldrich) supplemented with 10% FBS (Sigma-Aldrich) and 1% 
penicillin-streptomycin (Sigma-Aldrich) under standard conditions (37°C, 5% CO2). After 
transfection, the antibiotics were omitted from the media to reduce extracellular stress for the 
cells. The following transfection strategies were used in this thesis. 
 
Transfection with calcium phosphate 
The calcium phosphate method was used for “easy to transfect” cells lines like HEK293 cells. The 
transfection was performed when cells were ~30% confluent. Per 15 cm plate, 5-20 µg of a 
eukaryotic expression vector encoding for the gene of interest were used and mixed with 123 µL 
of 2 M CaCl2 solution and filled up to 1 mL with ddH2O. This solution was further applied drop 
by drop and while shaking to a second tube containing 1 mL of 2 x HEPES buffered saline (HBS) 
and incubated at RT for 10 minutes. After incubation, the solution was slowly added to the cells 
and transient expression was performed for 48 h. 
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Transfection with Lipofectamine LTX 
Lipofectamine LTX (Thermo) was used for “hard to transfect” cells lines like MEF cells. All 
transfections were performed in 6-well culture plates. For a reverse transfection, 0.8 x 10
6
 MEF 
Dcr
-/-
 cells were used and cultivated overnight. For the forward transfection, which worked better 
for the MEF Dcr
-/-
 cells, 1.6 x 10
6
 cells were used and transfected the same day. For the 
transfections a total amount of 3 µg of a eukaryotic expression vector were applied to 500 µL of 
Opti-MEM
®
 I Reduced Serum Media (Thermo Scientific) and supplemented with 2.5 µL of 
PLUS™ Reagent. After gentle mixing, 8 µL of Lipofectamine were added to the reaction tube 
and briefly vortexed. The reaction mix was incubated for 15 min at RT and added drop by drop to 
the cells which were supplied with 2 mL of antibiotic free medium. The transfection was 
performed for 6-8 h and cells were split to 10 cm culture dishes afterwards. 
 
5.2 Cell culture of insect cells 
Drosophila Dmel-2 cells were cultured in Express Five® SFM medium (Thermo Scientific) 
supplemented with GlutaMAX™ (Thermo Scientific) and Sf21 cells were cultured in Sf-900TM II 
SFM medium (Thermo Scientific). All insect cells were grown in a tempered cell culture room at 
27°C while shaking. 
 
Bac-to-Bac® Baculovirus Expression System (Invitrogen) 
Expression of proteins in Sf21 cells with a recombinant baculovirus was performed according to 
supplier’s protocols. 
 
6. Protein-purification 
All purification steps of recombinant proteins were performed at 4 °C. Protein concentration was 
determined spectrophotometrically at 280 nm. GST-tagged proteins were expressed from pGEX-
4T-1, His6-Thioredoxin tagged proteins from pET32a and His tagged proteins from pColdI.  
 
6.1 Expression- and solubility-screens 
For the expression of a recombinant protein in E. coli, the protein coding sequence (CDS) was 
inserted into the expression vectors pET32a, pColdI and pGEX4T-1. After transformation, clones 
were isolated from an agarose plate and cultivated overnight at 37°C. From that culture 300 mL of 
LB-medium supplemented with selection antibiotics were inoculated and grown to an OD600 of 
0.6. After induction of protein expression with 1mM IPTG, the culture was split to three 100 mL 
cultures which were grown at 18, 25 and 37°C respectively. After 2, 4 and 6h (37°C) or 4, 6 and 
16 h (18 and 25°C) 1 mL sample was taken and centrifuged for 10 min (5000x g, 4°C). Then the 
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LB-Medium was removed and the bacterial pellet was re-suspended in 300 µL HisA (His-tagged 
proteins) or GSTA buffer (GST-tagged proteins) and lysed via sonication (Pulse 50, intensity 3, 
45 pulses, RT) and samples were taken before (total) and after (soluble) centrifugation (17000x g, 
10 min, 4°C) and supplemented with 1 x Laemmli sample buffer. Expression and solubility were 
validated via SDS-Gel electrophoresis where 20 µL from each sample were loaded and coomassie 
stained after running. 
 
6.2 Preparation of bacterial lysates 
For the generation of lysates for purification, the best conditions from the initial solubility and 
expression screens were used. Therefore one colony from a transformed expression-strain 
containing the respective expression vector was selected and grown over night in 5 mL LB-
medium at 37°C. Then an expression culture containing LB-medium with all selection antibiotics 
was inoculated 1:2000 and grown to an OD600 of 0.6 at 37°C. After the induction with 1mM 
IPTG, expression was performed under the optimal expression-time and –temperature. Bacteria 
were harvested by centrifugation (5000x g, 10 min, 4°C) and resuspended in 20 mL lysis buffer, 
containing 1 mM AEBSF and 10 U/mL benzonase (Novagen), per 1 L LB-culture. To prevent 
oxidation of thiol groups within the recombinant protein, 1 mM DTT was added for all GST-
tagged proteins or 5 mM of -mercaptoethanol for His-tagged proteins. Cells were lysed via 
sonication (Pulse 50, Intensity 7, 3x3 min on ice) and cell debris were removed with a 
centrifugation step (40000xg, 40min, 4°C) and the supernatant was filtrated (Pall Life Sciences, 
Acrodisc 25mm, 0.45 µm membrane) prior loading. 
 
6.3 Purification of His-tagged Loqs-constructs 
Crystallization-construct pET32a-Gly2-dsRBD3 
For the generation of high amounts of the recombinant protein, 4 L of an overnight LB-culture 
were used and after lysate generation, the supernatant was loaded onto the IMAC II column 
(Material Chapter 1.9) charged with Ni
2+
. After washing with buffer His-A, elution was conducted 
with His-B buffer and His6-trx fusion protein-containing fractions were pooled. The tag was 
cleaved off during dialysis in presence of a His-tagged TEV protease (1 µg TEV per 100 µg of 
protein, dialysis overnight at 4°C against His-A buffer). The tag and the protease were removed 
by a second IMAC II column (Material Chapter 1.9) and the flowthrough was concentrated by 
ammonium sulfate precipitation (50% w/v), resuspended in SEC 1 buffer and loaded onto a S75 
26/600 column (Material Chapter 1.9). Methylation of the protein required for crystallization was 
performed according to (Walter et al., 2006) and excess of methylation agent was removed with a 
second S75 26/600 column equilibrated with buffer SEC 2. After desalting to SEC 3 buffer with 
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HiPrep Desalt 26/60, the final concentration of the methylated protein was adjusted to 15 mg/mL 
and used for protein crystallization (Results Chapter 2.3). 
 
6.4 Purification of GST-tagged Loqs-constructs 
GST-Tagged proteins were loaded onto a 5 mL GSTrap column (GE), which was equilibrated 
with GST-A buffer prior usage. Unbound proteins were removed using 5 column volumes (cv) 
GST-A buffer supplemented with 1M NaCl. After 1 cv of GST-A, bound protein was eluted with 
GST-B buffer. GST fusion protein containing fractions were pooled and applied to a Hiprep 26/10 
desalting column and buffer was exchanged to GST-A. 
Proteins, which were used for the GST pulldown assay, were supplemented with 5 % glycerol and 
1mM DTT, frozen in liquid nitrogen and stored at -80 °C. 
For other applications, where the tag was not needed, GST-proteins were digested overnight at 
4°C, using a GST-tagged TEV protease. The protease and the GST-tag were removed by a second 
5 mL GSTrap column. The flowthrough was pooled and concentrated. Purified proteins were 
supplemented with 5 % glycerol and 1mM DTT, frozen in liquid nitrogen and stored at -80 °C. 
 
6.5 Purification of Brat-constructs 
Brat-constructs were fused to a His6-ubiquitin-tag using the pHUE vector system as described 
previously (Baker et al., 2005; Catanzariti et al., 2004). The Drosophila Brat-NHL domain was 
expressed in Escherichia coli (E.coli) BL21(DE3). A lysate containing the Brat-NHL domain was 
loaded on the IMAC I (Material Chapter 1.9) column and eluted by buffer HisB. His6-ubiquitin 
fusion protein-containing fractions were pooled, and the His6-ubiquitin moiety was cleaved off by 
incubation with the Usp2cc enzyme overnight at 4°C in buffer HisB containing 1 mM DTT. The 
protein solution was subsequently applied to a S75 26/60 column (Material Chapter 1.9) 
equilibrated with SEB2. Fractions containing highly pure protein were pooled, supplemented with 
5 % glycerol and 1mM DTT, frozen in liquid nitrogen and stored at -80 °C. 
 
7. X-ray crystallography 
7.1 Crystallization 
All crystallization trials were performed using the vapor diffusion method. Thereby a droplet with 
the purified protein is mixed with reservoir solution containing the precipitant and equilibrated 
against a higher volume of the reservoir in a sealed reaction chamber. Upon equilibration of the 
protein solution and the reservoir solution, the protein concentration increases and leads to a 
destabilization of the solution that ideally results in crystal formation. 
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Initial crystals were screened using the “sitting drop” method. For this purpose, commercially 
available crystal screens (Table 4.11) were used, that were generated on statistical analysis of 
conditions which promoted crystal growth. 70 µl of each reservoir solution from a crystal screen 
were submitted to a 96 well plate (Hampton Research) and 1 µl of the respective reservoir 
solution was mixed with 1 µl of the protein solution on a pedestal on top of the reservoir solution. 
Then the 96 well plate was sealed with Crystal Clear Tape and stored at 4, 20 and 37°C 
respectively. 
 
Table 4.11: List of different crystal screens. 
Crystal screen Distributor 
JBScreen classic 1-10 Jena Bioscience (Jena, Germany) 
JBScreen basic 1-4 Jena Bioscience (Jena, Germany) 
JBScreen Pentaerythritol Jena Bioscience (Jena, Germany) 
JBScreen Wizard Jena Bioscience (Jena, Germany) 
Crystal screen 1+2 Hampton Research (Aliso Viejo, USA) 
Crystal Screen Cryo 1+2 Hampton Research (Aliso Viejo, USA) 
Natrix 1+2 Hampton Research (Aliso Viejo, USA) 
 
 
Cryo protection and preparation of protein crystals 
For the storage and measurements of protein crystals, a suitable cryoprotectant needs to be 
identified. A cryoprotectant, when added to the crystal and crystallization reagent, is able to 
generate a glass like surrounding around the crystal upon cooling to cryogenic temperature. This 
surrounding prevents the formation of ice rings and cryo-damage to the crystal. As 
cryoprotectants, glycerol, Methylpentanediol (MPD), low-molecular-weight polyethylene glycols 
(PEG), alcohols and sugars can be used. For all crystallographic experiments from this thesis, 
glycerol worked best as cryoprotectant. 
After the identification of a suitable cryoprotectant, the crystals were transferred from the 
respective drop using cryo-loops (Hampton Research) and briefly soaked in cryo-solution, 
containing the mother liquor with the cryoprotectant. After incubation in cryo-solution, crystals 
were loaded into a cryo-loop and flash frozen in liquid nitrogen. Until the measurement at the 
synchrotron, crystals were stored in a Dewar flask, containing liquid nitrogen. 
 
7.2 Incorporation of SeMet into proteins 
For the preparation of SeMet-derivatized proteins, E.coli BL21(DE3) cells were transformed with 
a respective expression vector and grown on LB plates, containing the respective antibiotic(s), at 
37°C overnight. A single colony from the plate was used for the inoculation of 100 ml LB 
medium (with antibiotics) and grown overnight at 37°C. After incubation, cells were harvested 
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(3000xg, 10 min and 4°C) and resuspended in 100 ml M9 medium (with antibiotics) (Material 
chapter 1.7), which was used for the inoculation (~1:50 v/v) of 2 L M9 medium (with antibiotics). 
The culture was grown to an OD600 of 0.6 and supplemented with 125 mg/l L-lysine (in H2O), 100 
mg/l L-phenylalanine (in 0.5 M HCl), 100 mg/l L-threonine (in 0.1 M HCl), 50 mg/l L-isoleucine 
(in 0.1 M HCl), 50 mg/l L-leucine (in 0.5 M HCl), 50 mg/l L-valine (in 0.5 M HCl) and 60 mg/l 
L-SeMet (in 0.1 M HCl) (modified from Van Duyne et al., 1993). The added HCl was neutralized 
by the addition of an equal amount on 2 M NaOH solution and cells were incubated for another 
15 min at 37°C. Protein expression was induce with 1 mM IPTG and cells were grown overnight 
at 18°C. To prevent oxidation of the SeMet side chain, reducing agents, 10 mM β-
mercaptoethanol for His6-containing proteins or 1 mM DTT for all other proteins, were added to 
every chromatographic step upon purification. 
 
7.3 Data-collection and -processing 
All data from the crystals were collected at BESSY (beamline BL14.2) in Berlin. Therefore, 
crystals were rotated in 0.5 ° steps and a picture after each rotation was taken. The length of 
exposure for each image was ~ 5 sec. For the measurement of native protein crystals, a 
wavelength of ca. 1 Å (ca. 12.4 keV) was used. For the measurements of MAD datasets, a 
fluorescence scan was performed to obtain suitable wavelengths for the peak-, inflection- and 
high remote-datasets (See Chapter 6.4.2). 
All data from this thesis were processed using the program XDS (Kabsch, 2010) together with the 
XDS-integrated programs XSCALE and XDSCONV, which leads to scaling and reduction of the 
data. The processing results in the cell parameters of the asymmetric unit cell (ASU). Additionally 
the Wilson-B-factor (temperature factor) is obtained using the program XSCALE. 
After the identification of the cell parameters using XDS, the Matthews coefficient can be 
calculated using MATTHEWS_COEFF (ccp4-suite (Collaborative Computational Project, 
1994)), resulting in the solvent content and the number of protomers within the ASU. 
 
7.4 Phasing 
7.4.1 Molecular replacement 
Molecular replacement (MR) can be used for the determination of the phase problem, when the 
structure of the crystallized protein has been solved or if a structure of a homologous protein 
exists. Thereby the known structure-model of the crystallized protein can be used as a search 
model. Through three dimensional rotation- and translation-operations, the search model is 
positioned within the electron density of the ASU, obtained for the newly crystallized protein. For 
this thesis, the program PHASER (McCoy, 2007) was used, which is based on the maximum 
likelihood method. Thereby, Z-scores above 6.0 can be regarded as reliable solutions. 
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7.4.2 Experimental phasing 
In cases where MR does not provide a solution, the phase problem has to be solved 
experimentally. This can be achieved by the incorporation of an electron rich heavy metal atom 
either by soaking protein crystals in a solution containing the heavy metal atom, or, as it is the 
case for this thesis, by incorporation of a heavy metal atom-derivatized protein, in this case 
selenium (SeMet). The anomalous diffraction from the heavy metal atoms, obtained by three 
different wavelengths (peak-, inflection- and high remote) is needed for the determination of the 
atomic positions of the heavy metal atoms within the ASU. For the calculation the and refinement 
of the heavy metal atom-positions, the programs SHARP and autoSHARP (Vonrhein et al., 2007) 
were used, respectively. 
 
7.5 Model building 
All model building was performed manually using the program COOT (Emsley et al., 2010). For 
refinement of the model and to reduce model bias, the program PHENIX.refine (Afonine et al., 
2012) was used. Thereby, non-crystallographic symmetry (NCS) restraints and simulated 
annealing were used. At the final stages of the Loqs dsRBD3, TLS-refinement was carried out. 
The model of the bound consensus front RNA at the Brat NHL-domain was improved by 
rebuilding using ERRASER (Chou et al., 2012). 
 
8. Fluorescence spectroscopic methods 
8.1 Fluorescence cross-correlation spectroscopy FCCS 
All FCCS measurements were carried out in the laboratory of Dr. Stefan Hannus and Dr. Frank 
Becker (Intana Bioscience, Munich). As an instrumental setup, a ConfoCor2 FCS unit connected 
to an Axiovert 100M stand equipped with a C-Apochromat NA 1.2 40-fold water immersion lens 
(Carl Zeiss, Jena, Germany). Excitation of fluorescing compounds was performed with a 488nm 
laser line of an argon-ion laser and with a 633 helium-neon laser respectively. Emitted photons 
were directed over an HFT 488/633 and NFT 635/IR beam splitter and detected after passing a BP 
505-550 filter or a LP 650 filter by an avalanche photo diode. Samples were distributed to a 384-
well glass bottom assay plate (SWISSCI AG, Neuheim, Switzerland) and acquisition was 
performed 5-8 times for 8-10 sec per data point. 
For titration experiments, the GFP labeled compound was diluted either with empty S100 lysate 
containing no GFP labeled proteins or in case of recombinant proteins with PBS containing 0.2 % 
BSA to prevent unspecific binding to the surfaces of the 384-well plate. The protein solution was 
dispensed as 20 µl aliquots and an Alexa 647 (Loqs-3) or Cy5 (siRNA) labeled component was 
added with the highest concentration to the first well. From that, serial dilutions from well to well 
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were carried out to generate a titration curve with decreasing concentrations. After incubation at 
RT for different time points, the FCCS measurements were done and fluorescence fluctuations 
were auto- and cross-correlated. A fitting-algorithm was employed accounting for two diffusing 
species for one fluorescently labeled compound and one diffusing species for the other one which 
was determined before by measuring the diffusion constant of the single compound in solution. 
The Kd value was calculated on the basis of free and bound fractions of both labelled interactors 
and the concentration of doubly labelled complexes. 
For the competition assays, the Kd value of one labeled reference component was determined as 
described above and a dual labeled complex was formed and distributed as a 20 µL aliquot to 
several wells of the 384 well plate where the competition assay is performed. A serial dilution for 
the unlabeled competitor was prepared and added to each well. After incubation at RT for 10 min, 
the FCCS measurements were performed and IC50 values were calculated by plotting of the 
concentration from the dual labeled complex against the concentration of the competitor. From 
the resulting IC50 values, the Ki values could be obtained by application of the Cheng Prusoff 
equation. 
 
8.2 Single-molecule co-IP experiments 
Single-molecule co-IP assays were carried out in a custom-built flow chambers based on fused 
silica slides, passivated with polyethylene glycol (PEG). Flow chambers were prepared and 
assembled as described previously (Gietl et al., 2014). For fluorescence measurements on single 
immobilized proteins, the flow chamber was filled with 0.1 mg/mL NeutrAvidin (Thermo 
Scientific) and incubated for 5 min and washed with PBS. Afterwards, the chamber was incubated 
with 15 nM biotinylated anti-GFP-antibody (Abcam) in PBS and washed again with PBS 
supplemented with 0.5 mg/mL BSA (Roche). In order to test for unspecific binding of Loqs-
3AF647, the chamber was incubated with Loqs-3
AF647
 in increasing concentrations (50 to 200 pM) 
for 5 min, washed with PBS/BSA and incubated for 5 min with oxygen scavenging buffer (Rasnik 
et al., 2006). In order to measure the oligomerization state of Loqs-3
AF647
 in complex with GFP-
dmDcr1, the chamber was incubated with preformed 50-200 pM GFP-dmDicer-1/Loqs-3
AF647
 
complexes in PBS/BSA for 5 min, washed with PBS/BSA, and incubated for additional 5 min 
with oxygen scavenging buffer. Prior incubation of the chamber, the GFP-dmDcr1/Loqs-3
AF647
 
complex was pre-formed by incubating GFP-dmDcr1 (final concentration 1.1 µM) with Loqs-
3AF647
 (final concentration 1.6 µM) for 2 h on ice before dilution with PBS/BSA. This procedure 
yielded a completely saturated GFP-dmDcr1 surface due to low-affinity interaction between 
Dicer-Loqs and immobilized Loqs-3
AF647
 density of approximately one molecule per 4 µm
2
. 
Afterwards, the flow chamber was flushed and incubated for 5 min with 1× PBS/BSA containing 
the glucose oxidase/catalase oxygen scavenging system. As a control, free AF647 dye (200pM) 
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was flushed over an antibody-GFP-dmDcr-1 surface and incubated for 5 min followed by oxygen 
removal. Single-molecule fluorescence measurements were performed on a homebuilt prism-type 
total internal reflection (TIRF) setup based on a Leica DMi8 inverse research microscope. 
Fluorophores were exited with a 488 nm solid-state laser (CoherentOBIS) with a power of 10 mW 
and 637 nm diode laser (Coherent OBIS, clean-up filter ZET 635/10, AHF Göttingen) with a 
power of 50 mW. The fluorescence was collected by a Leica HC PL Apo 63x N.A. 1.20 water 
immersion objective and split by wavelength with a dichroic mirror (HC BS 560, AHF Göttingen) 
into two detection channels that were further filtered with a 635-nm long-pass filter (LP Edge 
Basic, AHF Göttingen) in the red detection channel. Both detection channels were recorded by 
one EMCCD camera (Andor IX on Ultra 897, EM-gain 20, frame rate 10 Hz, 200–300 frames) in 
a dual-view configuration (TripleSplit, Cairn Research). The videos were analyzed employing the 
iSMS software (Preus et al., 2015). Molecule spots were detected using a threshold of 200 for 
Alexa647 spots. Single molecule data were acquired as the average number of Loqs-3
AF647
 
fluorescent molecules per imaging area  6800 μm2) as shown in the histograms. The error bars 
represent standard deviation of the mean values from 11 imaging areas. The number of 
fluorescence photo bleaching steps of Alexa 647-labeled Loquacious was determined for detected 
spots with a fluorescence intensity of at least 600 (arbitrary units) for single-step bleaching and 
1200 for double-step bleaching. The number of molecules showing one or two bleaching steps 
was accumulated from four independent experiments to obtain the stoichiometry of the complex. 
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